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Abstract 
Neglected Tropical Diseases (NTDs) belong to the group of infectious diseases. They 
are endemic in most parts of the world, affecting more than one billion people 
worldwide, especially low income populations from developing regions. The infection 
to humans is characterized by a chronic and prolonged asymptomatic incubation period 
without noticeable symptoms of the disease, which delays the prescription of a suitable 
and timely medical treatment. The prevention, diagnosis and control of these diseases 
still remain an unsolved medical challenge.  
This thesis is aimed to develop a non-invasive, safe and patient-friendly methodology 
for rapid diagnosis of NTDs. The thesis work was founded on disease diagnosis via 
exhaled breath samples analyses, which are easy to obtain and present no discomfort or 
risk for patients’ health. The thesis work was focused on three different types of 
neglected tropical diseases (Dengue, Echinococcosis and Leishmaniasis) caused by 
three different pathogens (viral, helminthic and protozoan infections, respectively). One 
of the challenges was to introduce and implement a simple and user friendly procedure 
for breath sampling, which was optimized in this study. For analyzing the breath 
samples, at first standard analytical techniques were employed for the identification of 
breath volatile biomarkers of these diseases. In the second part of the thesis work, an 
array of cross reactive chemical gas sensors based on ultrapure metal nanoparticles – 
ligand nanoassemblies comprising diverse functional organic ligands was designed, 
fabricated and employed for the analysis of the breath print profiles of the diseases 
under study. The responses of the chemical gas sensors to the breath samples were used 
to build predictive pattern recognition models for the diagnoses of these diseases. The 
results obtained revealed that exhaled breath analysis with cross reactive gas sensors 
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arrays based on ultrapure metal nanoparticles-ligand nanoassemblies holds significant 
potential as a cost-effective, simple and non-invasive diagnostic test for NTDs.   
The thesis is organized as follows:  
Chapter 1 presents a brief introduction to the neglected tropical diseases, with focus on 
the three diseases that I studied in my PhD thesis: Dengue, Leishmaniasis and 
Echinococcosis. 
Chapter 2 presents the state of the art in breath analysis, with emphasis on analytical 
methods and chemical gas sensors.  
Chapter 3 explains the experimental methods that I employed for the fabrication, 
deposition and characterization of chemical gas sensors based on ligand capped 
ultrapure metal nanoparticles.  
Chapter 4 presents the methods for breath sampling and study population statistics that 
employed in the breath analysis of volunteers. 
Chapter 5 presents the analytical studies and breath biomarkers identification. A 
discussion on their possible origin is also provided.  
Chapter 6 presents the sensing measurements and the results of the sensing tests.  
Chapter 7 summarizes the conclusions of my study and presents future perspective. 
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Resumen 
Las enfermedades tropicales desatendidas (ETD) pertenecen al grupo de enfermedades 
infecciosas. Son endémicas en la mayor parte del mundo y afectan a más de mil 
millones de personas, especialmente a las poblaciones de bajos ingresos de las regiones 
en desarrollo. La infección en humanos se caracteriza por un período de incubación 
asintomática crónica y prolongada sin síntomas notables de la enfermedad, lo que 
retrasa la prescripción de un tratamiento médico adecuado y oportuno. La prevención, el 
diagnóstico y el control de estas enfermedades siguen siendo un desafío médico no 
resuelto. 
Esta tesis ha tenido como objetivo desarrollar una metodología no invasiva, segura y 
amigable para el paciente para un diagnóstico rápido de las ETD. El enfoque de mi tesis 
se basó en el diagnóstico de la enfermedad a través del análisis de muestras de aliento 
exhalado, que son fáciles de obtener y no presentan molestias ni riesgos para la salud de 
los pacientes. El trabajo de mi tesis se centró en tres tipos diferentes de enfermedades 
tropicales desatendidas (dengue, equinococosis y leishmaniasis) causadas por tres 
patógenos diferentes (infecciones virales, helmínticas y protozoarias, respectivamente). 
Uno de los desafíos fue introducir e implementar un procedimiento de muestreo de 
muestras de aliento simple y fácil de usar, que se optimizó durante mi tesis. Para 
analizar las muestras de aliento, primero se emplearon técnicas analíticas estándar para 
la identificación de los biomarcadores volátiles de estas enfermedades. En la segunda 
parte del trabajo de mi tesis se diseñó y fabricó una matriz de sensores de gases 
químicos con sensibilidades cruzadas basados en nanopartículas de metal ultrapuro 
funcionalizadas con diversos compuestos orgánicos, que se empleó para el análisis de 
los patrones de las enfermedades estudiadas en las muestras de aliento. Las respuestas 
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de los sensores químicos de gases expuestos a las muestras de aliento se usaron para 
construir modelos de reconocimiento de patrones para el diagnóstico de estas 
enfermedades. Los resultados obtenidos han revelado que el análisis del aliento 
exhalado con una matriz de sensores de gases basados en nanoensamblajes de 
nanopartículas de metal ultrapuro tiene un gran potencial como prueba de diagnóstico 
fiable, simple y no invasiva para las ETD. 
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Resum 
Les malalties tropicals desateses (ETD) pertanyen al grup de malalties infeccioses. Són 
endèmiques en la major part del món i afecten més de mil milions de persones, 
especialment a les poblacions de baixos ingressos de les regions en desenvolupament. 
La infecció en humans es caracteritza per un període d'incubació asimptomàtica crònica 
i perllongada sense símptomes notables de la malaltia, el que retarda la prescripció d'un 
tractament mèdic adequat i oportú. La prevenció, el diagnòstic i el control d'aquestes 
malalties segueixen sent un desafiament mèdic no resolt. 
Aquesta tesi ha tingut com a objectiu desenvolupar una metodologia no invasiva, segura 
i amigable per al pacient per a un diagnòstic ràpid de les ETD. L'enfocament de la meva 
tesi es va basar en el diagnòstic de la malaltia a través de l'anàlisi de mostres d'alè 
exhalat, que són fàcils d'obtenir i no presenten molèsties ni riscos per a la salut dels 
pacients. El treball de la meva tesi es va centrar en tres tipus diferents de malalties 
tropicals desateses (dengue, equinococcosi i leishmaniosi) causades per tres patògens 
diferents (infeccions virals, helmíntiques i protozoàries, respectivament). Un dels reptes 
va ser introduir i implementar un procediment de mostreig d'alè simple i fàcil d'usar, 
que es va optimitzar durant la meva tesi. Per analitzar les mostres d'alè, primer es van 
emprar tècniques analítiques estàndard per a la identificació dels biomarcadors volàtils 
d'aquestes malalties. A la segona part del treball de la meva tesi es va dissenyar i va 
fabricar una matriu de sensors de gasos químics amb sensibilitats creuades basats en 
nanopartícules de metall ultrapur funcionalitzades amb diversos compostos orgànics, 
que es va emprar per a l'anàlisi dels patrons de les malalties estudiades en les mostres 
d'alè. Les respostes dels sensors químics de gasos exposats a les mostres d'alè es van 
usar per a construir models de reconeixement de patrons per al diagnòstic d'aquestes 
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malalties. Els resultats obtinguts han revelat que l'anàlisi de l'alè exhalat amb una matriu 
de sensors de gasos basats en nanoensamblajes de nanopartícules de metall ultrapur té 
un gran potencial com a prova de diagnòstic fiable, simple i no invasiva per les ETD. 
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2 Neglected Tropical Diseases 
 
Chapter 1 
Included in this chapter are brief introduction to Neglected Tropical Diseases 
(NTDs), and the infection, diagnosis and global distribution of the pathogenic 
diseases studied in my thesis. 
1.1. Background 
Nowadays, the world contends with tremendous global challenges in many parts of 
the globe, associated to global warming, frequent human and natural disasters, global 
immigration, population growth, wars and violence. Such diverse and enormous 
challenges are provoking huge environmental and economic distortions, which affect 
the life and well-being of the humans, and increase the mortality.  
The World Health Organization (WHO) classifies the causes of death in three major 
groups [1]: 
 Group I – related to communicable diseases, maternal, perinatal and nutritional 
causes. They are very common in poorer populations;  
 Group II – associated to non-communicable diseases. Account for about 60% of 
deaths, and are highly dominant in high-income countries; 
 Group III – injuries, accidents and others, which contribute to a large amount of 
deaths and disabilities.  
Notably, as the world is in continuous swing, the global health problem is alarmingly 
increasing, and affects millions of people in every corner of the world [2]. Based on the 
data retrieved from the global diseases burden index reported in 2016, about 740 deaths 
per 100,000 people are caused by 21 categorical diseases (Figure 1.1) [3].  
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Figure 1.1: Global death caused by 21 categorical diseases, adapted from [3]. 
 
Out of 56.4 million deaths in 2015, more than 54% were caused by top 10 diseases, 
among which Ischemic heart disease and stroke are the world’s biggest killers of non-
communicable diseases [1].  
In low income countries, more than 50% of deaths are due to communicable diseases 
[1], among which infectious diseases are the main cause of death as a result of 
infectious pathogens and outbreaks. The Disability Adjusted Life Years (DALYs) 
indicator, which represents the number of years loss from early deaths and years lost 
from disability due to illness per 1000 people, revealed that more than 31% of total 
DALYs were caused by communicable diseases in 2015 [1]. Even though HIV/AIDS, 
Malaria and Tuberculosis are among the major global killers among communicable 
diseases, infectious diseases (including NTDs) have also a major contribution to chronic 
disability, and thwart the economic development in the poorest countries.  
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1.2. Neglected Tropical Diseases 
Tropical diseases encompass all diseases that occur solely, or principally, in the tropics, 
and the term is often taken to infectious diseases that thrive in hot, humid conditions. 
Within the tropical diseases, WHO defined a group of 20 neglected tropical diseases: 
Buruli ulcer; Chagas disease; Dengue and Chikungunya; Dracunculiasis (guinea-worm 
disease); Echinococcosis; Foodborne trematodiases; Human African trypanosomiasis 
(sleeping sickness); Leishmaniasis; Leprosy; Lymphatic filariasis; Mycetoma, 
chromoblastomycosis and other deep mycoses; Onchocerciasis (river blindness); 
Rabies; Scabies and other ectoparasites; Schistosomiasis; Soil-transmitted 
helminthiases; Snakebite envenoming; Taeniasis/Cysticercosis; Trachoma; and Yaws 
(Endemic treponematoses) [4,5]. These diseases are categorized in function of the 
pathogen: bacteria, virus, helminths, and protozoa (Figure 1.2). 
 
Figure: 1.2: Neglected Tropical Diseases caused by a variety of infectious pathogens 
including bacteria, virus, helminths, and protozoa. 
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In terms of geographical distribution, the NTDs are most prevalent in Africa, South 
America, and most parts of Asia (Figure 1.3), where vector transmission and 
distribution match with high population density and marginalized societies. 
 
Figure 1.3: The global prevalence and distribution of Neglected Tropical Diseases by country. 
The burden of NTDs in different countries is expressed as the number of NTDs prevalent in 
the country. Reproduced from [4].  
 
NTDs are characterized by high morbidity and low mortality. One billion people are 
currently infected by one or several NTDs, and more than half of world’s population is 
at risk [4]. Annually, NTDs cause more than half a million deaths. Transmission to 
humans may be either direct, or indirect through vectors such as mosquitos, animal 
reservoirs, or other zoonotic agents found in water, food, and soil. Some vectors are 
likely to better reproduce and transmit the disease under certain environmental 
conditions, for example at high temperature and humidity, or near water reservoirs. 
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The NTDs cause massive suffering, life-long disability and death, stigma, mental 
distress and discrimination, as well as severe impairment and years of silent infection. 
They are mainly concentrated in remote rural areas and shantytowns, and their 
distribution is subject to socioeconomic factors such as inaccessibility to health 
facilities, consume of unpurified water, malnutrition, poor housing, poor sanitation, and 
high exposure to the vectors. Therefore, these diseases share common features related to 
impoverished population with low visibility and little political voice, and they cause 
stigma and discrimination, especially in girls and women.  
Importantly, NTDs can be controlled, prevented, and eliminated using effective and 
feasible solutions [5]. In this regard, WHO introduced global health initiatives and 
control polices to eradicate and eliminate NTDs through intensive public health 
interventions and vector controls. However, currently the control and eradication of 
NTDs remain a top global health challenge. They require a strategy based on 
interventions centered on reaching poor and marginalized communities.  
The implementation of alternative diagnostic approaches that could be easily deployed 
in areas lacking suitable healthcare resources for identifying the disease at an early 
stage, or that could be employed for mass screening, would be highly desirable in 
interventional and control programs. 
In my PhD studies, I assessed a new non-invasive, fast, easy-to-use and cost-effective 
diagnostic method for NTDs diagnosis based on exhaled breath analysis, which I tested 
on representative categories of NTDs (Dengue, Echinococcosis and Leishmaniasis) 
caused by different pathogens (viral, helminthic and protozoan infections, respectively). 
These diseases are briefly discussed in the following subchapters. 
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1.2.1.  Dengue fever 
Dengue is the most important viral vector-borne disease in the world [6]. It is an acute 
systemic viral disease transmitted through the bite of infected female mosquito Aedes 
aegypti (as primary vector) or Aedes albopictu. Dengue virus (DENV) belongs to the 
genus Flavivirus of the family Flaviviridae, which consists of more than 70 species that 
include other important viruses such as Zika and Chikungunya [7].  
Dengue disease is characterized by fever, arthralgia, myalgia, abdominal pain, rash and 
viremia that begin 3-4 days following the infection by the bite of the DENV-
transmitting mosquito. The disease is caused by four distinct but closely related DENV 
serotypes: Dengue virus non-structured proteins (NS) types 1 to 4 (DENV-NS1, DENV-
NS2, DENV-NS3 and DENV-NS4) [7,8]. The infection to humans with any of these 
serotypes leads to mild fever, known as Dengue fever (DF), which can be characterized 
by clinical responses of the body, but also by no clinical manifestation at all. Infections 
by two different DENV serotypes can lead to severe syndromes, commonly known as 
Dengue haemorrhagic fever/Dengue shock syndrome (DHF/DSS), which are 
characterized by rapid onset of capillary leakage and a potential damage of the liver [9]. 
Although primary infection with a particular serotype induces lifelong protective 
immunity to that serotype, the protection against the other DENV serotypes is generally 
weak. After a short period of cross protection, typically between 2-3 months, 
individuals infected with one serotype are again susceptible to infection with the other 
serotypes, in which case the severity of the disease increases, and sometimes progresses 
even into fatal outcomes [10]. 
Owing to the uncontrolled urbanization, global immigration, and increased spread of 
DENV-transmitting mosquitoes, Dengue epidemics has increased both in frequency and 
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magnitudes in many parts of the world, and is ubiquitous throughout the tropics [7,10-
12]. As a result, Dengue infection is a major public health threat with a global 
estimation of about 400 million new infections every year. Moreover, over two million 
DHF/DSS cases and 20,000 deaths are estimated to occur each year [13]. Reported 
WHO estimations refer to 50-100 million Dengue infections every year, and over 2.5 
billion people are currently at risk from Dengue. Informal online data sources that were 
collected by the web-based system HealthMap, which estimates infectious diseases 
outbreak, revealed dengue outbreak of more than 1000 cases between January and April 
of 2018 [14]. 
 
Figure 1.4: Countries at risk of Dengue transmission; the two contour lines indicate the 
potential geographical limits of the northern and southern hemispheres for year round 
survival of Aedes Aegypti mosquito vector of DEN, from [15]. 
 
More than 100 countries are seriously affected by Dengue infection (Figure 1.4) [16]. 
South America and Asia has larger contributions to the global burden of Dengue 
Countries at risk of Dengue, 2011 
Not available 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
9 Neglected Tropical Diseases 
 
Chapter 1 
disease, which might be related to the high suitability of the disease transmission 
because of proper environmental conditions and high population density in these 
regions [13]. However, the number of cases varies substantially from year to year, and 
underreporting and misdiagnoses are possible obstacles in understanding of the full 
burden of Dengue.  
 
Figure 1.5: Global risk and burden of Dengue (2010). Reproduced from [13]. 
 
Notably, in tropical areas where the spread and epidemics of DENV-transmitting 
mosquitoes is favourable, the outbreak of Dengue infection is a huge health and 
economic problem [13,17]. As mosquito-borne disease, Dengue transmission is climate 
sensitive for several reasons: mosquitoes require standing water to breed and warm 
ambient temperature, while if the climate is too cold, viral development is slow and 
mosquitoes are unlikely to survive long enough to transmit the infection [11].  
Nevertheless, the symptoms of Dengue are generally difficult to recognise from a 
normal flu or other viral infections, and in most cases the disease is asymptomatic or 
mild, and can even pass unobserved [18]. Due to its asymptomatic symptoms, the 
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control and diagnosis of Dengue infection remain a top global health challenge. Current 
laboratory diagnosis methods for confirming DENV infection relies either on direct 
viral detection in serum (i.e., isolation of virus in cell culture, and identification of 
nucleic acid or antigens), or on indirect methods that involve serological tests for the 
detection of virus specific antibodies [19] (Figure 1.6). Direct virus detection could be 
also used for serotype specific identification of dengue infection in the acute phase of 
the disease [19-21]. For this, DENV is isolated by inoculation of diagnostic samples 
into mosquitoes for cell culturing, detection of viral nucleic acid in serum by 
polymerase chain reaction (PCR) assays, or detection of non-structured protein type 1 
(NS1) by enzyme linked immunosorbent assay (ELISA), providing better sensitivity 
and accuracy during the acute stage of the disease [19]. Nevertheless, the sensitivity and 
accuracy of the direct methods are influenced by the duration of the patient’s illness. 
Moreover, diagnosis of Dengue infection by direct detection of viral components in 
serum is not routinely performed, as these methods require expertise and expensive 
laboratory equipment [19], which are of limited access in the endemic areas.  
By contrast, serologic diagnosis of Dengue (i.e., through indirect methods) relies on the 
detection of high levels of serum immunoglobulin M or G (IgM, IgG) that bind Dengue 
virus antigens in an ELISA based assays. However, the specificity of these assays varies 
depending on whether the individual has a primary or secondary Dengue infection. As 
these antibodies are immune responses to foreign antigens, the presence of IgM in the 
diagnostic assay might not be associated only to Dengue infection, but could be also 
related to other similar flavivirus infections [8,19]. Hence, serological tests based on 
IgM based assay could provide false results. Although there is no specific treatment for 
Dengue fever or for haemorrhagic Dengue, its diagnosis at an early stage can decrease 
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mortality rates below 1% [21]. However, all these diagnostic tests may be negative in 
the early stage of the disease. 
 
Figure 1.6: Comparisons of different laboratory methods for the diagnosis of Dengue 
infection and their accessibility and/or diagnostic reliability [19,21]. 
 
Moreover, with the exception of serology, these laboratory tests are only of diagnostic 
value during the acute phase of the illness, whereas the tests for Dengue virus-specific 
antibodies (IgG and IgM) can be useful to confirm the diagnosis in the later stages of 
the infection, as both IgG and IgM are produced after 5-7 days from the onset of the 
disease.  
1.2.2. Leishmaniasis  
Leishmaniasis is caused by several protozoal parasites of the genus Leishmania, and 
is transmitted by the bite of infected female phlebotomine sandflies. There are over 20 
Leishmania species, and over 90 sandfly species are known to be Leishmania- 
transmitting vectors. The various species of Leishmania parasites relevant to humans 
are divided into two broad categories: New World species such as L. chagasis, L. 
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Mexicana, L. braziliensis, L. shawi, L. amazonensis, L. naïffi, and L. guyanensis – 
which are endemic in Middle and South America; and Old World species including L. 
lnfantum, L. major, L. tropica – which are highly prevalent in the Mediterranean basins, 
the Middle East, the horn of Africa and India [22].  
Depending on the infecting species, three major forms of the Leishmania diseases are 
developed: Visceral Leishmaniasis (VL), also known as kala-azar, which is the most 
severe form of the disease, and in some cases it is lethal if left untreated; Cutaneous 
Leishmaniasis (CL); and Mucocutaneous Leishmaniasis (ML). CL is the most prevalent 
clinical form of Leishmaniasis [23], caused by a variety of Leishmania species: L. 
major, L. tropica, L. Mexicana and L. Braziliensis. Therefore, the clinical manifestation 
of CL tends to vary between and within these regions [22]. 
Unlike other infectious tropical diseases, the incidence of Leishmaniasis is continuously 
increasing [24,25]. Leishmaniasis disease is endemic in about 98 countries. More than 
350 million people are susceptible to Leishmania parasite, and 2 million new cases 
occur every year. About 95% cases of Leishmaniasis disease belong to Cutaneous 
Leishmaniasis, and they mostly occur in the Americas, the Mediterranean basins, 
Middle East and Central Asia (Figure 1.8).  In most cases, infections by Leishmania 
remain asymptomatic. In the case of CL, the skin lesions usually develop within several 
weeks or months after exposure [27]. They eventually develop to ulcers and skin 
lesions, leaving life-long scars, serious disability as well as substantial psychological 
burden [28]. 
The diagnosis and identification of Leishmania parasite is often laborious, and depends 
on the variety of the Leishmania parasite. In some cases, routine identification might be 
necessary, as the Leishmania species strongly determines how the diseases evolve. For 
this reason, a number of diagnostic methods have been described [23]. However, none 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
13 Neglected Tropical Diseases 
 
Chapter 1 
of these methods showed adequate sensitivity and accuracy for the diagnosis and 
detection of Leishmaniasis disease. 
 
Figure 1.8: Global status of Cutaneous Leishmaniasis, 2015, WHO report. Reproduced from 
[26]. 
 
And the absence of microscopy capabilities in many endemic regions makes diagnosis 
even more difficult. The current existing diagnosis and treatment practice are expensive 
and complicated, and thus the detection and control of the disease becomes challenging. 
Indirect parasitological examinations including microscopy, histopathology, and 
parasite culture, and/or indirect testing with serology and molecular diagnosis, often 
provide a huge variation in diagnostic accuracy [29].  
 
1.2.3. Echinococcosis 
Human Echinococcosis (HE) is a zoonotic infection caused by the larval stage 
(metacestode) of the tapeworm that belongs to the genus Echinococcus of the family 
Taeniidae. It is characterized by a long-term growth of metacestode-larval stages (i.e., 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
14 Neglected Tropical Diseases 
 
Chapter 1 
hydatid cysts) in internal organs (mainly in the lungs and liver) of intermediate host 
animals. Although there are different species of Echinococcosis, only four of them 
(Echinococcus granulosus, Echinococcus  multilocularis, Echinococcus oligarithms, 
Echinococcus Vogeli) are recognized as taxonomically relevant. The most frequent 
clinical and epidemiological forms of Echinococcosis that are pathogenic to humans are 
Cystic Echinococcosis (CE) and Alveolar Echinococcosis (AE), caused by the species 
Echinococcus granulosus and Echinococcus multilocularis, respectively.  
The lifecycle of Echinococcus species involves two hosts: a definitive carnivore host 
such as dog and fox, and an intermediate herbivore host including sheep, cattle, and 
goat. The intermediate hosts become infected by ingesting parasite’s eggs, which are 
then released in the feces of definitive hosts. The eggs hatch in the gastrointestinal tract 
and become activated larvae, which penetrate the intestinal wall and enter the 
bloodstream, eventually locating in internal organs where they develop into hydatid 
cysts. Thus, the parasite lifecycle alternates between an adult segmented egg-producing 
tapeworm in the small intestine of a canid definitive host, and a larval cystic stage of the 
tissues of ungulates and rodents. 
Infection to humans occurs through the ingestion of parasite eggs in contaminated 
water, food or soil, or through direct contact with animal hosts. The two main forms of 
Echinococcosis disease, CE and AE, are distinguished by the development of unilocular 
fluid filled bladders (i.e., hydatid cysts), and a multilocular root-like network of 
interconnecting vesicotubular structures, respectively. The larval growth of the parasites 
separates the malignant AE from the benign CE [30]. CE is the most common type of 
echinococcosis and the cyst growth usually occur in the liver (rarely in the lungs), upon 
infection by the species E. granulosus. AE affects the liver (>98% of cases), which is 
characterized by tissue fibrosis and necrosis, and commonly with a poor prognosis [31].  
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Infections with Echinococcosis are a major public health concern that is globally spread, 
particularly in developing regions with limited economic resources, whereas in some 
areas it has become an emerging or reemerging disease [32-36]. The CE form of the 
disease is globally distributed in every continent (Figure 1.7). AE, which is life 
threatening and severe (90% of AE patients die if left untreated), is endemic in most 
regions of China and remerging in many European countries [36,37]. In the endemic 
areas, CE incidence ranges from less than 1 to 200 per 100,000 person-years, and that of 
AE from 0.03 to 1.2 per 100, 000 persons-years [38,39].  
 
Figure 1.7: Global distribution of Echinococcus granulosus and Cystic echinococcosis, 
WHO report, 2009. Reproduced from [40]. 
 
Despite its wide spread in most of the tropical zones, the mortality rate of CE is lower 
than for AE, but it might increase considerably if medical treatment and care are 
inadequate [38]. This zoonotic disease causes chronic infections in humans 
characterized by an initial asymptomatic period, which could last several years prior to 
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the onset of clinical signs associated with pressure effect exerted by the cyst or tissue 
necrosis in the affected area (in the case of CE), or the development of a tumor-like 
lesion, normally in the liver (in the case of AE). Diagnosis of Echinococcosis is 
generally done by physical imaging techniques that include ultrasonography, computed 
axial tomography (CT scanning), Magnetic Resonance Imaging (MRI) and radiology, 
which are generally accompanied by serological tests [33,41]. In most cases, image 
based and stage-specific diagnosis of CE disease are useful to choose the best treatment 
options from percutaneous treatment, surgery, anti-infective drug treatment or watch 
and wait approaches, even though there is no best treatment options [42]. Nevertheless, 
imaging techniques are constrained by the small size of lesions that are visualized, and 
moreover they are expensive and inaccessible in most remote areas. Thus, the diagnoses 
of echinococcal infections by imaging techniques are usually performed in the late 
stages of the disease, which makes difficult the control and treatment of the infection, 
especially in the case of AE.  
Immunological tests have been considered as useful methods for confirming clinical 
findings in the early stage of infection, as well as whenever imaging techniques had 
failed to visualize the parasite, or when imaging techniques are not readily available 
[43]. The immunological tests of CE are related to the evaluation of specific antibodies 
and native antigens including E. granulosus hydatid cyst fluid (HCF) and purified 
components from HCF, as well as E. granulosus adult-worm antigens; in this regard, 
crude HCF has shown higher sensitivity than purified components of HCF [43,44]. 
However, not all patients with hydatic cysts may produce detectable serum (IgG) 
antibodies, and ELISA test might exhibit false negative results. The AE specific 
antigen, Em18, derived from E. multilocularis, is considered the potential species-
specific antigen for the immunodiagnosis of AE; it is capable of differentiation between 
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AE and CE, and it can distinguish active and inactive AE. In general, immunodiagnostic 
tests for the confirmation of AE or CE are relatively easy to use and are suitable for 
large-scale screening of population at risk in the early stage of the infection [44]. 
However, all the diagnostic tools developed so far are generally applicable at laboratory 
scale. In addition, both the diagnosis and treatment of HE are relatively expensive. The 
disease is complicated to treat, and in some cases it requires extensive surgery and/or 
prolonged drug therapy, as well as socio-economical and psychological burden [34].  
 
1.3. Conclusions 
The neglected tropical diseases affect many regions across the world and represent a 
huge global health threat. The control, prevention and treatment of these infections 
require extensive interventions, global coalition and strong policies centered on 
reaching poor and marginalized communities, where most cases occur. Early detection 
and prompt treatment in endemic areas would help to reduce transmission and to 
monitor the spread and burden of these diseases. The current lack of suitable resources 
and equipment in these areas make their diagnosis extremely challenging. Therefore, the 
development of a simple, rapid, fast and non-invasive diagnostic method that is user 
friendly and accessible in low economic and low resource settings is of paramount 
importance to combat the neglected tropical diseases globally.  
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 Included in this chapter are brief introduction to exhaled breath, possible 
origin of exhaled air components in abnormal body’s conditions, analytical 
techniques commonly used for breath analysis and biomarkers identification, and 
a short review on exhaled breath analysis with electronic devices based on 
chemical gas sensors. 
  
2.1. Introduction 
Breath testing dates back to the early history of medicine in Ancient Greece, when 
physicians started to consider that human breath contains a clue to the body’s health and 
physiological status. They observed that the aroma of patient’s breath could be 
associated to a certain disease, and breath testing might provide an insight into the 
pathophysiological processes in the body during illness [1]. For example, a sweet smell 
of exhaled breath indicates uncontrolled diabetes mellitus, while a urine-like odor smell 
is considered a result of kidney failure, and a musty or fishy reek smell of breath is 
related to liver disease [2,3]. Therefore, they tried to diagnose illnesses by the 
distinctive breath odors that were perceived as indicators of the disease.  
Later in the 18th century, Antoine Lavoisier reported the first quantitative analysis of 
carbon dioxide (CO2) in Guinea pig breath, whereas CO2 was also found in human 
breath as a product of slow burning of oxygen and food in the body [1,4,5]. Starting 
from these findings, specific breath test applications have begun to be implemented, and 
the first breath test called Capnography was developed [6]. Capnometry measurements 
are used to monitor the level of carbon dioxide in exhaled breath and to gather 
information from the systemic metabolism of the patient, as well as data from both 
circulatory and respiratory systems [7]. Subsequently, many other breath testing 
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applications were developed, and some of them are currently in use, including the 
alcohol Breathalyzer that is used to determine the amount of alcohol in blood through 
indirect ethanol measurements in breath [8], as well as the urea breath test for the 
detection of Helicobacter pylori bacteria [9]. 
On the other hand, acetone was found in urine of diabetic patients, and the strange 
apple-like odor breath of diabetics was presumed to be due to the presence of acetone in 
exhaled air [5]. Additionally, the presence of water vapor in exhaled breath has been 
used as a non-invasive approach for mortality monitoring for many years.  
Based on all these findings, the idea of using information in breath to determine the 
physiological state of humans has been followed aiming the development of non-
invasive diagnostic devices for breath testing.  
2.2. Exhaled Breath  
For many beings, it is essential to inhale oxygen and in turn to exhale carbon dioxide as 
a result of the respiration process. Such gas exchange occurs at the alveolar–blood 
capillary membrane of the respiratory tract, where the diffusion of gases with significant 
vapor pressure is governed by their concentration differences across the alveoli–blood 
capillary junction [10]. The compounds from the inhaled air tend to pass into the blood, 
and the molecules from the blood tend to pass into the breath, respectively.  
During the exhalation process, thousands of molecules are expired into the air. The 
composition of the exhaled breath is constituted by nitrogen (74%), oxygen (21%), 
small inorganic gases such as NO, H2, NO2 CO, H2S, NH3, CO2  (totally accounting for 
almost 5%), water vapor and trace amounts of several thousands of volatile organic 
compounds (VOCs) and non-volatile organic compounds [3,11]. Most of the VOCs in 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
26 Exhaled Breath Analysis 
 
Chapter 2 
the breath are present in very low concentrations that range from parts per trillion (ppt) 
to parts per million (ppm), which makes them far complex to detect as compared to the 
dominant molecules such as nitrogen, oxygen, water vapor and carbon dioxide [10]. 
Notably, the total amount of these VOCs account for not more than 100 ppm of the total 
breath volume, being acetone, isoprene and alcohols the most abundant, whereas 
aldehydes, ketones and pentane are found at very low concentrations [12].  
The VOCs reach the exhaled breath from the deeper parts of the lungs called alveoli, as 
a result of the exchange process with the blood, therefore they are found in the so-called 
“alveolar breath”. Although the specific biochemical pathways of their generation, 
distribution and origins is not well understood, some of them can be associated with 
normal metabolism (e.g., ethanol, isoprene, propanone, and methanol), others are 
products of oxidative stress (e.g., ethane and pentane), while others result from 
environmental and occupational exposures (e.g., trichloromethane and benzene 
derivatives) [5,13].  
The terms exogenous and endogenous are used to describe the origins of the VOCs that 
come from external sources (during inhalation of environmental air, ingestion of food 
and beverages, smoking, or entered the body through other routes such as dermal 
absorption) or are produced inside the body (during the metabolism, or originated from 
bacteria in the gut or the airways), respectively.  
The concentration of exogenous VOCs in the breath is generally higher than that of the 
endogenous compounds [14]. The exogenous volatiles are possibly metabolized in the 
body, mainly by the liver enzymes. They can be modified or stored, and excreted by 
expiration or through other body fluids [15]. In many cases, these VOCs are considered 
highly reactive and typically cause physiological damage to different cell structures 
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such as lipids, DNA and proteins, and/or are stored in different body organs or tissues 
causing later different diseases and body complications [16]. Typical examples of 
exogenous VOCs are aromatic hydrocarbons, such as benzene, ethylbenzene, p-xylene, 
para-dichlorobezene and other hydrocarbons, which derive from environmental 
contaminants and other exposure sources [17], and alkanes derived from different air 
pollutants.   
Endogenous VOCs are biologically generated compounds during the physiological 
processes occurring in the body. Mainly they are hydrocarbons such as isoprene, 
acetone, methanol, ethanol, pentane and acetaldehyde, and nitrogen and sulfur 
containing compounds. Table 2.1 shows some of the common breath endogenous VOCs 
and their physiological origins. Acetaldehyde is derived from ethanol metabolism, 
methyilamine is derived from proteins metabolism, ethane and pentane are a result of 
lipid peroxidation of the polyunsaturated fatty acids (PUFAs), isoprene is generated by 
cholesterol biosynthesis, etc [18]. The endogenous VOCs are continuously excreted 
from the body via the skin, feces, urine, breath, saliva, etc [19].  
Volatile organic compounds Physiological basis 
Hydrocarbons Lipid peroxidation  
Acetone Decarboxylation of acetoacetate 
Acetaldehyde Ethanol metabolism  
Ammonia Protein metabolism 
Ethane, pentane Lipid peroxidation 
Carbon disulfide, ethanol, hydrogen Gut bacteria 
Isoprene  Cholesterol biosynthesis  
Methylamine  Protein metabolism 
Table 2.1: Physiological origins of some endogenous breath VOCs [20] 
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2.3. Volatile organic compounds generated by abnormal body 
conditions 
Some of the physiological phenomena that generate VOCs in abnormal body conditions 
are explained below. 
Oxidative damage  
Molecular oxygen is an essential molecule for cellular metabolism, and the body has 
developed a protective mechanism to sustain oxygen homeostasis in order the normal 
physiological functioning of the body to be maintained. During the process of aerobic 
energy metabolism, oxygen is reduced by cytochrome c oxidase (four electron 
reduction) to water and energy required by the body, which makes the mitochondrial 
oxidative phosphorylation the major source of energy [6]. Oxygen uptake in neutrophils 
and macrophages is due to the action of NADPH-oxidase complex associated with the 
plasma membrane. The electrons released by NADPH oxidation reduce oxygen to 
superoxide radicals. In some cases, the four electron transfer process undergoes a 
stepwise reduction producing highly unstable intermediate radicals containing unpaired 
electrons or ions called reactive oxygen species (ROS), such as the superoxide oxygen 
ion (O2
-), hydrogen peroxide (H2O2), hydroxyl radical (
•OH), as well as nitric oxide 
(NO) and others, which are highly toxic for biological systems [21]. These superactive 
molecules with unpaired electrons are easily carried and can bind to different 
components of the cell.  
In the process of phagocytic killing of foreign molecules, the body relies on the toxicity 
of ROS produced molecules through the NADPH-dependent oxidase activity present in 
monocytes [6]. For example, the recruitment, differentiation and activation of 
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monocytes are mostly signaled by ROS molecules. On the other hand, the biological 
systems develop a multiple antioxidant defense mechanism such as specific enzymes 
(superoxide dismutase) and non-enzymatic species such as Vitamins A, C and 
glutathione as a defense to protect against foreign toxins. All these antioxidants tend to 
control the formation of ROS molecules by reducing them into less reactive molecules 
such as water or non-oxygen centered reactive molecules. Figure 2.2 shows the 
successive production of ROS molecules, where the red ones are the most toxic to cell 
components.  
In abnormal body conditions, the production of ROS molecules overwhelm the normal 
antioxidant capacity, and uncontrolled formation of ROS molecules inflicts adverse 
modifications to the cell components, such as lipids, proteins, carbohydrates and DNA 
[18]. Hence, the cells suffer a cellular condition known as oxidative stress, which occurs 
when the balance between oxidants and ROS is disrupted because of either depletion of 
antioxidants or accumulation of ROS molecules in the cell periphery. During oxidative 
stress, the cells attempt to counteract the oxidant effects and restore the redox balance 
by activation or silencing of genes encoding transcription factors, defensive enzymes 
and structural proteins [22].  
Lipid peroxidation  
Lipids are molecular components of cellular and subcellular membranes. They have 
hydrophobic and hydrophilic layers of long chain fatty acids, and are the most exposed 
parts of the cellular membrane. These fatty acids, which are either saturated, 
monounsaturated and polyunsaturated, are highly susceptible to ROS molecules due to 
the presence of less energetic bis-allylic hydrogen in the carbon chain between the 
double bonds [23]. 
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Figure 2.2: Formation and elimination of Reactive Oxygen Species (ROS) 
 
Lipid peroxidation is an oxidative chain reaction initiated by any primary free radicals 
with sufficient reactivity to subtract an allylic hydrogen atom from a reactive methylene 
group (-CH2-) of polyunsaturated fatty acid side chains [24]. The oxidation process 
follows the self-initiated chain reactions. It begins with the formation of initiating 
species upon the attack produced by a radical molecule, and is accompanied by bond 
rearrangement that is stabilized by diene-conjugates formation. The lipid radicals take 
up oxygen to form highly unstable peroxy radicals (ROO*). Shortly after this initiation 
process, the peroxy radicals are able to synthesize H from an adjacent fatty acid, causing 
an autocatalytic chain reaction that leads to the formation of lipid hydroperoxides. This 
reaction can be repeated many times during the propagation phase [23,24]. An initial 
event triggering lipid peroxidation by active radicals such as ROS molecules can be 
multiplied as long as oxygen supplies and unoxidized polyunsaturated fatty acids chains 
are available. The chain reaction terminates when either two radicals with unpaired 
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electrons (i.e., peroxy radicals) react, forming stable non-radical products, or when an 
antioxidant species reduces the peroxyl to a hydroperoxide whereas it is transformed 
into another stable radical. The lipid peroxyl radicals initiate or enhance other cellular 
processes such as cholesterol oxidation, reaction with proteins, and impairment of 
critical enzymatic functions and receptors, thereby disrupting the normal physiological 
processes of the body [24]. The accumulation of hydroperoxides and their subsequent 
decomposition into different subcomponents including alkoxyl and peroxyl radicals can 
accelerate the chain reaction of polyunsaturated fatty acid peroxidation, leading to 
oxidative damage of the cells.  
Lipid peroxidation can also be initiated by different enzymatic activities such as 
cyclooxygenase and lipoxygenase, which are associated with normal cellular 
physiology. Under normal physiological conditions, these enzymes catalyze the addition 
of molecular oxygen to various polyunsaturated fatty acids, and they are converted into 
biologically active molecules including prostaglandins along with other fatty acid 
hydroperoxides [24,25]. However, in abnormal conditions, the physiological balance 
can be disrupted and excessive enzymatic lipid peroxidation will prevail, inducing 
oxidative damage to the cells and tissue membranes. 
 Figure 2.3 shows the schematic representation of lipid peroxidation and the 
biochemical pathways of hydrocarbon formation. Primary lipid peroxidation yields a 
variety of secondary reactions with evolvement of hydrocarbons (both saturated and 
unsaturated), aldehydes, ketones, and other low molecular weight volatile substances 
[14]. Examples of compounds produced by lipid peroxidation are ethane and pentane, 
which derive from the oxidation of n-3 and n-6 polyunsaturated fatty acids, respectively 
[26,27]. 
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Figure 2.3: Polyunsaturated fatty acid oxidation and the biochemical pathway of 
hydrocarbons adapted from [23]. 
 
Hence, exhaled concentration of pentane and ethane can be used to monitor the degree 
of oxidative damage in the body [28]. In addition, in vivo studies of lipid peroxidation 
of n-4 and n-7 polyunsaturated fatty acids demonstrated an increased emission of 
propane and hexane in rats, respectively [26]. Therefore, the classification of VOCs 
produced during lipid peroxidation also depends on the type of PUFAs implied in the 
free radicals oxidation process. Furthermore, secondary products of lipid peroxidation 
can be accumulated in human fats depots and released slowly over a period of several 
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days, and during this time they might be further metabolized by different body enzymes. 
For example, pentane is partially metabolized by the hepatic cytochrome – P450 
systems, whereas ethane is highly volatile and relatively insoluble in tissues and exhaled 
as produced [18,29]. On the other hand, alkanes are metabolized to alkyl alcohols by 
cytochrome –P450-mixed oxidase enzymes [30]. 
Apart from saturated hydrocarbons, unsaturated hydrocarbons such as isoprene are 
endogenously produced by cholesterol biosynthesis during cholesterol related disorders 
and oxidative damage [14,18]. Isoprene is always present in human breath and thought 
to be produced along the mevalonic pathway of cholesterol synthesis [14,31].  
Oxygen containing breath VOCs, such as acetone and acetaldehyde, are originated 
either as products of lipolysis during lipid peroxidation or as a result of endogenous 
carbon metabolism in the liver [18]. For example, when the body lacks of primary 
energy, energy sources such as fatty acids become a secondary source of fuel for the 
cell, which leads to the endogenous formation of ketone bodies including acetoacetate, 
acetone, and 3-hydroxybutyrate [14]. This is apparently common in individuals with 
diabetic mellitus complications, in whose case the presence of these ketone bodies are 
clearly manifested in body fluids [21]. Figure 2.4 illustrates the general biochemical 
formation of ketone bodies including isoprene and acetone generated via the 
decarboxylation of excess acetyl-CoA as a result of fatty acid β-oxidation. Ketone 
bodies (e.g., acetone), are oxidized via Krebs cycle in the peripheral tissue. Acetone, 
which is abundant in humans, is ultimately produced by the liver via decarboxylation of 
acetoacetate [15,32].   
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Figure 2.4: Decarboxylation of excess acetyl-CoA for ketone bodies generation and 
biochemical pathway of acetone generation. 
 
Other Nitrogen and/or Sulfur containing VOCs 
Endogenous breath VOCs also includes sulfur or nitrogen containing compounds. 
Sulfur containing compounds are endogenously generated through both normal and 
abnormal metabolic processes occurring in the body [19]. For example, volatile sulfur 
containing compounds such as ethyl mercaptane and dimethylsulfide, are generated by 
incomplete metabolism of methionine in the transamination pathways [33,34]. These 
sulfur containing compounds are dominant in patients with liver impairment of liver 
function and they are associated with hepatic diseases and malodor [14,32]. It is thought 
that the ROS molecules deplete intracellular thiols, which lead to the inducement and 
stimulation of the redox sensitive transcription factors AP1 and NF KB that cause the 
production of inflammatory cytokines IL1 and TNF beta [35].  
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Finally, nitrogen containing compounds such as dimethylamine and trimethylamine are 
associated with the impairment of liver function in converting ammonia into urea and 
other compounds [14,18,36]. Ammonia is endogenously produced from protein and 
nucleic acid metabolism, and significant level of ammonia appears in the blood of 
uremic patients [35]. Thus, the presence of nitrogen containing compounds in breath is 
associated with the imbalance of urea metabolism due to kidney disorders or ulcers 
caused by bacterial stomach infections [18]. 
2.4. Breath Biomarkers 
The presence of a physiological malfunction in the course of infection or metabolic 
disorder (i.e., an abnormality) leads to changes in the breath VOCs concentrations, or to 
the generation of new VOCs characteristic to the physiological changes occurring in the 
body. As a result, the composition of the exhaled breath air is altered. The detection and 
measurement of the changes in the exhaled VOCs pattern can give an insight about the 
disease and can provide a mean for diseases diagnosis and monitoring [18].  
A breath biomarker is a chemical compound endogenously produced within the body 
or exogenously introduced into the organism, which can be detected and measured in 
the exhaled breath, and serves as an indicator to differentiate between the normal and 
abnormal state of the body [37]. Generally, the concentration of disease-related VOCs is 
higher in the disease state as compared to the normal condition, with the exception of 
the cases when certain compounds are retained by malfunctioning organs that cannot 
adequately treat them [18]. Nevertheless, the concentration of VOCs in breath is always 
higher when their origin is exogenous. 
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A specific disorder is characterized by a volatile biomarkers pattern rather than a 
specific biomarker, while some breath VOCs are related to more than one disease [38]. 
For example, specific sets of volatile biomarkers (e.g., styrene and toluene) are 
indicators of very different diseases or disease states, such as oxidative stress [39], lung 
cancer [40], cystic fibrosis [41,42] and liver diseases [43]. The association of some 
volatile biomarkers to different types of diseases suggests that it should be some 
commonality in the effects of pathogenesis associated with various diseases, which may 
result in similar alterations in the biochemical pathways produced within the body that 
generate the same abnormal VOC metabolites in unrelated diseases [37]. Hence, the 
presence of these specific VOC biomarkers may be a good general indication of 
abnormal conditions in the body, and prompt to other diagnostic investigations to 
identify the specific disease among those that are mostly associated with the particular 
biomarkers detected.  
Many studies have focused so far on the identification of VOCs that differ qualitatively 
and/or quantitatively between groups of diseased and healthy subjects. However, the 
origin and the pathophysiological significance of the putative biomarkers identified in 
these studies have been frequently neglected. Thus, regardless of their origin, any 
volatiles whose concentrations significantly differed between healthy subjects and 
patients have been claimed as potential disease biomarkers of the disease under 
investigation [44]. For example, environmental contaminants including hydrocarbons 
such as octane, decane, and benzene derivatives commonly known as BTEX (benzene, 
toluene, ethylbenzene, xylene) have been also considered as disease biomarkers [44,45]. 
Obviously, these patterns of exogenous VOCs in exhaled breath are mostly likely to 
derive from body exposure to pollutant VOCs absorbed into the body, which were 
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exhaled back either in the same form as inhaled or modified by the organism. Therefore, 
they should be rather used for human exposure assessment to pollutant environments, 
cigarette smoke, or other external conditions.  
Thus, despite many (exogenous and endogenous) VOCs have been claimed as potential 
biomarkers, only a few of them have been consistently demonstrated for clinical 
conditions. Table 2.2 presents some examples of breath VOC biomarkers and their 
clinical significance. These VOCs are believed to be generated by endogenous body 
processes, and the biochemical pathways of their generation have been well studied. 
VOCs Family Clinical significance Metabolic 
pathway 
Ethane, pentane 
 
Saturated 
hydrocarbons 
Oxidative damage Lipid peroxidation  [14,18,35] 
Methylated 
hydrocarbons 
¿? Lung or breast 
cancer 
Oxidative stress/Lipid 
peroxidation [46] 
Isoprene Unsaturated 
hydrocarbon 
Oxidative damage Cholesterol biosynthesis [14,18] 
Acetone  
 
Oxygen 
containing 
compounds 
Diabetes mellitus, 
Ketonemia 
Decarboxylation of acetoacetate 
and Acetyl-CoA [14,18],  
Acetaldehyde ¿? Lung cancer Ethanol metabolism [40,47] 
Ethanol  ¿? Gut bacteria Intestinal bacterial flora [18,47] 
Dimethylamine, 
Trimethylamine 
Nitrogen 
containing 
compounds  
Kidney & liver 
impairment, 
Uremia 
Urea conversion [14,18] 
Dimethyl sulfide 
Dimethyldisulfide 
Ethylmercaptane 
 
Sulfur containing 
compounds 
 
Liver impairment  
Metabolism of methionine and 
transamination pathways [14,18] 
Table 2.2: Examples of breath VOC biomarkers and their clinical relevance 
 
On the other hand, small inorganic volatiles such as hydrogen sulfide (H2S), nitric oxide 
(NO) and carbon monoxide (CO) have been identified as important breath biomarkers 
for respiratory–specific diseases such as asthma [48-50]. H2S, which originates from the 
lower respiratory tract, is also used as biomarker of airway inflammations [51,52], while 
high concentration of NO in breath manifests higher risk of inflammatory diseases [53]. 
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In contrast, exhaled NO remains normal in patients with chronic obstructive pulmonary 
disease (COPD), which is one of the most common airway inflammatory diseases. 
However, CO showed an increase in both asthma and COPD patients, and hence 
exhaled CO and NO are complementarily used as breath biomarkers for pulmonary 
diseases [50,53].  
Nevertheless, most of the breath biomarkers of a disease appear in much lower 
concentrations and are far dominated by other irrelevant VOCs during breath analysis. 
Moreover, it is important to take into account the level and presence of the biomarkers 
in the exhaled breath of healthy people, referred to as normal or nonexistent levels. The 
abnormal levels of these breath volatiles indicative of adverse clinical conditions can 
only be recognized after the ranges of their normal levels have been identified or 
established. On the other hand, the inter-individual physiological differences give rise to 
inconsistencies in the level of the breath biomarkers within the study population and 
hold considerable challenges that require serious debates.  
Although with a few breath VOCs it is already possible to asses a relevant span of 
diseases, the capability to analyze the entire volume of exhaled breath composition 
would possess countless advantages in the diagnosis of specific diseases. Hence, breath 
samples can be analyzed not only for the search of biomarkers, but as a whole complex 
matrix with thousands of volatile organic compounds that can offer a general profile or 
pattern to distinguish and identify the disease. Instead of seeking for the evidence of 
already determined compounds, the attempt to extract relevant information from the 
“big picture” and link it with a particular health condition provides a panel of possible 
volatiles pattern with an explicit advantage over single biomarkers analysis.  
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Studies that analyzed the whole breath volume and linked it to different groups of 
diseases were already reported. For example, breath tests were employed to diagnose 
lung diseases (e.g., lung cancer, asthma, COPD, cystic fibrosis, bronchiectasis and 
pneumonia), gastrointestinal diseases (e.g., starch metabolism, lactase deficiency, 
bacterial overgrowth, Helicobacter pylori infection and liver impairment), as well as to 
understand the state of oxidative stress in the body [3].    
2.5. Analytical Methods 
The analytical methods are useful for the identification and quantification of individual 
compounds in gaseous mixtures. Since 1970s, analytical techniques have been widely 
employed for the analysis of VOCs in exhaled breath samples as a promising disease 
diagnostic approach. During that distant period, Teranishi et al. reported the use of gas 
chromatographic analysis of volatiles from breath, and demonstrated the presence of 
many volatile organic compounds in exhaled breath that can indicate the presence of 
body malfunctions in human beings [54]. Pauling et al. used a cold trap to freeze the 
breath VOCs, followed by heating the sample and injecting it into a gas chromatograph, 
and concluded that the chromatographic analysis of normal human breath samples 
reveals many different VOCs in very low concentrations [55]. However, exhaled breath 
analysis remains very difficult to perform because most of the breath VOCs that are 
clinically relevant are present in very low concentrations, the relative humidity of 
exhaled breath is very high (generally around 80%), and it is a lack of sufficiently 
sensitive and capable measurement techniques. The scientific and technical advances of 
different analytical techniques over the years has progressively improved their 
performance for the quantitative and qualitative determination of VOCs in exhaled 
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breath [1]. For the purpose of this thesis, some of the most common techniques that 
have been employed so far for the measurement of breath samples are next presented.  
2.5.1. Gas Chromatography Techniques 
Pauling et al. pioneered the comprehensive breath analysis using Gas Chromatography 
(GC) [55]. Since then, GC became one of the most widely used analytical technique to 
detect and quantify compounds in exhaled breath [54,56]. The GC technique allows for 
separating the multicomponent matrix of exhaled breath in individual constituent 
compounds, and provides information about the molecular composition and the 
molecular identity of the compounds. For being analyzed, the sample is injected into an 
inert carrier gas (usually helium), which transports it into the chromatographic column. 
Compounds separation occurs due to their different partitioning rates when coming in 
contact with the stationary phase of the column. According to the affinity and relative 
interaction of the different compounds with the stationary phase, each compound elutes 
at a different time, i.e., each compound has a specific retention time and reaches the 
detector at a different time. The retention time of each compound depends on different 
parameters such as temperature, molecular identity and column’s length. The column is 
typically coiled, thin (usually having 0.25 mm internal diameter) and very long (tens of 
meters in length), and is placed in a relatively small temperature controlled oven [57].  
However, given the low concentration and the complex nature of the compounds from 
the exhaled breath, the analysis of breath using GC has important limitations for 
accurately identifying the breath volatiles at low concentrations. For this reason, GC 
combined with other analytical techniques such as flame ionization detection (FID), 
mass spectrometry (MS) or ion-mobility spectrometry (IMS), is commonly employed in 
the analysis of trace components in exhaled breath.  
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GC-FID is a widely used technique in breath analysis, where FID is mostly used for the 
detection of organic compounds [3,26]. This method is based on the combustion of 
organic compounds in the FID, which produces ions and electrons that can conduct 
electric potential that is used for the qualitative and quantitative detection of the breath 
components. In general, GC based on FID detectors provides fairly high sensitivity and 
large linear response ranges, however it tends to be mass sensitive and its response is 
independent of the flow rate of the mobile phase. Employing GC-FID, Phillips et al. 
reported the accurate quantification of isoprene and several other compounds in the 
breath  [58]. On the other hand, gas chromatography coupled with ion mobility 
spectroscopy (GC-IMS), was also introduced for the use of field monitoring technique 
or detecting vapor phase organic compounds, widely used for the detection of chemical 
warfare agents [59]. IMS detection methods involve the ionization of molecules into 
constituents ions by an electric field against a drift gas, and ions are detected based on 
mobility which depends on mass, charge, size and shape of ions [60]. IMS enables the 
identification of and quantification of of gas phase molecules and its important 
characteristics and is extremely sensitive while the results are obtained rapidly and the 
simple experimental setup enables the construction of handy instruments [61].  
Later in the 1990’s, the further advancement of analytical techniques has emboldened 
gas chromatography coupled with mass spectrometry (GC-MS) as one of the gold 
standard techniques for the qualitative and quantitative analysis of trace components in 
exhaled breath. Phillips et al. systematically assayed VOCs and their variations in the 
breath of 50 healthy humans using GC-MS, reporting more than 3400 VOCs that were 
totally found in the breath samples of this study population, whereas only 27 VOCs 
were common for all 50 subjects [29]. Gordon et al. developed a special breath 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
42 Exhaled Breath Analysis 
 
Chapter 2 
collection method and computer assisted GC-MS to analyze breath samples of lung 
cancer patients and healthy controls, and the breath VOCs profiles obtained completely 
distinguished lung cancer patients (12 samples) from healthy controls (17 samples) [62]. 
2.5.2. Proton Transfer Reaction –Mass Spectroscopy (PTR-MS) 
Proton Transfer Reaction-Mass Spectroscopy is a modern analytical technique that is 
mostly employed to detect VOCs in air [63]. For breath analysis, it is an alternative to 
the GC that enables direct sample measurement and real time identification and 
quantification of VOCs [63-65].   
PTR-MS technique is based on the soft chemical ionization through proton transfer of a 
gaseous sample in a reaction chamber (drift tube), which is a conducting enclosure 
connected at a constant potential. The charged particles suffer no change in velocity 
inside the drift tube, enabling a stable reaction time for the ions as they flow through the 
tube [64]. PTR-MS generally uses the hydronium ions (H3O
+) as precursors. Basically, 
pure water vapor enters in the ion source hollow cathode, where it is protonized to H3O
+ 
and transported to the drift tube where encounters with the gaseous VOCs sample. As a 
result, the VOCs from the sample experience the non-dissociative proton transfer and 
are analyzed by a mass spectrometer, whose results are easily interpretable and trustable 
[64]. PTR-MS devices commonly perform the separation of protonized compounds by a 
quadrupole mass filter, and this technique is limited by low mass resolving power, 
hence different compounds with the same normal mass may not be accurately 
discriminated, and moreover the sensitivity is poor. As an alternative to the quadruple 
filter analyzer, the time-of-flight (TOF) mass analyzer has been more recently 
introduced as detector. This mass analyzer produces continuous highly resolved mass 
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spectra, enabling the possibility to discriminate nominally isobaric compounds on the 
basis of accurate masses [63,66,67].    
The first application of PTR-MS in breath analysis dates from 1994, when it was used 
to measure methanol, ethanol and acetone in human breath [68]. Since then, the use of 
PTR-MS to measure and monitor the composition of breath as an indicator of a disease 
has been increasingly explored [63,69,70]. Example of studied diseases are lung cancer 
[71], breast cancer [72], H. Pylori infection [73,74], Coeliac diseases [75], kidney 
malfunction [76], as well as risk environment monitoring through exhaled breath 
analysis [77].   
 
2.6. Chemical gas sensors 
In contrast with the analytical techniques, which are employed for individual 
compounds identification but are not able to identify complex breath sample signatures 
as a whole, the chemical gas sensors can analyze the overall complex composition of 
the sample. They present various advantages, such as small size, simple operation and 
low cost. Therefore, they can be easily miniaturized and are suitable for developing 
portable breath analysis devices. Compounds detection with these devices is realized 
indirectly, by analyzing the change in one of more of the sensors properties when 
exposed to the sample. They are not compound selective, but depending on the sensing 
material employed, they are prone to react with certain families of chemical compounds.  
Electronic noses or e-noses are gas sensing systems that contain an array of cross 
reactive chemical gas sensors, where every sensor has a different sensing material and 
responds differently to the complex VOCs mixture from the sample. Their responses are 
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analyzed by specific data analysis tools and pattern recognition algorithms for building 
classification models [78,79]. A major advantage of using e-noses for diseases 
diagnoses is that they provide quick results and cause less stress or anxiety to the 
patients.  
A wide range of chemical gas sensors based on different operating technologies have 
been used in clinical disease diagnostic applications [78]. The most common types 
include surface acoustic wave, quartz crystal microbalance and chemiresistive sensors 
based on different sensing materials such as metal oxides and metal oxide nanowires, 
carbon nanotubes, organically capped metal nanoparticles, and conducting polymers. In 
particular, the chemical gas sensors of chemiresistive type based on different broadly 
cross-sensitive sensing elements arose as one of the most promising approaches in the 
breath analysis field [37].  
A simple schematic representation of a chemiresistive gas sensor is shown in Figure 
2.5, together with the ideal characteristic response signal showing the changes in 
sensor’s resistance upon the interaction with an analyte. The chemical and/or physical 
adsorption/desorption processes of the analyte on the sensing material is usually 
reversible, leading to the recuperation of the initial baseline conditions of the measured 
sensor’s characteristic (resistance in Figure 2.5) after analyte evacuation. 
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Figure 2.5:  Typical schematic representation of a chemiresistive gas sensor with a sensing 
film deposited between two parallel electrodes (left); Measured resistance changes over time in 
the absence/presence of the analyte (right).    
 
 
2.6.1. Nanomaterial Based Chemical Gas Sensors for Breath 
Analysis   
The nanomaterials are preferred as sensing films for the chemical gas sensors because 
of their high surface-to-volume ratio, which provides an increased number of interaction 
sites for the exposing volatiles [80,81]. A broad range of functional nanomaterials have 
been used as transduction elements for breath VOCs detection, including metal oxides 
[82], silicon nanowires [83-85], metal nanoparticles [86-91], carbon nanotubes (CNTs) 
[92-94], and polymers [95] are among others [81,86,93,96-99]. The use of selectively 
permeable, hydrophobic materials simultaneously serving as water passivators and 
VOCs preconcentrators can further enhance breath VOCs detection [81,93]. 
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2.6.1.1. Chemical Sensors Based on Ligand-capped Metal 
Nanoparticles  
 
Metal nanoparticles functionalized or capped with different organic ligands, also known 
as ligand-capped metal nanoparticles, emerged as a new frontier of gas sensing 
nanomaterials since twenty years ago [100]. They are hybrid materials that combine the 
advantage of the organic ligand’s affinity to targeted breath VOCs, with the robustness 
of inorganic metal nanoparticles (Au, Ag, Pt, Cu, Ni, and others), offering better 
selectivity and specificity to the sensed VOCs, as well as lower power consumption 
because of room temperature operation features [101]. Gold is the most preferred choice 
for the metal, whereas the capping ligands are usually selected from the thiol group 
because that can easily bind to the metal nanoparticles [102]. Sensors based on ligand-
nanoparticles nanoassemblies are also of special interest due to their high sensitivity, 
low detection limit, fast response, low output impedance and easy integration with 
standard microelectronics [88,103]. These hybrid nanomaterials have been integrated in 
a variety of sensors types, including resistors [104,105], capacitors [106,107], quartz 
crystal microbalances [108,109], colorimetric sensors [110], and Schottky diode sensors 
[111].   
For example, Han et al. reported nanostructured sensing arrays that consisted of thin 
film assemblies of different alkanethiols-monolayer capped gold nanoparticles for the 
detection of VOCs and nitro-aromatic compounds [112]. The sensing elements of these 
sensing devices displayed linear responses to the concentrations of the VOCs tested 
(hexane, benzene, toluene, p-xylene, o-xylene, m-xylene, nitrobenzene, 2-nitrotoluene, 
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and 3-nitotoluene). Whereas the response profiles of the different sensing films for the 
same VOC were similar, the sensitivities varied dramatically.  
Dovgolevsky et al. fabricated chemiresistors based on cubic platinum nanoparticles 
(PtNPs) functionalized with four representative organic ligands (11-
mercaptoundecanoic acid, 11-mercaptoundecanol, benzylmercaptan, and oleylamine) 
for VOCs sensing in highly humid atmosphere simulating the relative humidity in 
breath [87], and revealed that the sensing of nonpolar VOCs (mostly reported as disease 
biomarkers) was much higher than that of polar VOCs, including water vapor [87].   
Chemiresistive sensors based on molecularly modified metal nanoparticles have been 
actively engaged in breath analysis for the diagnosis and monitoring of several diseases. 
Promising results have been obtained in the diagnosis of different type of cancers such 
as gastric cancer lung cancer, prostate cancer, as well as colorectal cancer [104,113-
116], kidney injury [116], chronic kidney disease [115,117,118], diabetes mellitus 
[118,119], Alzheimer’s and Parkinson’s diseases [115,120], renal disease [92], gastric 
cancer asthma and obstructive pulmonary disease [85,121], and multiple sclerosis, 
among others diseases [115].  
 
2.6.1.2. Sensing Mechanism of Ligand-capped Metal 
Nanoparticles Sensors 
In VOCs sensing with ligand-capped metal nanoparticles films, the metallic 
nanoparticles provide the electric conductivity through the film, while the organic 
ligand provides sorption sites for the analytes. The physical properties of the sensing 
film are mainly controlled by features such as nanoparticles size, type of capping ligand, 
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and distance between adjacent MNPs. Although it is still under debate, the conductivity 
of ligand-capped metal nanoparticles films has been qualitatively discussed from the 
view of an activated tunneling model [101,122]. In the context of this theory, VOCs 
response mechanism of the ligand-MNPs nanoassemblies in electrical sensors involves 
electrons tunneling between the metal cores, and charge hopping through the atoms of 
the organic ligand. The electronic conduction,  in a ligand-capped metal 
nanoparticles film is described by [101,107]: 
 ………………………… (1) 
and              ………………………………. (2) 
where  is a constant pre-exponential tunneling factor,  is the electron tunneling 
coefficient,  is the edge-to-edge separation of the metal cores,  is the tunneling 
activation energy associated with the charging of adjacent metal cores,  is the 
Boltzmann constant, and  is the absolute temperature.  
The two exponential factors in Eq. (1) describe two types of contributions to the 
electronic conductivity of the film. The first exponential factor takes into account the 
charge tunneling between neighboring particles through the organic ligand, which also 
describes the exponential dependence of  on  [123]. The second exponential factor 
includes the activation energy, , which is required to generate one positively and one 
negatively charged metal cores from two initially neutral cores, for charge transport to 
occur between them. Eq. (1) contains moreover the electric field induced activated 
tunneling, whereby adjacent metal cores become charged/discharged as electrons pass 
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through the intercore dielectric medium. Hence, the activation energy  also accounts 
the electronic charge, , the dielectric constant of the surrounding medium, , and the 
permittivity of the free space, , as well as nanoparticles radius,  as described by Eq. 
(2). Therefore, during VOCs sorption into the ligand capped-MNPs films, the molecules 
contact and react with tailored organic functional groups attached (or linked) to the 
MNPs, leading to changes in the measured electrical properties of the film, which can 
induce ligand-MNPs films swelling and/or change the permittivity of the medium 
between the MNPs metal cores [87]. These two competitive mechanisms induce 
electrical changes according to either of the following mechanism: i) 
reduction/increment in the number of electrically conductive percolation pathways 
between the MNPs (i.e., changes in the core-edge-to edge distance ( ), and/or ii) 
changes in the dielectric constant ( ), which can be a crucial factor during the 
absorption of small dielectrically different molecules into the sensing film [89]. For 
example, analyte molecules with high dielectric constant (e.g., ethanol, water, methanol, 
and ethanol) tend to provoke a decrease in the resistance of the film, while those with 
low dielectric constants (e.g., toluene and n-hexane) produce an increase in the 
resistance [124].  
The conductivity changes in ligand-capped MNPs nanoassemblies upon analytes 
exposure are also predominantly affected by the size and morphology of the metal cores 
as well as by the functional organic ligand attached to the MNPs [88]. Figure 2.6 
illustrates the response model for ligand-capped MNPs films to an analyte exposure as a 
function of film morphology and thickness. It is noted that two metal nanoparticles 
separated from each other can be electrically treated as a capacitor in parallel with a 
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resistor, where the organic matrix separates the two metal particles in a similar manner 
as a dielectric medium separates a plate capacitor [125]. In isolated ligand-MNPs films, 
where the distance between the metal cores becomes small enough, the charge can 
tunnel between the MNPs promoting a capacitive or resistive behavior of the junction 
when applying a bias. On the contrary, Joseph et al. showed that for ligand capped 
MNPs where the metal cores are separated by a large distance, the film remains non-
conductive and the ligand-MNPs nanoassemblies exhibit no response upon exposure to 
the analyte [101], as it is shown in Figure 2.6a [91].  On the other hand, as the core-to-
core MNPs are close enough, providing an island dominated morphology, charge 
transport occurs after a 1-dimensioanl percolation pathway is formed. Therefore, this 
percolation pathway contains large island-to-island gaps, which are bottlenecks for 
charge transport due to their high resistance, and result in Coulomb blockade behavior. 
Notably, changes in permittivity and a swelling-induced decrease of the distance of the 
island to island gaps are thought to be responsible for the observed decrease in 
resistance shown in Figure 2.6b. The origin of the non-linearity in the I-V curves can 
be related to the fact that the bottleneck junctions are single electron-charging carriers in 
the percolation pathways [91]. In a 3-dimensional network-like film, as the one shown 
in Figure 2.7c, where many percolation pathways are possibly formed, the ligand-
MNPs films usually respond with an increase in resistance when dosed with an analyte, 
assuming that film swelling increases the tunneling distance between the neighboring 
particles [91]. However, the films may swell only along the normal pathways, thereby 
only the percolation pathways that contribute to analyte sorption are influenced by the 
swelling [101]. On the contrary, swelling in the direction of the substrate might lead a 
decrease (shrinking) in the interparticles separation within the continuous 3D network-
like structure of the film, and hence the resistance of the film decreases.    
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Figure 2.6: Model for the ligand capped metal nanoparticles nanoassemblies film growth upon 
exposure to an analyte: a) during island nuclei formation and island growth; b) film at the 
percolation threshold; c) in three dimensional film after the percolation threshold, and their 
characteristic I-V curves measured during film exposure to the analyte (  – film resistance, 
 – minimum and initial resistance, and  –resistance change). Adapted from [91].  
 
2.7. Conclusion  
Due to its broad scope and applicability, breath analysis holds a great potential for 
diseases diagnosis because the VOCs profile in exhaled breath can provide both non-
invasive and continuous information on the metabolic and physiological state of an 
individual. Analytical techniques allow for the identification of the specific biomarkers 
of a disease, and can provide new insight into understanding the pathobiology of the 
disease. Electronic systems based on cross-reactive chemical gas sensors are suitable for 
the analysis of the overall complex mixture of volatiles from the exhaled breath, and 
due to their miniaturization features hold great potential for building small, easy-to-use, 
portable breath analysis diagnostic tools.    
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This chapter presents the . fabrication and characterization of the ultrapure 
ligand-capped metal nanoparticles chemical gas sensors, and prelimary VOCs 
sensing measurements.   
3.1. State-of-the-art 
A large number of metal nanoparticles- MNPs (Au, Cu, Pt, Pd, Ag, Fe, Zn, Cd) can be 
nowadays synthesized through different preparation routes, including chemical methods 
(e.g., chemical reduction of metal salts [1,2], sonochemical reduction [3], chemical 
vapor deposition [4], microemulsions [5], supercritical fluids [6,7], electrochemical 
synthesis [8]), and physical methods (physical vapor deposition [4,9], microwave 
irradiation [10], pulsed laser deposition [11], thermal evaporation [9], gamma radiation 
[12,13]). Generally, nanoparticles fabrication can be roughly divided into two 
categories: bottom-up approaches that comprise nanoparticles synthesis from their 
atomic and molecular precursors through chemical reactions while controlling their 
nucleation and growth to obtain the desired size and morphology, and top-down 
approaches that comprise nanoparticles synthesis from macroscopic precursors through 
subsequent subdivision into smaller particles through physical processes such as 
lithography, sputtering, laser ablation, and vapour phase deposition.     
The chemical methods are based on the use of microheterogenous systems such as 
colloids, liquids, crystals, gels or micellar solutions. The particles formed are 
suspended-like colloids, usually with particles size below 100 nm [14]. Through this 
method, the metal nanoparticles are produced in a liquid phase by reduction of their 
metallic salt precursors upon addition of reducing agents [14]. For example, gold 
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nanoparticles are synthesized using a two phase reduction approach as reported by Brust 
et al [14] (Figure 3.1).  
 
Figure 3.1: Brust’s method for the synthesis of gold nanoparticles by two phase chemical 
reduction process. Reproduced from [15].  
 
The method involves the transfer of gold hydrocholorate solution (HAuCl4.2H2O) into 
an organic phase (usually toluene) through  tetraoctylammonium bromide (TOAB), 
which is used as a stabilizing phase transfer agent, followed by the addition of aqueous 
sodium brorhydride (NaBH4) to reduce Au(III) to Au(0). This simple procedure allows 
the formation of 5-6 nm size AuNPs. However, the as produced nanoparticles have a 
natural tendency to form agglomerations or coalescence, and hence an efficient surface 
modification and stabilization are required. Strong nanoparticles stabilization can be 
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obtained by the use of alkylic thiols (usually from C6-C18 groups), resulting in a self-
assembled monolayer of nanoparticles. Nevertheless, the solvent based chemical 
synthesis of metal nanoparticles presents the drawback of using contaminants such as 
polymers that leave traces in the synthesized film, and requires a two phase process 
during nanoparticles surface modification with the desired functional organic ligand.   
Metallic nanoparticles can also be prepared by physical methods from their bulk metals 
through application of mechanical pressure, high energy radiation, evaporation or 
condensation as well as thermal energy to cause abrasion. These methods that mainly 
operate on the top-down approach are advantageous as they are free of solvent 
contamination and produce uniform nanoparticles.  
In view of these considerations, in my thesis I introduced an innovative physical route 
based on the Advanced Gas Deposition (AGD) technique, aiming at the fabrication of 
ultrapure monodispersed metal nanoparticles. The AGD process allows for log-normal 
size distribution of the nanoparticles, and crystalline ultrapure nanoparticles can be 
produced. The nanoparticles are less prone to agglomeration and coalescence, which are 
the major problems in the case of the MNPs prepared by other physical methods 
[16,17]. 
3.2. Fabrication of Ultrapure MNPs by Advanced Gas 
Deposition Technique  
Three different MNPs (AuNPs, PtNPs and CuNPs) were directly generated from their 
pure metal precursors and deposited on different substrates by the advanced non-
reactive gas deposition technique (Ultra Fine Particle Equipment, ULVAC Ltd, Japan 
[17]). The AGD technique consists two separating chambers, a lower chamber 
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evaporation occurs at (P1), and an upper depositing chamber- which is kept under good 
vaccuum (P2). A pellet of a precursor to be converted into particles is placed on top of a 
pedestal in the evaporation chamber and is heated by an inducton copper coil to the 
required temperature. Hense, the intense heating cuases the precursor to be evaporated. 
In addition, a a high purity cooling gas, usually inert gases (He or Ar), is introduced at 
the bootom of the lower chamber, and allows the vapor to transport from the vapor 
zone, thereby collides with the gas atoms or molecules and hence cooled,  leading to the 
formation of clusters of atoms, which ends up formation of ultrafine particles. Finally, 
the single nanopartiles are quickly transported to the deposition chmaber owing to the 
pressure gradient [17].  Hence, in our fabrication process, high purity metal pieces of 
gold (99.999 % purity), platinum wire (99.99 % purity), and copper pellets (99.99 % 
purity), were used as precursors for nanoparticles fabrication.  
 
Figure 3.2:  Schematic representation of the AGD equipment adopted in this study for 
ultrapure monodispersed metal nanoparticles fabrication 
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The AGD setup adopted in this study for the fabrication of ultrapure monodispersed 
metal nanoparticles is shown in Figure 3.2. Before starting nanoparticles synthesis 
process, the two AGD chambers (lower evaporation chamber and upper deposition 
chamber) were evacuated by means of several oil pumps until their pressure reached 
~0.02 mbar, in order to eliminate all the impurities from the equipment. After that their 
pressures were set to the adequate values that were determined for each metal in part 
(see Table 3.1), being the lower chamber kept at higher pressure (adjusted for each 
MPNs formation – see Table 3.1) and the upper chamber at lower pressure ( 0.09 
mbar) during metal nanoparticles synthesis.  
By applying a suitable power to the induction coil surrounding the metal source (4 kW 
for Au, 12 kW for Pt, and 3 kW for Cu), the metal precursor started to melt. The vapour 
zone formed above the molten metal consisted of metal atoms that gradually cooled 
down while they diffused through the He carrier gas introduced underneath the heated 
metal piece at a flow rate of 20 L/min, which carried them upwards. As the metal atoms 
experienced several collisions with each other, they started to agglomerate in such a 
way that nanoparticles were formed, leading to the nucleation and growth of ultrafine 
metal nanoparticles in the lower chamber. The stream of ultrafine nanoparticles 
generated in the lower chamber was then propelled to the upper chamber through the 
thin transfer pipe (3 mm diameter) that linked the two AGD chambers, which was 
heated by applying 40 kW power for avoiding condensations on its walls. Due to the 
pressure difference between the two chambers, the metal nanoparticles impinged at high 
speed onto the deposition substrate placed on the movable support in the upper 
chamber, and got sticky deposited on it. The speed of the movable support and the 
number of deposition cycles (i.e., number of times that the stream of nanoparticles 
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impinged onto the substrate during its movement inside the upper AGD chamber) were 
optimized to obtain a monolayer of dispersed metal nanoparticles. 
MNPs Precursor 
Purity (%) 
Metal Melting 
Point (ºC) 
Power 
(kW) 
pdep 
(mbar) 
pev 
(mbar) 
He flow 
(L/min) 
AuNPs 99.999 1064 4 0.09 90.8 20 
PtNPs 99.99 1768 12 0.09 90.8 20 
CuNPs 99.99 1085 3 0.09 94 20 
 
Table 3.1: Optimal conditions for the synthesis of monodispersed MNPs, where Pdep and Pev 
correspond to P2 and P1 of the deposition and evaporation chambers.  
 
3.2.1. AuNPs Fabrication 
For AuNPs synthesis, by optimizing the pressure in the evaporation chamber of the 
AGD equipment at 90.8 mbar, the formation of monodispersed AuNPs was achieved 
during one deposition cycle for the speed of the movable support set to 1 mm/sec 
(Figure 3.3a). The increase of the pressure in the evaporation chamber to 100 mbar 
favored the formation of small clusters of AuNPs because of the tendency of the 
nanoparticles to agglomerate due to Van der Waals interactions occurring between them 
at this higher pressure, which led to the deposition of small aggregates of AuNPs even 
at the highest speed of the movable support (2.5 mm/sec), set in order to minimize the 
deposition time of the AuNPs onto the substrate (Figure 3.3b). Importantly, 
nanoparticles size and shape did not change by modifying the pressure in the 
evaporation chamber, as it can be seen by the closer examination of the AuNPs clusters 
in Figure 3.3b. Further increase of the number of deposition cycles led to the formation 
of continuous networks of linked AuNPs (Figure 3.3c). A continuous thin film of 
AuNPs that fully covered the substrate (~30 nm thicknesses) was achieved by 
increasing the deposition time through lowering the speed of the movable support to 
1.25 mm/sec (Figure 3.3d).  
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Particles size distribution displayed in Figure 3.3e showed that the monodispersed 
AuNPs had a normal distribution, with a mean diameter of 9.7 ± 0.1 nm. The XRD 
Figure 3.3: SEM images of the AuNPs synthesised using the following experimental 
parameters of AGD (pressure in the evaporation chamber, speed of the movable support, and 
number of deposition cycles): (a) 90.8 mbar, 1 mm/sec, 1 cycle; (b) 100 mbar, 2.5 mm/sec, 1 
cycle; (c) 100 mbar, 2.5 mm/sec, 3 cycles; (d) 100 mbar, 1.25 mm/sec, 3 cycles. (e) Histogram 
of particles size distribution for the SEM image shown in Figure 3.3a. (f) X-ray diffractogram 
of the AuNPs thin film shown in Figure 3.3d. 
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spectra acquired on the thin AuNPs film, depicted in Figure 3.3f, exhibited diffraction 
peaks at 2θ diffraction angles of ~ 38.30, 44.40, 64.80 and 77.80, which were indexed to 
the (1 1 1), (2 0 0), (2 2 0) and (3 1 1) planes corresponding to face-centred cubic (fcc) 
Au (ICCD: 04-003.5615). A very strong intensity peak for Au (1 1 1) plane was 
observed at 2θ ~ 38.30, while weak intensity peaks were observed for Au (2 0 0) and Au 
(2 2 0) planes, which corresponds to the formation of pure crystalline AuNPs in 
agreement with that elemental Au. The mean crystallites size of the AuNPs calculated 
using Scherrer’s equation applied to the Au (1 1 1) peak at 38.30 was found to be ~10.7 
nm, which is in good agreement with the particles size distribution obtained from the 
SEM image of monodispersed AuNPs. This finding further confirmed that the size of 
the nanoparticles deposited by AGD does not change as a function of coverage, and 
even in the limit of a dense film the MNPs size is maintained. 
 
3.2.2. PtNPs Fabrication 
The deposition conditions determined for the synthesis of dispersed AuNPs were next 
applied for the generation and deposition of platinum nanoparticles (PtNPs) from their 
pure metal precursor. However, a higher induction heating power was needed for the 
generation of PtNPs because of the considerable higher melting point of Pt (1768 ºC) as 
compared with Au (1064 0C). Because of the different chemical and physical 
characteristics of the two metals, including saturated vapour pressure and melting 
temperature, a quasi-continuous thin film of PtNPs was formed (Figure 3.4a). The 
shape and particles size depend on the heating temperature, molecular weight, total 
pressure and flow rate of the inert gas [17]. Therefore, the size and distribution of the 
PtNPs deposited by AGD were different from those of the AuNPs employing the same 
experimental conditions, with the exception of the higher heating induction power. The 
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mean PtNPs size calculated from the histogram of the PtNPs shown in Figure 3.4a was 
found to be 3.0 ± 0.1 nm, while the narrow size distribution of the nanoparticles 
exhibited a statistical log-normal distribution (see Figure 3.4b), as it is commonly 
observed in the case of nanoparticles evaporated in an inert gas [17]. Because of the low 
diffusion rate of the Pt atoms into the He career gas, Pt particles nucleation and growth 
was rather limited, leading to the synthesis of ultrafine PtNPs of extremely small size. 
The X-ray diffractogram of the PtNPs thin film shown in Figure 3.4a, depicted in 
Figure 3.4c,  indicated four peaks attributed to four different crystalline phases of Pt at 
2θ ~ 39.8º, 46.2º, 67.4º and 81.2º, indexed as (1 1 1), (2 0 0), (2 2 0) and (3 1 1) planes, 
respectively (ICCD: 04-001-0112). The spectra exhibiting a strong diffraction peak at ~ 
39.8º depicted the deposition of pure crystalline PtNPs with a preferred growth 
orientation of Pt (1 1 1). The broadening and weak intensities of the other three 
diffraction peaks suggested relatively small surface density and particles size. Applying 
Scherrer’s formula to the (1 1 1) peak, the mean crystallites size was calculated as ~3 
nm, which is in excellent agreement with the mean Pt particles size estimated from the 
SEM analysis. 
 
Figure 3.4. (a) SEM image of the PtNPs deposited by AGD using the following processing 
parameters: 90.8 mbar pressure in the evaporation chamber; 1 mm/sec speed of the movable 
support; 1 deposition cycle. (b) Histogram of PtNPs size distribution calculated from Figure 
3.4a. (c) XRD spectra acquired on the PtNPs thin film shown in Figure 3.4a. 
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3.2.3. CuNPs Fabrication 
Finally, the same experimental conditions were employed for the generation and 
deposition of CuNPs. As copper has a melting point (1085 0C) close to the gold (1064 
0C), similar characteristics were expected for the CuNPs, comparable with those of the 
AuNPs. However, the vapor region formed above the melted Cu precursor contained a 
very low concentration of Cu atoms in the He carrier gas where particles nucleation and 
growth took place. For this reason, barely few nanoparticles were deposited on the 
substrate. In order to enhance particles nucleation, the pressure in the evaporation 
chamber was increased to 94 mbar. Figure 3.5a shows the SEM image of the thin film 
formed on the substrate when the pressure in the evaporation chamber was set to 94 
mbar. This figure revealed the deposition of a continuous layer of ultrafine particles of 
extremely small grain size. The CuNPs, moreover, showed to be partly oxidized under 
the low vacuum conditions employed in AGD, and a thin oxide protective layer was 
inferred from XRD and FTIR studies. This is not surprising considering that Cu is 
known to be highly susceptible to oxidation [18]. The histogram of particles size 
distribution indicated a mean particles size of 2 ± 0.05 nm, with narrow size and 
statistical log-normal distribution (Figure 3.5b), similar to the case of PtNPs. The 
structure and surface analysis of the thin film shown in Figure 3.5a was next 
characterised by XRD. The diffraction peaks acquired, shown in Figure 3.5c, confirmed 
the formation of both metallic CuNPs and cuprous oxide (Cu2O). The diffractogram of 
the film analyzed inferred six diffraction patterns, with 2θ diffraction angles at ~ 29.9º, 
36.9º, 43.3º, 50.4º, 62.2º and 74.1º, indexed with the Cu2O (1 1 0), Cu2O (1 1 1), Cu (1 
1 1), Cu (2 0 0), Cu2O (2 0 0) and Cu2O (3 1 1) planes characteristic for metal copper 
and its Cu2O oxide, respectively (ICDD:04-006-5764; ICCD:04-004-7864) [19,20]. The 
strong diffraction peaks observed at 2θ ~ 36.9º and 43.3º exhibited characteristic peaks 
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corresponding to cuprous oxide and metallic Cu in their (1 1 1) preferred crystallite 
phase orientation. The weak intensity peak at 74.1º where Cu (2 2 0) and Cu2O (3 1 1) 
crystal planes overlapped, confirming the coexistence of both metallic CuNPs and 
cuprous oxide.  
 
In general, the XRD analysis revealed the generation and deposition of ultrafine single 
crystalline metallic CuNPs and Cu2O nanoparticles. No characteristic peaks of cupric 
oxide (CuO) were observed in the XRD pattern, indicating the formation of an ultrapure 
nanocrystalline thin film. The mean crystallites size of the nanoparticles, calculated 
 
Figure 3.5: (a) SEM image of CuNPs deposited by AGD using the following processing 
parameters: 94 mbar pressure of the evaporation chamber, 1 mm/sec speed of the movable 
support, 1 deposition cycle. (b) Histogram of Cu nanoparticles size distribution calculated from 
Figure 3.5a. (c) XRD spectra acquired on CuNPs thin film shown in Figure 3.5d. Raman 
spectra of the CuNPs film showing traces of Cu2O layer. 
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using Scherrer’s formula applied to the (2θ) peaks at ~ 36.9º and 43.3º, were found to be 
~4 nm and ~4.5 nm for CuNPs and Cu2O, respectively. The difference between 
crystallites size calculated by applying Scherrer’s formula and the mean particles size 
estimated from the SEM histogram presented in Figure 3.5b came from the level of 
SEM resolution.  
Raman spectroscopy studies ascertained the formation of cuprous oxide layer at the 
surface of the metallic copper nanoparticles.  
The corresponding Raman spectra shown in Figure 3.5d revealed a composite 
Cu2O/CuNPs film exhibiting characteristic Cu Raman peaks at 148 cm
-1 and 213 cm-1, 
and peaks at 530 cm-1 and 628 cm-1 that were assigned to the Cu2O phase [21]. No 
Raman bands were recorded above 800 cm-1, which further indicates that no other 
oxides were formed. 
 
3.3. Surface Functionalization of the as-Deposited MNPs 
In the next experimental step, the metal nanoparticles as-deposited by AGD were 
functionalized with a broad  range of organic ligands with different carbon chains (C3 to 
C18), tail structures and head groups (either thiol or amine), for promoting the 
formation of MNPs-organic nanoassemblies through the nanoparticles-ligand 
interaction [22]. The selected molecular ligands comprized either a long hydrocarbon 
chain or an aromatic ring in their tail, which enables the interaction between 
neighbouring tails, while the thiol or amine head groups provide binding affinity with 
the MNPs surface [23]. The ligands were selected such as to cover a wide range of 
possible tail functional groups, head groups and chain lengths, for assessing the ability 
of the MNPs fabricated by AGD to build strong and stable self-assembled MNPs-
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organic ligand nanoassemblies. The following four groups of organic ligand were 
totally employed:  
I. Ligands with non-polar hydrocarbon chain in their tail and a thiol head group: (A) 
2-butanethiol (2-BUT), (B) 1-decanethiol (1-DT), (C) 1-dodecanethiol (1-DDT);  
II. Ligands with non-polar aromatic ring in their tail and a thiol head group: (D) 4-
methoxy-α-toluenethiol (4-MTT), (E) 2-mercaptobenzoxazole (2-MBZO); 
III. Ligands with hydrocarbon chain and polar functionality in their tail and a thiol head 
group: (F) 11-mercaptoundecanol (11-MUD), (G) 11-mercaptoundecanoic acid 
(11-MUDA), (H) methyl-3-mercaptopropionate (MMPP);  
IV. Ligand with long hydrophobic chain with non-polar tail and amine head group: (I)      
oleylamine (ODA).  
The structures of the selected organic ligands are shown in Figure 3.6.  
For MNPs functionalization, solutions were prepared as follows: 100 µL of 2-
butanethiol, 1-deanethiol, 1-dodecanethiol, oleylamine, 4-methoxy-α-toluenethiol and 
methyl-3-mercaptopropionate (liquid in their normal sate) were dissolved in 20 mL 
ethanol; 10 mg of 11-mercaptoundecanoic acid and 75 mg of 2-mercaptobenzoxazole 
(solid in their normal state) were dissolved in 20 mL of ethanol; and 5 mg of 11 
mercapto-1-undecanol (solid in its normal state) was dissolved in 5 mL of chloroform. 
The solutions were stirred with a magnetic stirrer for 30 min at room temperature to 
ensure homogeneity.  
 
The dip coating method was then employed for the functionalization of the as-deposited 
metal nanoparticles with the organic ligands. 
The substrates with the metal nanoparticles deposited by AGD were dipped into the 
solution of each ligand for one hour, and then the substrates were dried in an oven for 
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one hour at 50 0C with a ramp of 10 0C/min to ensure solvent evaporation. This process 
was repeated in some cases several times until a self-assembled MNPs-organic ligand 
monolayer was formed. In the case of AuNPs, the functionalization was performed on 
the monodispersed AuNPs structure shown in Figure 3.3a, while in the case of PtNPs 
and CuNPs, ligand bonding was done on the structures shown in Figure 3.4a and 
Figure 3.5a, respectively. 
 
Figure 3.6: Molecular structure of the organic ligands used for MNPs functionalization. 
 
The ligands bounded through the thiol or amine head groups to the free regions of the 
MNPs not attached to the substrate, available for molecules attachment. The capping 
ligands under study had distinct characteristics, which produced different 
nanoassemblies structures and different surface coverage for each ligand, which are 
summarized in Table 3.2.  
The morphology of the nanoassemblies characterised by SEM is presented in Figure 
3.7 for some of the organic ligands. 
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In the case of AuNPs functionalization, all ligands were able to bind the surface of the 
AuNPs, producing self-assembled monolayer nanoassemblies after a single or several 
dipping processes into the ligand solution. It is assumed that the monodispersed AuNPs 
provided surface interactions for the ligands through their head group, while the tail-tail 
interactions of neighbouring ligands completed the network. 
 
The self-assembly of the alkanethiols was driven by the strong affinity between the 
sulphur and the gold, with Van der Waals interactions between the alkyl (aromatic) 
chains, and dipole interactions between the polar end groups.  
Figure 3.7a displays a well-ordered self-assembled monolayer of 1-dodecanethiol 
linking the AuNPs, which fairly covered the surface of the base substrate, while figure 
Figure 3.7b depicts a denser monolayer of 4-methoxy-α-toluenethiol chemisorbed onto 
AuNPs surfaces. These two ligands most likely exhibited strong attachment on AuNPs 
surfaces and achieved tail to tail hydrogen bonding with the neighbouring attached 
Organic ligand AuNPs PtNPs CuNPs 
2-BUT Clusters network, low 
coverage (24%) 
No ligand capping No ligand capping 
1-DT Linked nanoparticles 
network, low coverage 
(26%) 
No ligand capping Well ordered, medium 
coverage (60%) 
1-DDT Well ordered, low 
coverage (34%) 
Medium coverage (56%) Clusters network, low 
coverage (37%) 
4-MTT High coverage (86%) Medium coverage (58%) Medium coverage (55%) 
2-MBZO Short-linked clusters 
network, high coverage 
(84%) 
Isolated clusters, low 
coverage (29%) 
Well ordered, medium 
coverage (51%) 
11-MUD Low coverage (18%) No ligand capping Low coverage (16%) 
11-MUDA Low coverage (24%) High coverage (71%) Medium coverage (66%) 
MMPP Low coverage (20%) Medium coverage (53%) No ligand capping 
ODA Low coverage (25%) Isolated clusters, low 
coverage (42%) 
Low coverage (26%) 
Table 3.2. MNPs-ligand nanoassemblies characteristics. Low coverage refers to surface coverage 
below 50%; medium coverage to surface coverage between 50% and 70%; and high coverage to 
surface coverage over 70%.  
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ligands. Figure 3.7c also demonstrates a high density self-assembled monolayer for 2-
mercaptobenzoxazole bonded on AuNPs surfaces. The ligands 4-MTT and 2-MBZO 
consisted of polar aromatic ring structures in their tail, and multiple H-bonding might 
have been developed between neighboring molecules leading to well-ordered self-
assembled monolayer nanoassemblies (Figure 3.7(b-c)). 
 
Figure 3.7: SEM images of self-assembled: (a) AuNPs capped with 1-DDT; (b) AuNPs capped 
with 4-MTT; (c) AuNPs capped with 2-MBZO; (d) AuNPs capped with 1-DT; (e) PtNPs 
capped with 1-BUT; (f) CuNPs capped with 2-MBZO.  
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Figure 3.7d shows the formation of a less-ordered monolayer with low surface 
coverage when the AuNPs were capped with 1-decanethiol, probably due to the steric 
stability of the AuNPs that drastically reduced the surface charge interactions towards 
the thiol, avoiding strong covalent bonding. In the case of PtNPs functionalization, 
some organic ligands (MMPP, 11-MUDA, 4-MTT, and 1-DDT) could form quite dense 
and rather homogenous monolayers of PtNPs-organic nanoassemblies, probably due to 
the extremely small crystallites size of PtNPs (3 nm mean diameter, in comparison with 
10.7 nm for AuNPs), which influenced their interaction with the organic ligands. For 
the first three ligands, this might be explained as these molecular organic ligands 
contain either polar or aromatic tail and a thiol head group that was chemisorbed on the 
surface of the PtNPs, promoting stable NPs-ligand nanoassemblies with strong tail-tail 
electrostatic interactions and hydrogen-bonding. The adsorption of the non-polar 1-
DDT on the surface of ultrafine PtNPs might be due to the compromize between the 
hydrocarbon chain length, suitable for the formation of a self-assembled monolayer, and 
the strong Pt-S interactions, leading to substantially stable NPs-ligand nanoassemblies. 
The organic ligands with hydrophobic and non-polar tail that did not form stable NPs-
ligand nanoassemblies had shorter carbon chains that might have accommodated head-
tail steric effects on the surface of the NPs (see Figure 3.7e as a representative example 
for this case). Although presenting a similar structure with 11-MUDA, the less polar 11-
MUD organic ligand has neither achieved suitable PtNPs linking. 
For CuNPs functionalization, all molecular ligands except 2-BUT led to the 
formation of NPs-organic nanoassemblies. The morphology of the CuNPs-
organic nanoassemblies revealed the formation of a flatted ligand-nanoparticles 
layer (Figure 3.7f). It is likely that the presence of the protective thin oxide layer 
on the nanoparticles surface enhanced the surface attachment of the ligands 
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through Cu2O-S, Cu-O=C and COO-Cu bonding in addition to the expected Cu-S 
attachment. In this case, the ligands might have multiple interactions through a 
strong H-bonding with the surface coating oxide and the NPs. In the case of 2-
BUT, the failure of adequate ligand capping could be explained as the smaller C-
C chain length of this ligand was not suitable to maintain tail-to-tail networking 
able to form ligand-NPs nanoassemblies. 
Notably, the CuNPs and PtNPs exhibited very different assembly patterns 
although their particle sizes were quite similar each other, which is attributed to 
the susceptibility to oxidation of the CuNPs surface expozed to environmental air, 
leading to composite Cu2O/CuNPs films (see Figure 3.5). 
The surface coverage of each nanoassembly was calculated considering the area 
covered by the MNPs and by the ligands networking the nanoparticles. For this 
end it was applied image analysis in Matlab, and the percentage of surface 
coverage was calculated as the fraction of the pixels covered by the nanoassmbly 
from the total number of pixels of the image. As a representative example, 
Figure 3.8 shows the AuNPs-1-DDT nanoassembly and the corresponding image 
mapping in Matlab that was used to calculate the surface coverage. For this 
nanoassembly the calculated surface coverage was 34%.  
XPS studies were also performed to further investigate the elemental composition 
of the nanoassemblies surfaces. The elemental surface composition of the MNPs 
before and after functionalization with different organic ligands is presented in 
Figure 3.9. 
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Figure 3.8: (a) SEM image of the AuNPs-1-DDT nanoassembly; (b) Image mapping of 
the SEM image from Figure 3.7a, used for image analysis in Matlab. 
 
PtNPs samples composition is not shown in Figure 3.9 because the PtNPs were 
too small and the XPS elemental composition was mostly dominated by 
photoelectrons coming from the substrate atoms corresponding to Si and O. 
 
Figure 3.9: Surface elemental composition calculated from the XPS spectra for: (a) AuNPs and 
various AuNPs-ligand nanoassemblies; (b) CuNPs, and both CuNPs-ligand and PtNPs-ligand 
nanoassemblies. 
 
As representative examples of AuNPs-ligand nanoassemblies, Figure 3.10a 
shows the XPS spectra of the AuNPs capped with three organic ligands (1-DDT, 
4-MTT and 2-MBZO). The XPS spectra of these films are consistent with the 
successful functionalization of the AuNPs with the organic ligands, as manifested 
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by the signal intensity of each core level region in each sample. Due to samples 
exposure to air, the XPS spectra revealed detectable oxygen in all MNPs-ligand 
nanoassemblies in addition to oxygen coming from the SiO2/Si base substrate. 
The elemental surface characterization of the nanoassembly formed by the PtNPs 
capped with 11-MUDA is shown in Figure 3.10b as a representative example of 
the self-assembled PtNPs-organic monolayers. The XPS spectra of this 
nanoassembly exhibited the presence of core-level spectra of Pt4f, C1s, S2p and 
O1s, which originated from the PtNPs and the corresponding adsorbed ligand, 
respectively. The XPS signal for Si2p is associated with the uncovered SiO2/Si 
substrate where the nanoparticles were deposited and functionalized. 
The elemental surface analysis of the CuNPs-organic nanoassemblies revealed 
that, in general, the sulphur S2p signal was very weak due to inelastic scattering 
of S2p electrons by the molecules in the monolayer, and in some cases the metal-
S covalent bonding resulted in partial oxidation at the metal-S interfaces 
mediated by the metal nanoparticles. The ultrafine CuNPs, however, exhibited 
high surface density atoms that enhanced the surface attachment of the organic 
ligands. XPS spectra of different CuNPs-organic nanoassemblies are presented in 
Figure 3.10c, for 11-MUDA, ODA and 2-MBZO capping. The acquired spectra 
illustrated that the surface density of the CuNPs-2-MBZO nanoassembly was 
much higher as compared with the CuNPs functionalized with 11-MUDA and 
ODA. This might be related to the surface charge density of the aromatic ring that 
electrostatically stabilized the small size CuNPs. Besides, the XPS surface 
analysis of the CuNPs-ODA and CuNPs-11-MUDA nanoassemblies presented 
very low percentages of CuNPs, which was beyond the sensitivity of the device 
that was unable to recognize the surface electrons originated from the CuNPs.  
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Figure 3.10: (a) XPS spectra acquired for: (a) AuNPs capped with: 1-DDT (black); 4-MTT 
(red); 2-MBZO (blue); (b) PtNPs capped with 11-MUDA; (c) CuNPs capped with: oleylamine 
(ODA) (black), 2-mercaptobenzoxazole (2-MBZO) (blue), and 11-mercaptoundecanoic acid 
(11-MUDA) (red). 
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Deeper XPS investigations focussed on the elemental scans of the 
nanoassemblies surfaces are shown in Annex I. 
 
3.4. Fabrication and Characterization of Ligand-Capped 
MNPs Chemical Gas Sensors 
3.4.1. Sensors Design and Fabrication 
Gas sensing devices were fabricated on a 2-inch, p-type, 10-20 Ω, <100> oriented, 275 
μm thick, single-side polished silicon wafer. A 200 nm thick SiO2 layer was first grown 
on top of the silicon wafer by dry thermal oxidation at 1100 ºC. Two parallel 15-m 
gapped gold electrodes were then patterned using thin positive photoresist and laser 
lithography. A 200 nm thick gold film and 15 nm thick titanium (Ti) was sputtered on 
the SiO2 surface, and a lift-off process with acetone was finally employed for removing 
the Au/Ti outside the electrodes area. Figure 3.11 illustrates the standard 
microfabrication process and the sensing substrates and the sensing devices.   
 
Figure 3.11: Sensors substrates microprocessing (left and middle), sensing devices (right) 
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3.4.2. Electrical Characterzation 
The electrical resistance of the MNPs films deposited between the two 15 m gapped 
sensors parallel gold electrodes was characterized after MNPs deposition, and after 
MNPs functionalization with the different organic ligands.  
No electrical current could be measured between the electrodes after the deposition of 
monodispersed MPNs by AGD, which confirmed that the MNPs were not linked with 
each other. After MNPs functionalization, the self-assembled nanostructures generally 
formed uninterrupted core-shell nanoparticle-ligand networks that promoted an electric 
path between the electrodes. Figure 3.12 shows the electrical resistance measured for 
all the nanoassemblies produced in this study; however, it is important to point out that 
the electrical properties of these nanoassemblies can be tuned by adjusting the 
fabrication parameters.  
As depicted in Figure 3.12, all capping ligands produced a continuous network of the 
self-assembled monolayer with the AuNPs (~10.7 nm mean diameter). Despite the 
smaller crystallites size of CuNPs (~4 nm mean diameter), most CuNPs-organic 
nanoassemblies exhibited an electrical resistances between the electrodes, while the 
nanoassemblies of monolayer-capped PtNPs (~3 nm mean diameter) were able to 
promote electronic conduction only for few organic ligands: MMPP, 11-MUDA, 4-
MTT and 1-DDT. The electrical resistance of these films was lower, confirming the 
medium-high surface coverage presented in Table 3.2. The robustness of the developed 
nanoassemblies was evidenced by the small drift produced in the electrical resistance 
during one year period (below 12% for all nanomaterials). 
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Figure 3.12: Electrical resistance of all the MNPs-ligand nanoassemblies produced.  
 
In these MNPs-ligand nanoassemblies, the MNPs are assembled via organic molecules 
that act as interparticles mediators, and the conduction through these nanostructures is 
provided by the electron tunnelling mechanism throughout the nanoparticles-ligand 
network. The MNPs provide the electronic charge, and electrons transport occurs by 
electrons jumping between neighboring nanoparticles through the organic matrix 
[24,25]. Even in the case of the long organic ligand that has no conjugation (i.e., 11-
MUDA), the carboxylic group from its tail could induce a chemical interaction with the 
tail of the neighboring organic molecule, which linked the MNPs and as a result an 
active percolation path was developed through the nanoassembly [26]. 
The further electrical characterization of the MNPs-ligand nanoassemblies revealed that 
the monolayer-capped AuNPs and the monolayer-capped PtNPs showed a Schottky 
diode behavior, where the electron transport through the sensing film is determined by 
the nano-assembly’s distribution of conducting paths, and the electrical conductivity 
depends on the actual current injection site that determines the positive and negative 
electrode, as indicated by the asymmetry of the I–V characteristic (Figure 3.13(a-b)). 
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On the other hand, the monolayer-capped CuNPs showed a resistor behaviour that is 
attributed to the formation of the thin Cu2O passivation layer on the nanoparticles 
surface (Figure 3.13c).  
 
Figure 3.13: I-V characteristic curves of: (a) AuNPs capped with 2-MBZO; (b) PtNPs capped 
with 4-MTT; (c) CuNPs capped with 2-MBZO. 
 
Figure 3.14: I-V characteristic of the dodecanethiol-capped AuNPs device. The zoom shows 
the value of the threshold voltage. 
 
Deeper characterization was performed on the dodecanethiol-capped AuNPs diode, 
which revealed a conduction threshold voltage of ~0.4 V, which is in line with data for 
(a) (b) (c) 
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typical metal-weakly doped semiconductor Schottky diodes (~0.3 V) [27] (Figure 
3.14). 
3.4.3. Gas Sensing Measurements 
Gas sensing measurements were performed by exposing the dodecanethiol-capped 
AuNPs Schottky-diode sensing device, placed inside a Teflon test chamber of ~4 cm3 
volume, to acetaldehyde as target VOC (selected as representative breath biomarker 
identified for lung cancer in previous studies [28]), and ethanol and ethylbenzene as 
interfering species. The device was operated in direct polarization mode, and the current 
between the electrodes was monitored while the applied voltage was successively swept 
forward and backward between 0 V and +10 V. The sensing measurements were 
performed at room temperature (22.5±1 ºC) and comprized successive exposure cycles 
to synthetic dry air (40 min) and to different concentrations of VOCs (obtained from 
100% purity bottles) diluted in synthetic dry air (20 min) at a constant flow rate of 200 
mL/min. Humidity effect was investigated by introducing water vapour to the 
measurement gas flow by means of a glass bubbler, such that to obtain at the output of 
the sensors chamber two different relative himidity (RH) levels (30 and 70%), covering 
a high RH range. 
The sensor response was extracted from the I–V characteristic at each voltage (see in 
Figure 3.15, as representative example, sensor’s response to 30 ppm acetaldehyde 
extracted at 3.33 V on the backward curve), and indicated good repeatability and 
recovery. Data were taken to assess the response to the gas at several voltages and to 
monitor the relative current change produced by sensor’s exposure to acetaldehyde in 
comparison with the current in synthetic dry air according to Equation 1.  
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
95 Fabrication and Characterization of Chemical Sensors 
 
Chapter 3 
 …………………………(1) 
where  is the sensor’s response at the voltage V,  is the current at voltage V in 
the presence of the VOC, and  is the current at voltage V in synthetic dry air prior to 
VOC exposure. The mean value over three successive exposures to the VOC were used. 
Figure 3.16 shows the response curve obtained from sensor’s exposure to 30 ppm of 
acetaldehyde. The diode sensing device was operated in the positive polarization mode, 
with the metal (i.e., the AuNPs) at a higher potential than the organic material. By 
increasing the voltage, the potential barrier is decreased. 
 
Figure 3.15: Sensor’s response extracted from the I-V characteristic at 3.33 V on the backward 
curve.  
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As the voltage exceeds the conduction threshold voltage (0.4 V; see Figure 3.14), 
electrons from the organic material cross over to the AuNPs. When the dodecanethiol-
capped AuNPs sensing material is exposed to acetaldehyde, there is charge exchange 
between the sensing material and acetaldehyde via steric interaction between the 
sensing film and the sensed analyte (i.e., film swelling due to analyte adsorption), which 
alters the charge carrier transport [29]. However, the passing over of the conduction 
threshold voltage does not produce an increase in the number of electrons that cross the 
potential barrier upon absorption of the VOC until the applied voltage reaches a 
sufficient value (3.33 V; see Figure 3.16). Favoured by the accumulation of electrons 
generated by the VOC adsorbed by the sensing film, there is a sudden enhancement of 
the electrons’ carrier transport and the sensor’s response reaches its maximum value. 
The response is then decreasing as the capacity of the adsorbed VOC to generate new 
electrons is limited by the total VOC concentration. When the voltage is swept 
backward, the observed phenomena are opposite, with the remark that the sensor’s 
response reaches its maximum value at a lower voltage compared with the forward 
characteristic (2.5 V; see Figure 3.16), which is attributed to the hysteretic behaviour of 
the Schottky barrier height variation arising from the material's polarization reversal 
[30]. By further lowering the value of the voltage applied, the potential barrier height 
increases over the value at which the electrons from the organic material could cross 
over to the AuNPs, which produces the inhibition of electrons' carrier transport through 
the Schottky diode device and sensor's response becomes zero. 
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Figure 3.16: Response curve obtained from the dodecanethiol-capped AuNPs sensor exposed 
to 30 ppm of acetaldehyde. 
 
These results allowed determining the voltage at which the maximum response point 
could be obtained (3.33 V on the forward curve), which was then used to asses sensor’s 
behavior at a constant bias. Sensor’s response to 30 ppm of acetaldehyde at a constant 
operation voltage of 3.33 V is shown in Figure 3.17. The response achieved in this case 
(13.3%) was quite similar with the response extracted at the same voltage on the 
forward curve when the sensor was operated as a Schottky diode (13.7%).  
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Figure 3.17: Sensor’s response to 30 ppm of acetaldehyde at a constant operation voltage of 
3.33  
 
For calculating the limit of detection (LOD) for acetaldehyde exposure, the sensor was 
exposed to different concentrations of acetaldehyde in the concentrations range from 5 
to 30 ppm. The calibration curve was plotted with the response values extracted at 3.33 
V on the forward curve (see Figure 3.18). The LOD was calculated with the formula 
from equation (2), giving a value of LOD ≈ 2.5 ppm. 
LOD = 3 x Sa/b  (2), 
where Sa is the standard deviation of the y-residuals and b the slope of the regression 
line of the calibration curve provided in Figure 3.18. 
When the sensor was exposed to acetaldehyde under different humidified backgrounds, 
it was observed a decrease in its response under the low humidity level (30% RH), 
while under the high humidity level (70%) sensor’s response dramatically increased 
(see Figure 3.19).  This is similar to other findings, which reported that the response of 
sensors based on gold-thiolate monolayer-protected nanoparticles decreases with 
humidity increase in the low humidity range, when the film swelling governs sensor’s 
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responses, while at high humidity the change in the dielectric properties governs the 
responses, which begin to reverse [31,32]. 
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Figure 3.18: Calibration curve for acetaldehyde detection  
 
Sensor’s responses to two interfering species (ethanol and ethylbenzene) showed 
significantly different response patterns (see Figure 3.19), which indicates that the 
measurement technique and the novel method introduced in this study to analyze the 
response of a Schottky-diode chemical gas sensor offers novel features for 
fingerprinting VOCs detection.  
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Figure 3.19: (up) Response curves to 30 ppm of acetaldehyde obtained under different 
RH levels; (down) Inset  
 
Importantly, the sensor was studied over a three years period, keeping intact its 
operation capabilities throughout all this period, which suggests a good robustness and a 
long lifetime period.  
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Figure 3.20: Response curve obtained from sensor’s exposure to different VOCs. 
 
3.5. Conclusion 
Ultrapure monodispersed metal nanoparticles of various metals (Au, Pt and Cu) were 
fabricated in a single step process from their pure metal precursors by the Advanced 
Gas Deposition technique. By employing this method, the major problem associated 
with nanoparticles tendency to aggregate that occurs in the case of other physical 
deposition techniques was avoided by the direct evaporation of the pure metal and 
nanoparticles growth by condensation under a high purity inert gas. Although the thesis 
work was focussed on AuNPs, PtNPs and CuNPs synthesis only (mean crystallites 
sizes: ~ 10.7 nm, 3 nm and 4 nm, respectively), the technique can be easily extended to 
practically any MNPs synthesis using the proper metal source and adjusting the 
synthesis parameters.  
A broad range of organic ligands with different carbon chains, tail structures and head 
groups, were then used to functionalize the MNPs by dip-coating the substrates in a 
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solution formed in high purity reagents, which led to the formation of self-assembled 
nanoparticles-organic monolayers with a network-like structure. The MNPs-ligand 
nanoassemblies presented hybrid characteristics, where the nanoparticles served for 
electrical conduction, while the capping organic molecule promoted electron tunnelling 
through the MNPs, which produced a measurable resistance in the range of tens of  kΩ 
to tens of MΩ for most of the nanoassemblies.  
These high-purity functional nanoassemblies could impart interesting chemical, 
physical and electrical properties, suitable for varios applications such as VOCs sensing. 
Importantly, the characteristic properties such as shape, size, and monodispesity of 
these nanoassemblies can be tuned by properly adjusting the fabrications parameters.  
Chemical gas sensing devices based on these functional nanoassemblies showed 
Schottky-diode and chemiresistive behavior. This was the first observation of Schottky-
diodes fabricated from nanomaterials based on metallic nanoparticles. Preliminary gas 
sensing experiments demonstrated that these devices were suitable for detection of 
volatile organic compounds.  
An array of chemical gas sensing devices based on these nano-assemblies was next 
employed during my thesis for assessing the potential of tropical diseases diagnosis 
through exhaled breath analysis. 
 
3.6. Experimental Methods 
3.6.1. Materials Characterization 
During the MNP fabrication and functionalization, the morphology and surface analysis 
studies were performed with a Zeiss LEO 1550 High Resolution Scanning Electron 
Microscope (HR-SEM), using a field emission gun as electron source, an acceleration 
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voltage of 10 kV and high magnification values (300,000-1,000,000), and 1 nm 
resolution. The structure and phase orientation of the metal nanoparticles were acquired 
by X-ray Diffraction (XRD) using a Siemens D5000 equipment operated with CuKα 
radiation (λ=1.54 Å). Crystallites size was calculated from the X-ray diffractograms by 
applying Scherrer’s formula: 
D= Kλ/βcosθ, 
where D is the volume-weighted average crystallite size, K is the Scherrer constant and 
takes into account the morphology of the crystallites (K = 0.94 corresponding to 
spherical crystallites was used here), λ is the x-ray wavelength, β is the peak width at 
Full width at Half Maximum (FWHM), and θ is the diffraction angle. The elemental and 
chemical composition of the nanoassemblies were characterised by X-Ray 
Photoelectron Spectroscopy (XPS) using a PHI Quantum 2000 equipment with an AlKα 
X-ray energy source of 1486 eV having a beam diameter of 200 µm. Survey scans were 
measured with a pass energy of 58.7 eV and resolution of 1 eV where high resolution 
scans were measured with a pass energy of 23.50 eV and 0.025 eV resolution. Energy 
range of the survey scans were 1100-0 eV. To control samples charging, a neutralizer 
filament was used in all measurements. CasaXPS software (version 2.3.16) was used for 
the spectral curve fittings, while the binding energies were referenced to the C1s of 
alkyl chains at 248.8 eV. The peaks were fitted with a Gaussian-Lorentzian function and 
Shirely type background. Raman Spectroscopic spectra of Cu2O NPs thin films were 
performed using Raman FTIR (Leica DM 2500 equipment) with laser energy of 514 
nm. Transmission Electron Microscopy (TEM) images were acquired employing a Jeol 
JEM 1011 equipment (1 nm maximum resolution), operated at 100 kV accelerating 
voltage under high vacuum. 
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Glass substrates (76×26×1 mm3, Gerhard Menzel GmbH, Germany) were used for XRD 
and FTIR analysis, and single side polished 4-inch Si wafer with 1 µm thickness silicon 
oxide on top (Silicon Materials, Germany) for SEM and XPS analysis.  
 
3.6.2. Substrates Treatment 
Before placing the substrates in the AGD equipment for nanoparticles synthesis, they 
were cleaned by successive wash in an ultrasonic bath for 5 min in propanol and 
acetone, followed by rinsing with deionised water and drying with blowing 
nitrogen flow. When the silicon substrates with the patterned gold electrodes 
were employed, the substrate was covered with Kapton tape that left uncovered 
only the gap between the gold electrodes for the deposition of the nanoparticles 
exclusively in between them. 
 
3.6.3. Electrical Measurements 
The electrical resistance of the sensors was measured with a high-precision 
Keysight power source (B2902A, Keysight Technologies, Hungary), using an 
internal applied voltage of 1 V. The characteristic I-V curves were measured by 
applying a sweeping voltage between -10V and +10V between the two sensor’s 
gold electrodes, at a sweep rate of 0.1 V/sec, and acquiring the current between 
the electrodes. 
3.6.4. Materials and Reagents 
All chemicals employed for nanoparticles functionalization were of analytical grade and 
used as received. 1-dodecanethiol: CH3(CH2)11SH (98% purity); 4-methxoy-α-
toluenethiol: CH3OC6H4CH2SH (90% purity); oleylamine: C18H35NH2 (98% purity), 2-
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
105 Fabrication and Characterization of Chemical Sensors 
 
Chapter 3 
mercaptobenzoxazole: C7H5NOS (99% purity); 11-mercaptoundecanoic acid: 
C11H22O2S (98% purity); 1-butanethiol: CH3(CH2)3SH (99% purity); 1-decanethiol: 
CH3(CH2)9SH (96 %  purity); methyl-3-mercaptopropionate: HSC4H5O2  (98% purity); 
11-mercapto-1-undecanol: HO(CH2)9SH (97% purity); ethanol (99.5% purity); 
chloroform (99% purity); acetone (95% purity) and  isopropanol (96%), were purchased 
from Sigma Aldrich. 
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This chapter presents the breath sampling procedure adopted in this study, 
and the study population that provided breath samples for analysis.  
 
4.1. Breath Sampling 
4.1.1. Introduction 
The reliable measurement of metabolic body conditions through exhaled breath analysis 
requires the use of a proper breath acquisition method that captures the alveolar part of 
the breath (which is most likely to contain the metabolites exchanged by the blood with 
the lungs and exhaled then through breathing [1]) and avoids as much as possible 
external interferences. Nevertheless, although the International Association for Breath 
Research (IABR) set up a sampling and standardization task force, breath sampling is 
not currently a standardized technique. Different breath capture methods were proposed 
so far, which ranged from directly breathing into an analysis platform, to the relatively 
simple collection in plastic Tedlar® bags, aluminized Mylar bags, or Bio-VOC™ 
samplers [2]. Because of important features such as simplicity of the sampling 
procedure, which can be performed with minimal training and without the need of 
attendance from medically qualified staff, and the possibility to capture the alveolar part 
of the breath, the Bio-VOC™ samplers (Markes International, UK) were selected for 
the collection of the breath samples provided by the volunteers of this study.  
4.1.2. Breath Sampling with the Bio-VOC 
The different components of the Bio-VOC sampler kit are presented in Figure 4.1a. 
The kit contains a 129 mL container with an open end without return made of an inert 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
112 Breath Sampling and Population Study 
 
Chapter 4 
non-emitting plastic material for avoiding sample contamination, a screw-in plunger 
that is used to steadily transfer the breath sample either into the measuring device or 
into a sorbent storage container, and a disposable mouthpiece for preventing disease 
transmission between patients. 
 
Figure 4.1: (a) Bio-VOC™ breath sampler kit components; (b) Breath sampling procedure with 
the Bio-VOC™; (c) Breath VOCs storage in Tenax TA absorbent material for offline breath 
analysis. 
 
Before breath samples collection, the volunteers were asked to fast overnight. The 
breath sampling procedure consisted of volunteers exhaling normally through the 
disposable mouthpiece into the breath sampler until empting the lungs (Figure 4.1b). 
The first portion of the breath exited through the open end, and the Bio-VOC retained 
inside only the end-tidal air that corresponds to the alveolar breath. Subsequently, the 
mouthpiece was replaced with the plunger, which was slowly pushed during 10 seconds 
within the whole volume of the Bio-VOC™ for transferring the alveolar breath retained 
inside the breath sampler either into the sensors test chamber (for the direct sensing 
measurements approach), or into two-bed ORBO 420 Tenax® TA sorption tubes 
(Sigma-Aldrich, Spain) suitable for breath VOCs preconcentration and storage (for 
analysis at a later stage employing analytical techniques or the indirect sensing 
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measurements approach). The sorbent tubes were stored at 4 ºC in a freezer for 
biomedical samples until analysis. For filling a sorbent tube, the entire process was 
repeated twice for the same volunteer in order to ensure a higher concentration of the 
volatiles retained by the sorbent material. Generally, two storage tubes with breath 
samples were collected per individual, for analysis with the chemical sensors array and 
with a gas chromatograph coupled with quadruple time of flight (GC/Q-TOF), 
respectively.  
For cleaning purposes, prior to the first use and after each use, the Bio-VOC samplers 
were disassembled, and all the components were cleaned by introducing them for 15 
minutes in a solution of 20 ml concentrated disinfectant (Amukina, Spain) dissolved in 
1 L of distilled water. Each component was then rinsed with distilled water and left to 
naturally dry without wiping to avoid contamination. 
 
4.2. Population Study 
Volunteers diagnosed with Dengue, Leishmaniasis and Echinococcosis were recruited 
in clinics from both endemic regions (Colombia for Dengue, and Tunisia for 
Leishmaniasis and Echinococcosis), and from a low prevalence region (Poland) for 
Echinococcosis, where the affected patients are mostly tourists travelling to endemic 
areas and soldiers fulfilling military missions in endemic regions. Age and gender 
matched (as much as possible) control volunteers were recruited from the medical staff 
of the clinics were the patients were attended. All patients and controls provided written 
informed consent for the collection of their breath samples and subsequent analysis. 
Only adult volunteers participated in the study. The personal data collected for the 
purpose of this study were anonymized by applying the aggregation and K-anonymity 
anonymization techniques for preventing volunteers’ identification. Because of this, 
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three age groups were defined instead of the real patients’ age: young (18-29 years), 
middle-aged (30-49 years), and senior (> 50 years).  
The study protocol, consent forms and procedures were reviewed and approved by the 
Ethics Committee of IPS Unipamplona (Colombia), Research Ethics Committee of ESE 
Erasmo Meoz Universitary Hospital (Colombia), Institut Pasteur de Tunis Ethical 
Review Board (Tunisia – valid for all Tunisia), and the Independent Bioethical 
Commission for Science Research at the Medical University of Gdańsk (Poland). 
 
4.2.1. Dengue  
The Dengue study included 46 volunteers: 23 patients diagnosed with Dengue 
hospitalized at Erasmo Meoz Universitary Hospital and at IPS Unipamplona (both 
clinics located in Cúcuta, Colombia), and 23 healthy controls. For the diagnosis of 
Dengue, the normal standard blood and serological tests (IgM) were performed. The 
patients were at different stages of the disease, and presented between 1 and 8 days of 
fever. The statistical data of the study groups whose samples were used for each 
analysis technique employed is presented in Table 4.1, while full information about the 
volunteers included in this study and the number of samples provided by each one of 
them is presented in Table 4.2. 
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Voluntee
r Label1 
Age 
inter
val 
Gende
r 
Smo
king 
Clinic2 Days of 
fever 
(Dengue 
Other 
diseases 
Medication No. of 
samples  
GC/Q-
TOF 
Sen-
sors 
D01 > 50 Male No IPS 4 – – – 1 
D02 18-29 Female No IPS 5 – Acetaminophen – 1 
D03 > 50 Female No IPS 5 – Aspirin – 1 
D04 18-29 Male No IPS 7 – – – 1 
D05 > 50 Male No IPS 6 – – – 1 
D06 > 50 Male No IPS 3 – – – 1 
D07 18-29 Male No IPS 5 – – – 1 
D08 18-29 Female No HUEM 4 – – 2 - 
D09 18-29 Male No HUEM 4 – – 2 1 
D10 > 50 Male No HUEM 5 Diabetes – 2 1 
D11 30-49 Male No IPS 6 Diabetes – 2 1 
D12 18-29 Female No HUEM 5 – – 2 1 
D13 18-29 Female No HUEM ? – – 2 1 
D14 18-29 Female No HUEM 4 – – 2 1 
D15 30-49 Male Yes HUEM 5 – – 2 1 
D16 30-49 Male No HUEM 5 Hypo-
thyroidism 
Levothyroxine 2 1 
D17 18-29 Male No HUEM 5 – – 2 - 
D18 > 50 Female No IPS 2 – – 2 - 
D19 > 50 Female No HUEM 1 High blood 
pressure 
Acetaminophen 
Enalapril 
2 - 
D20 30-49 Female No HUEM 8 – Acetaminophen 2 - 
D21 18-29 Female No HUEM 1 – – 2 - 
D22 30-49 Female No IPS 1 Ulcer Acetaminophen 
Ranitidine 
2 - 
D23 30-49 Male No HUEM 5 – – 1 - 
C01 > 50 Male No IPS – – – – 1 
C02 18-29 Female No IPS – – – – 1 
C03 > 50 Male No IPS – Arterial 
hypertension 
Minart  
 
– 1 
C04 18-29 Male No IPS – – – – 1 
C05 > 50 Male No IPS – – – – 1 
C06 > 50 Female No IPS – – – – 1 
C07 18-29 Female No IPS – – – 1 1 
C08 18-29 Female No IPS – – – 2 - 
C09 18-29 Female No HUEM – – – 2 1 
C10 > 50 Female No IPS – Diabetes Glucovance 2 1 
C11 30-49 Female No IPS – – – 2 1 
C12 18-29 Female Yes IPS – – – 2 1 
C13 18-29 Male No IPS – – – 2 - 
C14 18-29 Female No IPS – Pneumonia Ciprofloxacin 2 1 
  GC/Q-TOF analysis Sensors measurements 
DEN CON Total DEN CON Total 
Number volunteers 16 17 33 15 13 28 
Male/Female  7/9 4/13 11/22 10/5 5/8 15/13 
Age:18-29/30-49/≥ 50 7/6/3 8/6/3 15/12/6 7/3/5 7/2/4 14/5/9 
Smoking 1 3 4 1 2 3 
Table 4.1: Statistical data of the study groups for the Dengue experiment included in each 
study performed. DEN: Dengue patients; CON: Controls. 
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C15 30-49 Female No IPS – – – 2 - 
C16 30-49 Male Yes IPS – – – 2 1 
C17 18-29 Male No IPS – – – 2 - 
C18 > 50 Female Yes IPS – – – 2 - 
C19 > 50 Male No IPS – High blood 
pressure 
Losartan 2 - 
C20 30-49 Female No IPS – – – 2 - 
C21 18-29 Female No IPS – – – 2 - 
C22 30-49 Female No IPS – – – 2 - 
C23 30-49 Female No IPS – – – 2 - 
1D: Dengue, C: Control; 2IPS: IPS Unipamplona; HUEM: Erasmo Meoz Universitary Hospital 
Table 4.2: Information about the volunteers from the Dengue study 
4.2.2. Leishmaniasis 
Volunteers diagnosed with human cutaneous leishmaniasis (HCL; n = 28) and healthy 
controls (CCL; n = 32) were recruited at Tunis Charles Nicolle University Hospital 
(North East Tunisia), Ben Arous Regional Hospital (North East Tunisia), Abderrahman 
Mami University Hospital (Ariana, North East Tunisia) and Gafsa Houssine Bouzaiene 
Regional Hospital (South East Tunisia). Patients’ diagnosis was based on microscopic 
tests (examination of skin-scraping smear samples) and clinical aspects of the lesions. 
The study population is presented in Table 4.3, while the statistical data of the study 
groups included in each study is presented in Table 4.4. 
 
Volunteer 
Label1 
Age Gender Smoking2 Hospital3 No. of samples  Country 
GC/Q-
TOF 
Sensors 
L01 18-29 Male No BAH x x Tunisia 
L02 18-29 Male No GH x x Tunisia 
L03 30-49 Female No CNH x x Tunisia 
L04 30-49 Female No GH x x Tunisia 
L05 30-49 Female No GH x x Tunisia 
L06 30-49 Male No BAH x x Tunisia 
L07 30-49 Male No GH x x Tunisia 
L08 30-49 Female N/A GH x x Tunisia 
L09 30-49 Female No GH x x Tunisia 
L10 30-49 Female No GH x x Tunisia 
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L11 30-49 Female No GH x x Tunisia 
L12 30-49 Male Yes GH x x Tunisia 
L13 >50 Female No GH x x Tunisia 
L14 >50 Female No GH x x Tunisia 
L15 >50 Female No GH x x Tunisia 
L16 >50 Female No GH x x Tunisia 
L17 >50 Female No GH x x Tunisia 
L18 >50 Female No CNH x x Tunisia 
L19 >50 Female No GH x x Tunisia 
L20 >50 Female No GH x x Tunisia 
L21 >50 Female No GH x x Tunisia 
L22 >50 Female No GH x x Tunisia 
L23 >50 Female No GH x x Tunisia 
L24 >50 Male No BAH x x Tunisia 
L25 >50 Male No GH x x Tunisia 
L26 >50 Male No GH x x Tunisia 
L27 >50 Male No GH x x Tunisia 
L28 >50 Male Yes CNH x x Tunisia 
C01 18-29 Female No CNH x x Tunisia 
C02 18-29 Female No CNH x x Tunisia 
C03 18-29 Female No CNH x x Tunisia 
C04 18-29 Female No CNH x x Tunisia 
C05 18-29 Female No CNH x x Tunisia 
C06 18-29 Female No CNH x x Tunisia 
C07 18-29 Female No CNH x x Tunisia 
C08 18-29 Female No CNH x x Tunisia 
C09 18-29 Female No CNH x x Tunisia 
C10 18-29 Female No CNH x x Tunisia 
C11 18-29 Female No CNH x x Tunisia 
C12 18-29 Female No AH x x Tunisia 
C13 18-29 Female No AH x x Tunisia 
C14 18-29 Female No AH x x Tunisia 
C15 18-29 Female No AH x x Tunisia 
C16 18-29 Male No CNH x x Tunisia 
C17 18-29 Male No CNH x x Tunisia 
C18 18-29 Male No AH x x Tunisia 
C19 18-29 Male Yes AH x - Tunisia 
C20 30-49 Female No CNH x x Tunisia 
C21 30-49 Female No CNH x x Tunisia 
C22 30-49 Female No CNH x x Tunisia 
C23 30-49 Female No CNH x - Tunisia 
C24 30-49 Female No CNH x x Tunisia 
C25 30-49 Female No AH x x Tunisia 
C26 30-49 Female No AH x x Tunisia 
C27 30-49 Male No CNH x - Tunisia 
C28 30-49 Male No AH x x Tunisia 
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C29 30-49 Male Yes CNH x x Tunisia 
C30 30-49 Male N/A AH x x Tunisia 
C31 30-49 Female No AH x x Tunisia 
C32 >50 Female No GH x - Tunisia 
1 L: Volunteer with human cutaneous leishmaniasis; C: healthy control  
2 N/A: Information not available  
2 CNH: Charles Nicolle Hospital; BAH: Ben Arous Hospital; GH: Gafsa Hospital; AH: Ariana 
Hospital 
 
Table 4.3: Information about the volunteers from the Leishmaniasis study 
 
 
 
4.2.3. Echinococcosis 
32 patients diagnosed with Cystic Echinococcosis (CE) were recruited at two medical 
centers from Tunisia (Charles Nicolle Hospital from Tunis Government and 
Abderrahman Mami Hospital from Ariana Government). After anamnestic, clinical, 
radiological and ichnographical suspicion of CE, an ELISA serological investigation 
using commercial kit (Ridascreen® Echinococcus IgG) was performed for CE 
diagnosis. Some cases were further confirmed after surgery. 43 CE controls (here 
denominated CCE) were selected from healthy medical personnel working in these 
clinics who did not have contact with the etiological agent of CE.  
  GC/Q-TOF analysis Sensors measurements 
HCL CCL Total HCL CCL Total 
Number of volunteers 28 32 60 28 28 56 
Male/Female  10/18 8/24 18/42 10/18 6/22 16/40 
Age: 18-29/30-49/≥ 50 2/10/16 19/12/1 21/22/7 2/10/16 16/12/0 18/22/16 
Smoking 2 2 4 2 1 3 
Table 4.4: Statistical data of the study groups for Leishmaniasis included in each analysis 
performed. HCL: Leishmaniasis patients; CCL: Controls. 
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16 patients diagnosed with Alveolar Echinococcosis (AE) were recruited from adult 
patients without pulmonary disorders hospitalized at the Clinic of Tropical and Parasitic 
Diseases from Gdynia, Poland. Several tests were performed for AE diagnosis: 
serological tests (ELISA, Western blot), analysis of DNA samples by Polymerase Chain 
Reaction (PCR), real-time PCR, and microscopic detection of parasites. Eight AE 
controls (here denominated CAE) were selected from volunteered personnel of the 
Clinic of Tropical and Parasitic Diseases from Gdynia. Although they were age and sex 
matched with the AE patients as much as possible, age matching was not accurately 
achieved, because most of the personnel of the clinic were younger (below 40, with only 
one exception) as compared with AE patients (over 40, with only one exception). 
Information regarding the volunteers included in each analysis performed is presented 
in Tables 4.5, 4.7, 4.9 and 4.11, while the statistical data of the study population 
included in each analysis is presented in Tables 4.6, 4.8, 4.10 and 4.12. 
 
Volunteer 
Label 
Age Gender Smoking Hospital1 No. of samples  Country 
GC/Q-
TOF 
Sensors 
CE 1 18-29 Male No HCN x x Tunisia 
CE 2 >50 Female No HCN x x Tunisia 
CE 3 >50 Female No HCN x x Tunisia 
CE 4 30-49 Female No HCN x x Tunisia 
CE 5 30-49 Male No HCN x x Tunisia 
CE 6 30-49 Female No HCN x x Tunisia 
CE 7 18-29 Female No HCN x x Tunisia 
CE 8 >50 Male No HCN x x Tunisia 
CE 9 >50 Female No HCN x x Tunisia 
CE 10 30-49 Female No HCN x x Tunisia 
CE 11 30-49 Female No HCN x x Tunisia 
CE 12 >50 Female No HCN x x Tunisia 
CE 13 >50 Female No HA x x Tunisia 
CE 14 30-49 Female No HA x x Tunisia 
CE 15 >50 Male Yes HA x x Tunisia 
CE 16 30-49 Female No HCN x x Tunisia 
CE 17 18-29 Female No HCN x x Tunisia 
CE 18 18-29 Male No HCN x x Tunisia 
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CE 19 30-49 Female No HCN x x Tunisia 
CE 20 30-49 Female No HCN x x Tunisia 
CE 21 30-49 Female No HCN x x Tunisia 
CE 22 30-49 Female No HCN x x Tunisia 
CE 23 30-49 Female No HA x x Tunisia 
CE 24 30-49 Female No HA – x Tunisia 
CCE 1 30-49 Female No HCN x x Tunisia 
CCE 2 30-49 Female No HCN x x Tunisia 
CCE 3 30-49 Female No HCN x x Tunisia 
CCE 4 18-29 Male No HCN x x Tunisia 
CCE 5 30-49 Female No HCN x x Tunisia 
CCE 6 18-29 Female No HCN x x Tunisia 
CCE 7 18-29 Female No HCN x x Tunisia 
CCE 8 30-49 Male No HCN x x Tunisia 
CCE 9 30-49 Female No HCN x x Tunisia 
CCE 10 30-49 Female No HCN - x Tunisia 
CCE 11 18-29 Female No HCN x x Tunisia 
CCE 12 18-29 Female No HCN x x Tunisia 
CCE 13 30-49 Male Yes HCN x x Tunisia 
CCE 14 18-29 Female No HCN x x Tunisia 
CCE 15 18-29 Female No HCN x x Tunisia 
CCE 16 18-29 Female No HCN x x Tunisia 
CCE 17 18-29 Male No HCN x x Tunisia 
CCE 18 18-29 Female No HCN x x Tunisia 
CCE 19 18-29 Female No HCN x x Tunisia 
CCE 20 18-29 Female No HCN x x Tunisia 
CCE 21 18-29 Female No HCN x - Tunisia 
CCE 22 30-49 Male - HA x x Tunisia 
CCE 23 18-29 Female No HA x x Tunisia 
CCE 24 18-29 Female No HA x x Tunisia 
CCE 25 30-49 Female No HA x x Tunisia 
CCE 26 18-29 Female No HA x x Tunisia 
CCE 27 30-49 Female No HA x x Tunisia 
CCE 28 30-49 Male No HA x x Tunisia 
CCE 29 18-29 Female No HA x - Tunisia 
CCE 30 18-29 Male No HA x - Tunisia 
CCE 31 18-29 Male Yes HA x - Tunisia 
CCE 32 >50 Female No HG x - Tunisia 
 1 HCN: Charles Nicolle Hospital; HA: Ariana Hospital; HG: Gafsa Hospital 
 
Table 4.5: Study population included in the indirect cystic echinococcosis study. CE: 
cystic echinococcosis; CCE: controls for cystic echinococcosis. 
  GC/Q-TOF analysis Sensors measurements 
 CE  CCE Total  CE  CCE Total 
Number of volunteers 23 32 55 24 28 52 
Male/Female  5/18 8/24 13/42 5/19 6/22 11/41 
Age: 18-29/30-49/≥ 50 4/13/6 19/12/1 23/25/7 4/14/6 16/12/0 20/26/6 
Smoking 1 2 3 1 1 2 
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Volunteer 
Label 
Age Gender Smoking Hospital1 Sensor 
analysis 
Country 
CE 1 30-49 Female No HCN x Tunisia 
CE 2 >50 Male Yes HCN x Tunisia 
CE 3 18-29 Female No HCN x Tunisia 
CE 4 30-49 Female No HCN x Tunisia 
CE 5 30-49 Female No HCN x Tunisia 
CE 6 >50 Male No HCN x Tunisia 
CE 7 30-49 Female No HCN x Tunisia 
CE 8 18-29 Female No HCN x Tunisia 
CCE 1 >50 Male Yes HCN x Tunisia 
CCE 2 30-49 Female No HCN x Tunisia 
CCE 3 30-49 Female No HCN x Tunisia 
CCE 4 30-49 Male No HCN x Tunisia 
CCE 5 30-49 Female No HCN x Tunisia 
CCE 6 30-49 Male Yes HCN x Tunisia 
CCE 7 30-49 Female No HCN x Tunisia 
CCE 8 >50 Female No HCN x Tunisia 
CCE 9 >50 Female Yes HCN x Tunisia 
CCE 10 18-29 Male No HCN x Tunisia 
CCE 11 18-29 Female No HCN x Tunisia 
CCE 12 18-29 Female No HCN x Tunisia 
CCE 13 18-29 Female No HCN x Tunisia 
CCE 14 18-29 Female No HCN x Tunisia 
CCE 15 >50 Male No HCN x Tunisia 
 
1 HCN: Charles Nicolle Hospital 
Table 4.7: Study population included in the direct cystic echinococcosis study.  
CE: cystic echinococcosis; CCE: controls for cystic echinococcosis 
 
 
 
Table 4.6: Statistical data of the study groups included in the indirect cystic echinococcosis 
study. CE: cystic echinococcosis; CCE: controls for cystic echinococcosis. 
  Sensors measurements 
 CE  CCE Total 
Number of volunteers 8 15 23 
Male/Female  2/6 6/9 8/15 
Age: 18-29/30-49/≥ 50 2/4/2 5/6/4 7/10/8 
Smoking 1 3 4 
Table 4.8: Statistical data of the study groups included in the direct cystic 
echinococcosis study.  CE: cystic echinococcosis; CCE: controls for cystic 
echinococcosis. 
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Volunteer 
Label 
Age Gender Smoking Hospital1 No. of samples Country 
GC/Q-
TOF 
Sensor 
AE 1 >50 Male No TPD x x Poland 
AE 2 >50 Male No TPD x x Poland 
AE 3 >50 Male No TPD x x Poland 
AE 4 30-49 Female No TPD x x Poland 
AE 5 >50 Male Yes TPD x x Poland 
AE 6 30-49 Male No TPD x x Poland 
AE 7 30-49 Female No TPD x x Poland 
AE 8 >50 Male Yes TPD x x Poland 
AE 9 >50 Female No TPD x x Poland 
AE 10 30-49 Female No TPD x x Poland 
AE 11 >50 Male No TPD x x Poland 
AE 12 >50 Female No TPD x x Poland 
AE 13 >50 Female No TPD x x Poland 
AE 14 >50 Female No TPD - x Poland 
CAE 1 18-29 Female No TPD x x Poland 
CAE 2 18-29 Female No TPD x x Poland 
CAE 3 30-49 Male No TPD x x Poland 
CAE 4 30-49 Female No TPD x x Poland 
CAE 5 30-49 Female No TPD x x Poland 
CAE 6 18-29 Female No TPD x x Poland 
CAE 7 30-49 Male No TPD x X Poland 
CAE 8 30-49 Male No TPD x X Poland 
 
1 TPD: Clinic of Tropical and Parasitic Diseases, Gdynia 
Table 4.9: Study population included in the alveolar echinococcosis study.  AE: alveolar 
echinococcosis; CAE: controls for cystic echinococcosis 
Volunteer 
Label 
Age Gender Smoking Hospital1 No. of samples  
Sensors Country 
CE 1 18-29 Male No HCN x Tunisia 
CE 2 >50 Female No HCN x Tunisia 
CE 3 >50 Female No HCN x Tunisia 
CE 4 30-49 Female No HCN x Tunisia 
CE 5 30-39 Male No HCN x Tunisia 
CE 6 30-49 Female No HCN x Tunisia 
CE 7 18-29 Female No HCN x Tunisia 
  GC/Q-TOF analysis Sensors measurements 
 AE  CAE Total  AE  CAE Total 
Number of volunteers 13 8 21 14 8 22 
Male/Female  7/6 3/5 10/11 7/7 3/5 10/12 
Age: 18-29/30-49/≥ 50 0/4/9 3/5/0 3/9/9 0/4/10 3/5/0 3/9/10 
Smoking 2 0 2 2 0 2 
Table 4.10: Statistical data of the study groups included in the alveolar echinococcosis study.  
AE: alveolar echinococcosis; CAE: controls for cystic echinococcosis. 
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CE 8 >50 Male No HCN x Tunisia 
CE 9 >50 Female No HCN x Tunisia 
CE 10 30-49 Female No HCN x Tunisia 
CE 11 30-49 Female No HCN x Tunisia 
CE 12 30-59 Female No HCN x Tunisia 
CE 13 >50 Female No HA x Tunisia 
CE 14 30-49 Female No HA x Tunisia 
CE 15 >50 Male Yes HA x Tunisia 
CE 16 30-49 Female No HCN x Tunisia 
CE 17 18-29 Female No HCN x Tunisia 
CE 18 18-29 Male No HCN x Tunisia 
CE 19 30-49 Female No HCN x Tunisia 
CE 20 30-39 Female No HCN x Tunisia 
CE 21 30-49 Female No HCN x Tunisia 
CE 22 30-49 Female No HCN x Tunisia 
CE 23 30-49 Female No HA x Tunisia 
CE 24 30-49 Female No HA x Tunisia 
AE 1 >50 Male No TPD x Poland 
AE 2 >50 Male No TPD x Poland 
AE 3 >50 Male No TPD x Poland 
AE 4 30-49 Female No TPD x Poland 
AE 5 >50 Male Yes TPD x Poland 
AE 6 30-49 Male No TPD x Poland 
AE 7 30-49 Female No TPD x Poland 
AE 8 >50 Male Yes TPD x Poland 
AE 9 >50 Female No TPD x Poland 
AE 10 30-49 Female No TPD x Poland 
AE 11 >50 Male No TPD x Poland 
AE 12 >50 Female No TPD x Poland 
AE 13 >50 Female No TPD x Poland 
AE 14 >50 Female No TPD x Poland 
1 HCN: Charles Nicolle Hospital; HA: Ariana Hospital; HG: Gafsa Hospital; TPD: 
Clinic of Tropical and Parasitic Diseases, Gdynia. 
Table 4.11: Study population included in the comparative study between 
cystic echinococcosis (CE) and alveolar echinococcosis, AE. 
  Sensors measurements 
 CE  AE Total 
Number of volunteers 24 14 38 
Male/Female  5/19 7/7 12/26 
Age: 18-29/30-49/≥ 50 4/14/6 0/4/10 4/18/16 
Smoking 1 2 3 
Table 4.12: Statistical data of the study groups included in the comparative study 
between cystic echinococcosis (CE) and alveolar echinococcosis (AE). 
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4.3. Conclusion 
The Bio-VOCTM samplers (Markes International, UK) were selected for the collection 
of the breath samples provided by the volunteers of this study because of important 
features such as simplicity of the sampling procedure that can be performed with 
minimal training and without the need of attendance from medically qualified staff, and 
the possibility to capture the alveolar part of the breath, which is most likely to contain 
the breath VOCs characteristic to the state of the body. 
After setting up the breath sampling protocol to be followed at all breath samples 
collection sites in order to avoid artefacts introduced by differences in the sampling 
procedure, breath samples were collected from patients diagnosed with Dengue 
(Colombia), Leishmaniasis (Tunisia) and Echinococcosis (Tunisia as endemic region 
and Poland as low prevalence region), as well as from a group of control volunteers 
recruited among the medical staff of the clinics where the patients were attended, which 
were age and gender matched with the patients as much as possible. 
The results of the breath samples analysis with analytical equipment and chemical gas 
sensors will be presented in the following chapters. 
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This chapter presents the results of exhaled breath samples analysis with standard 
GC-Q/TOF analytical equipment. The putative breath biomarkers for each 
infectious tropical disease studied (Dengue, Leishmaniasis and Echinococcosis) 
were identified, and their possible origin during body infection was discussed. 
Discrimination models built with the identified biomarkers were moreover 
assessed. 
 
5.1. Analytical Studies and Biomarkers Identification 
Analytical studies of the breath sample were performed employing a 7890A gas 
chromatograph (GC) coupled to a 7200 quadruple time of flight (Q-TOF) mass 
spectrometer (Agilent Technologies, Santa Clara, CA, USA).  
For analyzing the breath samples stored in the sorbent tubes, the Tenax TA material 
storing the breath volatiles was transferred into a 20 mL glass vial that was sealed with 
a septum and introduced for 20 min in an oil bath placed on a temperature-controlled 
hotplate heated at a suitable temperature (200 ºC were used in the case of the samples 
from the Dengue experiment, while 100 ºC were used in the case of the samples from 
the Leishmaniasis and Echinococcosis experiments). This procedure caused desorption 
of the VOCs trapped by the sorbent material, which formed a headspace above the 
Tenax material inside the sealed vial. Solid Phase Micro-Extraction (SPME) with 
Divinilbenzene/Carboxene/Polydimethylsiloxane (DVB/CAR/PDMS) fiber, introduced 
for 30 min in the headspace formed by the released breath volatiles inside the vial, was 
used to capture and concentrate the desorbed VOCs and to inject them into the GC/Q-
TOF splitless port for analysis. The oven conditions of the chromatograph were: 
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desorption time: 1 min, desorption temperature: 250 ºC. The oven program was set as 
follows: initial temperature: 50 ºC, 10 ºC/min ramp until 155 ºC, 20 ºC/min ramp until 
270 ºC, 10 min at 270 °C. Mass spectrometry measurements were performed by 
electron impact ionization, with 70 eV electron energy and the temperature source held 
at 230 ºC. Mass-to-charge ratios between 35 and 400 m/z were acquired at 5 spectra/s 
rate. Chromatograms deconvolution was processed employing the Unknown Analysis 
software (Qualitative and Quantitative Analysis B.07.00, Unknown Analysis, Agilent 
Technologies, Santa Clara, USA) operated in the automatic mode, with a match factor 
set to 70. Compounds identification was achieved using the NIST 14 mass spectral 
library. 
The experimental flow cycle employed for the analysis of the breath samples stored in 
the Tenax sorbent tubes with the GC/Q-TOF equipment is shown in Figure 5.1.  
 
Figure 5.1: Experimental flow cycle employed for breath samples analysis with the analytical 
equipment 
 
As a typical example, chromatogram obtained from the analysis of different breath 
samples is shown in Figure 5.2. On the other hand, several breath samples provided by 
the same volunteer that were analyzed at established time intervals (every six month) 
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over a prolonged period of time (two years) in order to determine the maximum storage 
time of the samples in the Tenax tubes without significant losses, revealed a suitable 
storing period of at least 1.5 years. 
 
Figure 5.2: Typical chromatograms acquired by GC-Q/TOF. The red chromatogram was 
acquired from the analysis of the breath composition of a Dengue patient, and the green 
chromatogram from the analysis of the breath composition of a control volunteer. 
 
It is noted that the chromatograms resulted from the breath samples of patient (Dengue-
green), and control (red) revealed significant differences between the breath 
compositions of the two subjects.    
The putative breath biomarkers of the studied diseases were identified applying the two-
tailed t-test for normally distributed data (the normal data distribution is shown in 
Figure 5.3). A standard cut-off value α = 0.05 was used for finding statistical 
significant differences between the patients and the control groups of each disease. The 
confounding factors assessed in this study for disregarding from the initial list of 
compounds those affected by external conditions were volunteers’ gender (for all 
studies) and age (with the exception of the AE study, because as explained in Chapter 4, 
the AE and CAE groups could not be age-matched). The three defined age groups were: 
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young (18-29 years), middle-aged (30-49 years), and senior (> 50 years). Smoking habit 
was not assessed as a confounding factor because of the low number of smoking 
volunteers that participated in this study.  
 
Figure 5.3: Representative example of one of the compounds (1-tridecene) identified as breath 
biomarker for CE, showing the normal distribution of the data. 
 
5.2. Dengue Breath Biomarkers  
The chemical analysis of the breath samples of 16 Dengue patients and 17 healthy 
controls identified 104 compounds in the majority of the breath samples. Among them, 
six compounds were found to have statistically significant different concentrations 
between the Dengue and Control groups. These compounds, presented in Table 5.1, 
were identified in the breath of at least 80% of the volunteers from each study group, 
and could represent putative breath biomarkers of Dengue disease. Four of them 
(styrene, toluene, 1-acetyl-1H-benzotriazole and 2-ethylsulfonyl ethanol) increased their 
concentration in the exhaled breath as a consequence of the disease, while the other two 
(n-propyl acrylate and 1-undecyne) were exhaled in lower concentrations as compared 
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with the normal state (Figure 5.4). The box plots drawn with their abundance in the 
breath of each patient are shown in Figure 5.5. 
VOC Compound CAS  No. m/z R.T p-value 
VOC01 Toluene 629-20-9 104.0631 3.253 0.0002 
VOC02 n-propyl acrylate 100-42-5 73.0464 3.276 0.019 
VOC03 Styrene 108-88-3 91.0558 4.037 0.014 
VOC04 1-undecyne 2243-98-3 67.0539 6.107 0.015 
VOC05 1-acetyl-1H-benzotriazole 1135-66-6 161.1329 10.134 0.004 
VOC06 2-ethylsulfonyl ethanol 513-12-2 161.1321 10.309 0.011 
Table 5.1: Putative Dengue breath biomarkers 
 
Figure 5.4: Mean values of the abundance (chromatographic peak areas) and error bars of the 
putative breath biomarkers for Dengue disease identified by GC/Q-TOF analyses. (*) p-value < 
0.05; (**) p-value < 0.01; (***) p-value < 0.001. 
 
The diagnosis potential of Dengue disease based on the putative breath biomarkers 
identified by the GC/Q-TOF studies was assessed by building a discrimination model 
employing the Discriminant Function Analysis (DFA) pattern recognition algorithm. 
The DFA model, built with the GC/Q-TOF peak areas of the breath biomarkers, showed 
very good discrimination of the Control volunteers (only one misclassified sample), 
whereas several Dengue patients were misclassified by the model (Figure 5.6a). 
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Volunteers’ classification, calculated using leave-one-out cross-validation, achieved 
84.4% accuracy, 94.1% specificity and 75% sensitivity. 
  
The area under curve (AUC) of the receiver operating characteristic (ROC) curve 
constructed with the values of the first canonical variable (CV1) of the DFA model was 
90.8% (Figure 5.6b), confirming the very good classification between Dengue and 
Control volunteers. Volunteers’ classification based on confounding factors such as 
gender and age achieved 54.5% and 33.3% accuracy, respectively, indicating that the 
breath biomarkers identified for Dengue disease in this study are not influenced by 
confounding factors. 
 
Figure 5.5: Box plots obtained with the abundances of the Dengue biomarkers: (a) VOC01; (b) 
VOC02; (c) VOC03; (d) VOC04; (e) VOC05; (f) VOC06. Each patient is represented by one 
point in the box plots. 
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Figure 5.6. Classification between Dengue and Control volunteers using the breath 
biomarkers: (a) Box plot of the first canonical variable (CV1) of the DFA model 
calculated with the peak areas of the biomarkers identified by GC/Q-TOF studies; each 
patient is represented by one point in the box plot; the dashed line represents the 
classification border between the two groups, Dengue being estimated above the dashed 
line and Control below the dashed line; (b) ROC curve constructed with the CV1 of the 
DFA model, yielding AUC = 90.8%. 
 
A rationale for the putative Dengue breath biomarkers identified in this study is next 
presented.  
Previous studies claimed that oxidative stress has a prime importance in the 
pathogenesis of Dengue infection [1,2]. In this regards, two of the identified 
biomarkers, styrene and toluene, are among the most significant compounds associated 
with oxidative stress [3,4]. Changes in the concentration of styrene and toluene invoke 
upregulation of various enzymes in the prostaglandin pathway that plays a critical role 
in the generation of inflammatory response as a consequence of disease onset, expressed 
by the generation of VOCs-induced oxidative stress markers [1,4]. Such oxidative stress 
can lead to lipid peroxidation that, mediated by hydroxyl radicals (OH*), possesses 
potential endothelial cell injury during Dengue pathogenesis [1,5].  
Being a viral disease, Dengue infection causes an early immunological reaction in 
humans. In response to the acute inflammation produced by Dengue virus, the 
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phospholipase enzymes regulate the formation of different anti-inflammatory molecules 
such as -3 polyunsaturated fatty acids (PUFA), which are released from cell 
membrane phospholipids by phospholipid hydrolysis [6]. The PUFAs fragment into 
various metabolites such as saturated and unsaturated hydrocarbons, some of them 
being released through the alveolar breath, and less volatile molecules excreted through 
other body fluids. Although fatty acid production is a normal process in the human 
body, the production of some PUFA could be either inhibited or overexpressed during 
inflammation. This might explain the decrease of 1-undecyne level (one of the products 
of PUFA fragmentation) in the exhaled air of Dengue patients.  
Moreover, as the pathogenesis of Dengue is host mediated, the infection with Dengue 
virus induces an elevated cytokine production in T-cells and macrophages in responses 
to the infection [7-10]. As a result of the unbalance between pro-inflammatory and anti-
inflammatory cytokines, endothelial cell lines might be damaged and the energy 
metabolism and proteins metabolism perturbed, leading to changes in the production of 
various secondary metabolites such as n-propyl acrylate and 1-acetyl-1H-benzotriazole. 
N-propyl acrylate can be produced through the decarboxylation of excess acetyl 
coenzyme A via Krebs cycle in peripheral tissue, and as a secondary metabolite in lipid 
peroxidation [11]; its decreased level in Dengue patients could be related to the rate of 
formation and excretion through the alveolar breath. The increased level of the 
heteroatom 1-acetyl-1H-benzotriazole in Dengue patients is not completely clear, 
however it might be associated with the RNA genome translation to polyproteins caused 
by the dengue virus as a consequence of its viral replication in the endoplasmic 
reticulum of the infected cells [12].  
The last biomarker, 2-ethylsulfonyl ethanol, which showed an increased level in Dengue 
patients, might be associated with the incomplete metabolism of methionine in the 
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transmission pathway and with its oxidation in the liver mitochondria coupled with the 
Krebs cycle [11,13].  
  
5.3. Leishmaniasis Breath Biomarkers  
The chemical analysis of the breath samples of 28 Human Cutaneous Leishmaniasis 
(HCL) patients, simply Leishmaniasis, and 32 healthy controls (CCL) identified 
approximately 120 chemical compounds in each breath samples. Among them, nine 
compounds were found in statistically different concentrations between HCL and CCL 
groups. They are indicated in Table 5.2 as putative breath biomarkers for HCL. All of 
them were present in at least 80% of the breath samples from each study group. 
Importantly, the abundance (area under the chromatographic peak) of all these 
compounds was higher in the breath of HCL patients as compared with the healthy 
controls (Figure 5.7a). Moreover, the mean variance of these compounds within the 
HCL group was much smaller than in the case of CCL group, indicating the 
homogeneity of the abundance of the HCL breath biomarkers in the breath of all 
patients. Although presenting lower abundance in the CCL group, the higher spread of 
these compounds in the controls group is due to the higher variability of the normal 
state. The diagnostic potential of the breath biomarkers to discriminate between HCL 
and CCL was assessed by building classification models based on the DFA algorithm 
using as input different biomarkers combinations. 
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The DFA classification model built with the abundances of only two biomarkers 
(VOC03 and VOC06) yielded 80% accuracy, 71.4% sensitivity and 87.5% specificity, 
while the DFA classification model built with the abundances of three biomarkers 
(VOC01, VOC06 and VOC07) yielded 80% accuracy, 75% sensitivity and 84.5% 
specificity (Figure 5.7b), revealing the remarkable discrimination capability of the 
breath biomarkers between the study groups. 
However, not all VOC biomarkers are equally significant for distinguishing between the 
diseased and healthy states. This is evidenced by the correlation matrix of biomarkers 
abundances (Figure 5.7c), which indicates that several biomarkers are highly correlated 
with each other (VOC03, VOC04 and VOC05), while others (VOC02 and VOC06) 
showed a negative correlation with the first ones. On the other hand, one biomarker 
(VOC07) showed a general correlation with almost all VOCs (with the exception of 
VOCs Compounds CAS No m/z R.T p-value 
VOC 01 2,2,4-trimethyl pentane 540-84-1 57.05 4.35 0.028 
VOC 02 4-methyl-2-ethyl-1-pentanol 106-67-2 67.05 4.9 0.042 
VOC 03 Methylvinyl ketone 78-94-4 43.05 5.28 0.015 
VOC 04 Nonane 1184-2 43.05 5.99 0.02 
VOC 05 2,3,5-trimethyl hexane 1069-53-0 85.01 6.53 0.012 
VOC 06 Hydroxy-2,4,6-trimethyl-5-(3-
methyl-2 butenyl) cyclohexyl) 
methylacetate 
1139-17-9 81.06 9.50 0.001 
VOC 07 Octane 111-65-9 57.05 9.75 0.008 
VOC 08 3-ethyl-3-methylheptane 17302-01-1 71.06 10.08 0.01 
VOC 09 2-methyl-6-methylene-octa-1,7-
dien-3-ol 
22459-10-5 67.05 10.86 0.03 
Table 5.2: Putative breath biomarkers for human cutaneous leishmaniasis (HCL) identified in 
the present study. 
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VOC02 and VOC06), while VOC08 and VOC09 exhibited positive correlation with all 
the other biomarkers. 
Figure 5.7: (a) Abundance of the HCL breath biomarkers. (*) p < 0.05; (**); p < 0.01; (b) 
Box plot of the first canonical variable (CV1) of the DFA model built with the abundances of 
three biomarkers (VOC01, VOC06 and VOC07 in Table 5.2); each volunteer is represented 
by one point in the box plot; the dashed line represents the threshold classification line 
between the two groups, HCL patients being estimated above the dashed line and healthy 
controls below the dashed line; (c) Biomarkers correlation map; (+1), (-1) and (0) indicate 
maximum positive, maximum negative, and no correlation, respectively.   
 
This explains why the DFA model built with the abundances of all biomarkers 
presented a lower classification potential (66.7% accuracy) than the models built with a 
limited number of selected biomarkers.  
An attempt to elucidate the biochemical processes that originated the biomarkers 
identified in the present study is presented below.  
First signs of lesions due to HCL, a widely distributed vector-borne disease that is never 
fatal, even if non-treated, are characterized by the appearance of a small erythema at the 
site of a sandfly bite. This erythema develops into a papule and nodule and the lesion 
becomes ulcerated. Both innate and adaptive immune systems form together the driving 
forces, which shape the disease outcome. The initial interaction with the innate immune 
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cells shapes the subsequent effector response. Effector function of activated CD4+ T 
helper cells is an integral component in determining the course of the disease. A Th1-
like response activates macrophages to clear the parasite. The cascade induced by 
interferon gamma (IFN-γ) in infected macrophages results in the production of Reactive 
Oxygen Species (ROS) that have the ability to kill intracellular Leishmania. In addition 
to ROS, IFN-γ and tumor necrosis factor (TNF) synergistically induce Nitric Oxide 
Synthase (iNOS) in macrophages, and Nitric Oxide (NO) production further promotes 
effective parasite killing. The increased IFN-γ production to elevate ROS level for 
controlling parasite invasion is associated with increased inflammatory reaction and 
development of cutaneous ulcers in the skin [14]. The imbalance of the general 
equilibrium between the formation and deactivation of ROS and free radicals can boost 
oxidative stress in the body. Thus, ROS can damage cellular and subcellular structures 
such as lipids, and induce upregulation of cytochrome p-450 enzymes to catalyze the 
oxidation of organic chemicals in the human tissues [15]. More specifically, lipid 
peroxidation occurs as a result of oxidative degradation of lipids, when free radicals 
attach themselves to electrons in cell membranes and thereby damage components of 
the cell membrane [16]. Due to the presence of reactive hydrogen of the methylene 
groups between the multiple double bonds, polyunsaturated fatty acids are commonly 
affecting the cell components [17-19]. For example, aldehyde, ethane, pentane, 
malondialdehyde, acrolein, hydroxynonenal and crotonaldehyde are well known PUFA 
products in the lipid peroxidation process [18].  
Nevertheless, the origin of the exhaled breath VOCs that were putatively identified in 
the breath of HCL patients is not completely elucidated. Although several biochemical 
pathways are possible, the peroxidation of PUFAs during the pathophysiology of HCL 
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might be considered as the main source of aliphatic hydrocarbons in the exhaled breath, 
such as nonane and octane.  
Earlier reports showed that enhanced levels of ethane and pentane can be associated to 
lipid peroxidation during oxidative stress in critical body conditions [20,21]. The 
generation of branched alkanes such as 2,2,4-trimethylpentane, 2,3,5-trimethylhexane 
and 3-ethyl-3-methylpentane might be also related to the byproducts of PUFA 
peroxidation. Nevertheless, it is argued that oxidative stress mechanism in mammals 
cannot produce straight chained or branched alkanes, and hence such branching alkanes 
occur during the isoprenoid synthesis [22]. On the other hand, alkanes are also present 
in the environment and are inhaled on a daily basis, being broken in the liver by the 
cytochrome p-450 enzymes, therefore the exogenous origin of these biomarkers cannot 
be discarded.  
Alcohols such as 4-methyl-2-ethyl-1-pentanol and 2-methyl-6-methylene-octa-1,7-dien-
3-ol might originate from the hydrocarbon metabolism. This could be either due to the 
alcohol metabolism catalyzed by cytochrome p-450 enzymes in the liver, or due to the 
oxidation of several different alcohols by alcohol dehydrogenase in the body [23]. 
Moreover, byproducts of lipid peroxidation might underway oxidation when they are 
catalyzed by the peripheral cell enzymes, being then exhaled through breath.  
Ketones such as methylvinyl ketone are related to excessive fatty acid oxidation due to 
metabolic changes produced by HLC disease onset, when the body uses fat instead of 
glucose for energy. For instance, acetone is produced in the liver by decarboxylation of 
acetoacetate during lipolysis as a secondary source of energy for the body [18]. Thus, 
methylvinyl ketone might be produced as a result of secondary metabolites in lipid 
peroxidation. Hydroxy-2, 4, 6-trimethyl-5-(3-methyl-2-buytenyl)cyclohexylmethylacetate 
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belongs to the branched ketone group and might be also related to excessive oxidation 
of fatty acids. 
Although deeper investigations are required to fully understand the origin of the HCL 
breath biomarkers identified in this study, based on the above analysis they are 
associated with biochemical changes linked to molecular processes such as oxidative 
stress, lipid metabolism, cytochrome p-450 enzymes, and carbohydrate metabolisms, 
produced in the body during pathogen infections with leishmania parasite.  
 
5.4. Echinococcosis Breath Biomarkers 
Exhaled breath samples collected from Cystic Echinococcosis (CE), Alveolar 
Echinococcosis (AE), and healthy controls for each group (here denominated CCE and 
CAE, respectively), were subjected to two independent analyses. Breath samples of 55 
volunteers (23 patients with CE and 32 CCE controls) were measured for the 
identification of CE biomarkers, whereas breath samples of 21 volunteers (13 patients 
with AE and 8 CAE controls) were measured for the identification of AE biomarkers. 
The chemical analyses revealed approximately 120 compounds in each breath sample. 
When comparing the CE and AE groups versus their corresponding control groups, it 
was found that two VOCs in the exhaled breath were present in statistically different 
concentrations between CE and CCE groups, while seven VOCs were found to be 
different between the AE and CAE groups. These compounds, presented in Table 5.3, 
represent putative breath biomarkers for CE and AE, respectively. The abundance of 
these compounds in the breath samples of all volunteers from each study group is 
shown in Figure 5.8. 
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Disease VOCs Chemical Name Family p-value 
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VOC 02 (E)-13-Docosenoic acid Unsaturated 
carboxylic acid 
0.045 
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VOC 03 Hexadecane Unbranched alkane 0.032 
VOC 04 Heptadecane Unbranched alkane 0.029 
VOC 05 Eicosane Unbranched alkane 0.027 
VOC 06 11-(pentan-3-yl)henicosane  Branched alkane 0.033 
VOC 07 Tetratriacontane  Unbranched alkane 0.046 
VOC 08 2-methyloctacosane Branched alkane 0.049 
VOC 09 Hentriacontane Unbranched alkane 0.044 
Table 5.3: Putative breath VOC biomarkers found for Cystic Echinococcosis and Alveolar 
Echinococcosis. 
Figure 5.8: Mean values of the abundance of the breath biomarkers found in this study for: 
a) Cystic Echinococcosis; b) Alveolar Echinococcosis. The error bars represent the standard 
error of the mean. 
 
The diagnostic potential of the identified breath biomarkers was assessed by building 
classifications model based on Discriminant Function Analysis. The DFA model built 
with the abundances of the two breath biomarkers of CE showed a fair discrimination 
between the CE and CCE volunteers (60.9% sensitivity, 68.8% specificity and 65.5% 
accuracy), while the DFA model built with two AE biomarkers (VOC03 and VOC05 in 
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Table 5.3) showed a good discrimination between the AE and CAE volunteers (92.3% 
sensitivity, 62.5% specificity and 80.9% accuracy). The box plot of the DFA 
classification model built with these two AE biomarkers, as well as ROC curve analysis 
that provided a maximum diagnostic accuracy of 77.9%, are presented in Figure 5.9. 
 
Figure 5.9: Classification between AE and CAE volunteers using two AE breath 
biomarkers (VOC03 and VOC05 in Table 5.3): (a) Box plot of the first canonical variable 
(CV1) of the DFA model calculated with the peak areas of the two biomarkers; each 
patient is represented by one point in the box plot; (b) ROC curve constructed with the 
CV1 of the DFA model, yielding AUC = 77.9%. 
 
An important remark from the closer examination of Figure 5.8 is that the 
concentration of all CE biomarkers increased in the CE group as compared with their 
corresponding controls (CCE), whereas the concentration of all AE biomarkers 
decreased in the AE group as compared with their corresponding controls (CAE). It is 
also remarkable that the putative biomarkers found for CE and AE are totally different 
for these two forms of the disease. Thus, even though these diseases are from the same 
family of Echinococcus, the pathogenesis of CE and AE infectious and the changes that 
they produce in the body chemistry appear to be completely different [24,25]. The 
identified biomarkers belong to the family of aliphatic hydrocarbons, except (E)-13-
docosenoic acid that is a monounsaturated fatty acid. A discussion about the possible 
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origin of the breath biomarkers for each type of the Echinococcosis disease is presented 
below. 
Cystic Echinococcosis  
Echinococcus granulosus infection is always asymptomatic and persists without 
noticeable pathologic events for a long period of time while a hydatid cyst is developed 
for avoiding host immune response. As a result, the parasite modulates host immune 
reaction to reduce the host response to pathogen invasion [26]. More specifically, the 
Antigen B from the hydatid cyst fluid guarantees parasite survival by suppressing 
human neutrophil chemotaxis, inhibiting lipid detoxification and affecting the 
metabolism by fatty acid binding, as well as by increasing cytokine dysfunctions [27]. 
Therefore, the infection induces an immune imbalance in the hepatic tissue leading to 
sever destruction of its architecture due to intensive inflammatory infiltrations in 
various sites of the body [28]. The pro-oxidant species tend to enhance the formation of 
reactive superoxide species in order to destroy the pathogen that in some cases 
introduces physiological disturbance in the cells that produce oxidative stress. Important 
metabolic processes such as the central carbon catabolism, protein synthesis and 
different cellular processes are therefore perturbed. As a result, alkene derivatives are 
thought to be generated from chain cleavage and recurrent oxidation products in the 
process of lipid peroxidation [29].  
The long chain hydrocarbon, 1-tridecene, might  originate as an intermediary specie 
from the carbon catabolism in the process of acetyl coenzyme A decarboxylation, and 
its presence in CE pathogenesis might be related to enhanced production of 
inflammatory molecules during chronic echinococcal infection at different parts of the 
body, mainly in the liver [28,30].  
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(E)-13-Docosenoic acid belongs to the family of monounsaturated hydrocarbons with 
polar carboxylic functional group, and is related to lipid peroxidation of polyunsaturated 
fatty acids during and after monocyte adhesion to endothelial cells to enable parasite 
survival in a pro-oxidant environment. Its presence in the exhaled breath might be 
associated with the long chain ω-9 polyunsaturated fatty acids generation as a result of 
parasite induced cytokine inflammatory activation and the oxidative damage of the cell 
membrane lipids [31]. 
Alveolar Echinococcosis  
In the case of Alveolar Echinococcosis infection, hexadecane, heptadecane and 
eicosane might be a result of oxidative degradation of polyunsaturated fatty acids 
inflicted by oxidative stress during Echinococcal chronic inflammatory infection 
[21,32]. They are all straight chain alkanes and their presence in the exhaled breath can 
be associated with the peroxidation of various PUFA such as linoleic and linolenic 
acids, which are cell membrane components [33].  
The long chain alkanes 11-(pentan-3-yl)henicosane, tetratriacontane, 2-
methyloctacosane and hentriacontane can also be produced from the lipid peroxidation 
of long chain PUFAs. These VOCs are generated as a result of excess reactive oxygen 
species due to either overproduction of pro-oxidants, or insufficient activity of 
antioxidants in the body. During the process of PUFA peroxidation, there is a scission 
of alkane fragments extending from the methyl end of the fatty acid to the double bond. 
Depending on the nature of the initial fatty acid, alkane molecules such as ethane and 
pentane are released by the oxidative damage of ω-3 polyunsaturated fatty acid and ω-6-
polyunsaturated fatty acid, respectively [34,35]. These molecules are partly metabolized 
in the liver by the microsomal oxidizing enzyme associated with the cytochrome P-450 
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and/or released in the breath, indicating the extent of lipid peroxidation in the body 
during inflammation [11,34]. Hence, the branched alkanes 11-(pentane-3-yl)henicosane 
and 2-methyloctacosane might undergo the Cytochrome P-450 metabolic process once 
they are released as intermediate products of lipid peroxidation of long chain PUFAs. 
 
5.5. Conclusion 
The chemical analysis at different time intervals of the composition of several breath 
samples provided by the same volunteer revealed that the breath volatiles can be stored 
without significant losses in the Tenax TA sorbent tubes for at least 1.5 years. 
The comparison of the breath composition of the volunteers diagnosed with each one of 
the studied diseases and their corresponding control groups permitted the identification 
of putative breath biomarkers of these diseases. Six biomarkers were identified for 
Dengue (toluene, n-propyl acrylate, styrene, 1-undecyne, 1-acetyl-1H-benzotriazole, 
and 2-ethylsulfonyl ethanol), nine biomarkers were identified for Cutaneous 
Leishmaniasis (2,2,4-trimethyl pentane, 4-methyl-2-ethyl-1-pentanol, methylvinyl 
ketone, nonane, 2,3,5-trimethyl hexane, hydroxy-2,4,6-trimethyl-5-(3-methyl-2 butenyl) 
cyclohexyl) methylacetate, octane, 3-ethyl-3-methylheptane, and 2-methyl-6-
methylene-octa-1,7-dien-3-ol), two biomarkers were identified for Cystic 
Echinococcosis (1-tridecene, and (E)-13-docosenoic acid) and seven biomarkers were 
identified for Alveolar Echinoccocosis (hexadecane, heptadecane, eicosane, 11-(pentan-
3-yl)henicosane, tetratriacontane, 2-methyloctacosane, and hentriacontane). By 
comparing them, it was observed that aromatic compounds were identified as 
biomarkers only for Dengue disease, esters for Dengue and Cutaneous Leishmaniasis, 
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alcohols and one ketone for Cutaneous Leishmaniasis, alkanes for Cutaneous 
Leishmaniasis and Alveolar Echinococcosis, one alkene for Dengue and a different one 
for Cystic Echinococcosis, and one acid for Cystic Echinococcosis. It is important to 
note also that, although Cystic Echinococcosis and Alveolar Echinococcosis are from 
the same family of Echinococcus, the putative biomarkers found for CE and AE were 
totally different for these two forms of the disease, indicating that the pathogenesis of 
CE and AE infectious and the changes that they produce in the body chemistry appear 
to be completely different. 
Classification models based on the DFA algorithm built with the putative biomarkers 
identified in this study yielded fair to good discrimination accuracies: 84.4% for Dengue 
diagnosis, 80% for Cutaneous Leishmaniasis diagnosis, 65.5% for Cystic 
Echinococcosis diagnosis, and 80.9% for Alveolar Echinococcosis diagnosis (all these 
statistical values were calculated through leave-one-out cross-validation). 
The possible origin of the biomarkers was discussed in light of previous reports related 
with infectious diseases and metabolic studies. Further investigation of their origin 
could provide new insight in the metabolism, biochemical pathway and disease 
pathogenesis, which presumably could lead to the development of improved therapeutic 
strategies. The biomarkers identified by the analytical studies formed the basis for a 
rational selection of the MNPs-ligands nanoassemblies that possess high affinity to 
them, which were employed as sensing materials for the chemical gas sensors arrays 
that were assessed in the next chapter of my thesis for the diagnosis of the studied 
tropical diseases from exhaled breath analysis. 
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5.6. Pattern Recognition Applied in this Chapter 
The Discriminant Function Analysis was used for building the classification models for 
diseases diagnosis. DFA is a supervised linear pattern recognition algorithm that 
calculates new, orthogonal variables (called Canonical Variables or CVs) as a linear 
combination of the input variables, under the constrain of minimizing the distances 
between the data points of the same class, while maximizing the distances between the 
data points of different classes. Linear discriminant analysis (LDA) finds a linear 
discriminant function (LDF) which is a linear combination of the original variables, 
such that the ratio of the between –class scatter and within-class scatter is maximized. 
Thus, the most discriminative DFA variable is the first canonical variable (CV1), for 
two-group classification cases (e.g., classification between the groups of patients 
diagnosed with one of the studied diseases and their corresponding controls, and 
between male and female groups) the mean values on the CV1 axis of all the samples 
from each group were calculated, and the separation between the two groups was given 
by the orthogonal line drawn on the CV1 axis that passed through the median point 
between the mean values of the two groups. For the separation between three groups 
(i.e., when volunteers age was considered as confounding factor), the classification of 
any sample was provided by the minimum distance from that sample to the centers of 
each group on the (CV1, CV2) axis, as the second canonical variable (CV2) represents 
an additional dimension of differentiation when three groups are to be distinguished 
[36]. 
The DFA models were built with the abundances (peak areas) of the breath biomarkers. 
As DFA is a supervised algorithm, the accuracy of the models was calculated applying 
leave-one-out cross-validation to avoid model overtraining while reducing its 
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generalization potential for the identification of new samples. Thus, while one sample 
was taken out from the available data set, the DFA classification model was built with 
the rest of the samples from the data set, and the sample taken out was then blindly 
projected onto the DFA model, which predicted its class. Applying this procedure for all 
the samples from the data set, allowed to calculate the classification accuracy, 
sensitivity and specificity from the true positives (TP), true negatives (TN), false 
positives (FP) and false negatives (FN) values, as follows: accuracy = 
(TP+TN)/(TP+TN+FP+FN); sensitivity = TP/(TP+FN); specificity = TN/(TN+FP) [37]. 
The area under curve (AUC) of the receiver operating characteristic (ROC) curve was 
constructed with the values of the first canonical variable (CV1) of the DFA models. 
The ROC curve is plotted as a function of true positive rate (sensitivity) versus false 
positive rate (1-specificity) for different cut-off points, whereas the area under the 
curve, defined as the area of the ROC curve minus the random result, measures how 
well the diagnostic test (accuracy) distinguished the diseased from the normal healthy 
state. 
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This chapter presents the diagnosis potential of infectious tropical diseases 
(Dengue, Cutaneous Leishmaniasis and Human Echinococcosis) through the 
analysis of exhaled breath samples with chemical gas sensor arrays. Both the direct 
breath measurement approach (which can be employed for on-site measurements) 
and the indirect breath measurement approach (which is necessary when the 
collection and measurement sites of the breath samples are different) were 
evaluated during this study.  
 
 
6.1. Breath Samples Measurement Setup 
Two different approaches were followed to measure the breath samples aiming both 
direct and indirect breath measurement, for which different setups were designed and 
fabricated. These setups are next presented.  
6.1.1. Direct Breath Measurement Approach 
In this approach, the breath samples are directly transferred after collection from the 
Bio-VOC sampler into the sensors test chamber. 
A Teflon test chamber (120×26×10 mm3 volume) provided with two openings for 
sample inlet and sample outlet, respectively, was designed and fabricated for the direct 
breath measurement approach. An electronics circuit board with pin sockets able to 
accommodate up to 10 chemical gas sensors was introduced inside the test chamber. For 
performing the breath measurements, the breath sample was directly injected from the 
Bio-VOC sampler into the sensors test chamber by steadily pushing the plunger during 
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10 seconds. The output opening of the test chamber was closed immediately after the 
whole volume of the breath sample was transferred from the Bio-VOC into the test 
chamber. Each sensing measurement comprised the following cycles: (i) 5 min under 
continuous synthetic dry air flow (0.5 L/min flow rate) for measuring sensors baseline; 
(ii) 5 min exposure to the breath sample under stationary conditions; (iii) 30 min under 
continuous synthetic dry air flow (0.5 L/min flow rate) for cleaning sensors surface and 
the measurement chamber.  
The direct breath measurement setup is shown in Figure 6.1. 
 
 
Figure 6.1: Direct breath measurement approach 
6.1.2. Indirect Breath Measurement Approach 
In this approach it is employed an intermediary step when the exhaled breath sample 
collected with the Bio-VOC sampler is stored in a sorbent tube before analysis. This 
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approach was necessary when the samples were measured at a different site than their 
collection place. 
A stainless steel test chamber (70×35×30 mm3 volume) provided with two openings, 
one used for sample inlet and for realizing the vacuum inside the test chamber, and the 
other one for sample outlet, respectively, was designed and fabricated for the indirect 
breath measurement approach. An electronics circuit board with pin sockets able to 
accommodate up to 8 chemical gas sensors was introduced inside the test chamber.  
In order to analyze the breath sample, the storage tube was cut and the sorbent material 
was introduced in a 20 ml glass vial that was hermetically sealed. To desorb the breath 
volatiles trapped by the sorbent material, the vial was heated for 10 min at 270 ºC in a 
conventional oven (UNE 300, Memmert GmbH, Germany). 10 mL of the headspace 
formed by the desorbed VOCs inside the sealed vial were extracted with a gas tight 
sampling syringe (VWR International EuroLab, Spain) and transferred into the test 
chamber for measurement. 
For sample measurement with the chemical gas sensors, at first it was evaluated the 
injection into a carrier gas of the breath volatiles captured by the gas syringe. Both N2 
and synthetic dry air were assessed as carrier gases, using different flow rates, starting 
with 100 ml/min. However, sensors response in this continuous flow approach, where 
the gaseous flow enters the measurement chamber through the inlet opening and 
immediately exits through the outlet opening, was much smaller than in the case of the 
stationary measurement approach that was next assessed. In this later approach, low 
vacuum (~ 600 mbar) condition was created for 5 min inside the sensor test chamber by 
means of an external electrical pump (Model C5, Electro A.D., Spain) prior to sample 
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measurement, and the breath volatiles captured by the gas syringe were directly injected 
into the sensors test chamber in vacuum and measured under stationary conditions for 
the desired period of time. Thus, by setting sensors exposure time to the breath sample 
to 320 seconds, which is considerable higher than their exposure time in the continuous 
flow approach (< 1 min even at the lowest carrier gas flow set), their responses were 
considerably higher.  
Therefore, the stationary approach was further adopted for measuring the breath 
samples in the indirect measurement approach, which led to the design of the 
measurement setup shown in Figure 6.2. Each breath sample measurement comprised 
the following cycles: (i) 320 sec under low vacuum conditions (~ 600 mbar); (ii) 320 
sec exposure to the breath VOCs under stationary conditions (pressure inside sensors 
chamber: ~ 875 mbar ± 3%); (iii) 30 min flushing with synthetic dry air (2 L/min flow 
rate) for sample evacuation and cleaning sensors surface and the measurement chamber. 
 
Figure 6.2: Indirect breath measurement approach. 
6.2. Sensors Operation 
In this study, the sensors were operated in the dynamic mode by switching them 
successively for short periods of time between the ON (application of DC voltage) and 
OFF (no DC voltage) states without reaching steady state conditions, in order to assess 
Heated Vial Chamber Gas tight syringes 
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their transient responses to the breath VOCs mixture, which contain more information 
than the static measurements [1].  
In the direct breath measurement approach, the sensors were sequentially operated at 5 
V for 10 sec in a switching mode, followed by 70 sec of inactivity. During the inactivity 
of one of the sensors, all the other sensors were operated each one for 10 sec in the 
mentioned switching mode. 
In the indirect breath measurement approach, both during the vacuum stage and breath 
sample exposure, the sensors were sequentially operated at 8 V for 10 sec in switching 
mode, followed by 70 sec of inactivity. During the inactivity of one of the sensors, all 
the other sensors were operated each one for 10 sec in the aforementioned switching 
mode. For speeding up the cleaning process after sample measurement, the sensors were 
operated at 10 V for 10 sec followed by 70 sec of inactivity in the same switching 
mode. 
Although a higher voltage span can favor the kinetic reactions that occur between the 
sensing nanomaterial and the breath volatiles, a lower voltage was applied in the case of 
the direct breath measurement approach to reduce sensors response due to local 
condensation of water from the humidified breath sample, which adds a competing 
conduction mechanism by ionic conduction in addition to the electrons tunnelling 
mechanism throughout the sensing film, and thus introduces additional noise in the data 
[2]. 
Each breath sample measurement comprised four consecutive acquisition cycles, lasting 
totally for 320 sec. During the whole measurement process, the DC current through the 
sensors was acquired at a sampling rate of 9 samples/sec for further analysis, so during 
one measurement cycle 90 data points were acquired for each sensor. For all sensing 
measurements, a high precision power source (B2902A, Keysight Technologies, 
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Hungary) was used to apply the desired DC operation voltage to the sensors, and a high-
resolution data acquisition system (34972A, Keysight Technologies, Hungary) for 
acquiring the DC current through the sensors. 
The results of a preliminary study performed with one of the sensors based on AuNP 
capped with decanethiol for assessing sensor’s detection potential in the direct and 
indirect breath measurement approaches is shown in Figure 6.3. Both breath samples 
were measured in the stationary mode during 10 min, while the sensor was successively 
operated at 8 V during 10 sec, followed by 0.16 sec of inactivity. The observed current 
changes through the sensor during one operation cycle were due to the dynamic 
modulation between the OFF and ON states of the switching sensor’s operation 
methodology proposed in this study.   
 
The higher sensor response in the case of the direct breath sample measurement is 
assumed to be due to the fact that, by avoiding the intermediate step of breath VOCs 
 
Figure 6.3: Sensor’s response to: Synthetic dry air flow (black); N2 flow (pink); 
Breath volatiles measured under stationary conditions in the indirect measurement 
mode (red); Breath sample measured under stationary conditions in the direct 
measurement mode (blue).  
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storage and their posterior desorption, all the volatiles were transferred with no loss 
from the Bio-VOC sampler into the sensors test chamber 
, as well as due to the humidity content present in the exhaled breath (Tenax TA is a 
hydrophobic material that does not retain the humidity from breath). On the other hand, 
as expected, sensor response to continuous flows of synthetic dry air and N2 
(200ml/min) was much lower.  
 
6.3. Tropical Diseases Diagnosis through Exhaled Breath 
Analysis 
6.3.1. Dengue Diagnosis 
The chemical gas sensors selected for assessing the diagnosis of Dengue from exhaled 
breath analysis are presented in Table 6.1. The organic functionalities of the sensors 
were selected based on their affinity to the breath biomarkers of Dengue identified by 
the analytical studies. In this regard, dodecanethiol and oleylamine, organic 
functionalities with saturated hydrocarbon in the tail, have good affinity to non-polar 
hydrocarbons such as 1-undecyne; 4-methoxy-α-toluenethiol and 2-
mercaptobenzoxazole, which possess an aromatic functionality, have high affinity to 
styrene and toluene; 11-mercaptoundecanol and 11-mercaptoundecanoic acid, with 
polar tail, have high affinity to n-propyl acrylate and 2-ethylsulfonyl through short 
range hydrogen interactions [3], while the benzoxazole group of 2-
mercaptobenzoxazole allows for good diffusion of 1-acetyl-1H-benzotriazole. It is 
important to note that the sensors having the same sensing material were not identical; 
they were fabricated in different batches and presented slightly different morphologies 
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and different reference values of their baseline resistance, thus suggesting slightly 
different behavior to the volatiles from the exhaled breath. 
Nº Sensor Metal nanoparticles Organic functionality R (MΩ) 
1 S1 AuNPs 1-decanethiol 2.2 
2 S2 CuNPs Oleylamine 41 
3 S3 CuNPs 11-mercaptoundecanol 4.3 
4 S4 PtNPs 4-methoxy-α-toluenethiol 0.5 
5 S5 CuNPs 11-mercaptoundecanoic acid 6.2 
6 S6 CuNPs Oleylamine 7.8 
7 S7 CuNPs 11-mercaptoundecanol 7.1 
8 S8 CuNPs 2-mercaptobenzoxazole 11.5 
Table 6.1: List of the chemical gas sensors used in the Dengue study 
 
This sensors array was used to measure the breath samples provided by 15 Dengue 
patients and 13 Control volunteers employing the indirect breath measurement 
approach. All sensors responded to the breath volatiles, exhibiting significant 
differences when exposed to breath samples of Dengue and Control volunteers (Figure 
6.4). When the sensors were exposed to the breath VOCs, Van der Waals interactions 
between the VOCs and the ligands are expected to be dominant [4], which is consistent 
with the observed rapid and reversible sensor responses from Figure 6.4. Moreover, 
sensors responses were similar during the four operation cycles, therefore for 
performing the data analysis it was selected the first operation cycle only, in order to 
reduce the computational costs. The current extracted at different time intervals after 
sensors exposure to the breath samples (during the first operation cycle) was used to 
build DFA discrimination models for Dengue. The exposure times selected for each 
sensor are given in Table 6.2. Volunteer classification achieved by the individual 
sensors, calculated employing leave-one-out cross-validation, is summarized in Table 
6.3. 
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Figure 6.4. Representative sensor responses to the exhaled breath of Dengue and Control 
volunteers: (left) Response produced by sensor S5 based on CuNPs functionalized with 11-
mercaptoundecanoic acid; (right): Response produced by sensor S7 based on CuNPs 
functionalized with 11-mercaptoundecanol. 
 
All sensors showed very high discrimination potential, with classification accuracy 
ranging between 82.1% and 96.4% – the highest achieved by S7, based on CuNPs 
capped with 11-mercaptoundecanol. The DFA models built with sensors responses and 
ROC curves are shown in Figure 6.5. 
Sensor Time intervals selected for each sensor (s) 
S1 6.9 7.7 8.0 8.3 8.8 8.9 9.7 9.8 
S2 6.9 7.3 7.4 7.8 8.0 8.4 8.7 9.1 
S3 6.9 7.3 7.6 7.9 8.0 8.1 8.3 8.5 
S4 7.1 7.5 8.3 8.4 8.7 8.9 9.1 9.2 
S5 6.9 7.3 7.6 7.9 8.1 8.3 9.3 9.6 
S6 7.2 7.3 8.4 8.9 9.2 9.7 9.8 9.9 
S7 7.7 7.8 8.0 9.1 9.3 9.4 9.7 9.9 
S8 6.9 7.2 7.4 7.7 8.3 8.4 8.7 9.2 
Table 6.2: Exposure times for each sensor at which were extracted the values of the current used 
to build the DFA models for Dengue discrimination. S1 to S8 indicate each one of the different 
sensors employed in this study. 
Sensor S1 S2 S3 S4 S5 S6 S7 S8 
TP 14 14 14 13 14 12 14 14 
TN 12 12 11 11 12 11 13 12 
FP 1 1 2 2 1 2 0 1 
FN 1 1 1 2 1 3 1 1 
Accuracy (%) 92.9 92.9 89.3 85.7 92.9 82.1 96.4 92.9 
Specificity (%) 92.3 92.3 84.6 84.6 92.3 84.6 100 92.3 
Sensitivity (%) 93.3 93.3 93.3 86.7 93.3 80 93.3 93.3 
Table 6.3: Classification between Dengue and Control volunteers, calculated employing leave-
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one-out cross-validation, using DFA models built with the current extracted at different exposure 
time intervals of the individual sensors to the breath samples. S1 to S8 indicate each one of the 
different sensors employed in this study. 
 
Figure 6.5: Classification between Dengue and Control volunteers using sensors responses to 
exhaled breath: (left) Box plots of the first canonical variable (CV1) of the DFA models calculated 
with the current extracted at different time intervals from each sensor response; each patient is 
represented by one point in the box plots; the dashed lines represent the classification border 
between the two groups; (right) ROC curves constructed with the CV1 of the DFA models; the 
resulting AUCs are indicated in each figure. S1 to S8 indicate each one of the different sensors 
employed in this study. 
 
In order to analyze the influence of volunteers’ gender and age on the models built with 
sensors responses, the classification based on these confounding factors was assessed 
using the DFA models built with the same currents as those selected for Dengue 
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classification. The low classification accuracy of these analyses proved the insensitivity 
of the sensors breath test to these possible confounding factors (Table 6.4). 
Accuracy (%) S1 S2 S3 S4 S5 S6 S7 S8 
Gender 46.4 42.9 39.3 17.9 42.9 42.9 46.4 39.3 
Age 25 28.6 21.4 53.6 42.9 64.3 42.9 25 
Table 6.4: Classification accuracy based on the confounding factors gender and age obtained 
from the DFA models built with sensors’ responses. S1 to S8 indicate each one of the different 
sensors employed in this study. 
The overall classification of each sample obtained by the predominant prediction of the 
majority of the chemical gas sensors is presented in Table 6.5. Based on this 
classification, the combined sensor system comprising 8 different sensors was able to 
obtain 100% accuracy in Dengue diagnosis, while samples classification based on 
confounding factors such as volunteers gender and age, reached 21.4% and 32.1% 
accuracy, respectively. 
Volunteer No. of 
sensors that 
classified as 
Dengue 
No. of 
sensors that 
classified as 
Control 
Disease 
prediction 
Gender 
prediction 
(M/F) 
Age prediction 
(Young/Middle-
Aged/Senior) 
D01 8 - Dengue F Senior 
D02 7 1 Dengue Unclassified Unclassified 
D03 8 - Dengue M Unclassified 
D04 7 1 Dengue M Young 
D05 7 1 Dengue M Middle-Aged 
D06 8 - Dengue M Middle-Aged 
D07 6 2 Dengue Unclassified Unclassified 
D09 7 1 Dengue Unclassified Young 
D10 8 - Dengue F Young 
D11 8 - Dengue Unclassified Middle-Aged 
D12 8 - Dengue F Young 
D13 7 1 Dengue M Young 
D14 7 1 Dengue M Young 
D15 7 1 Dengue M Young 
D16 7 1 Dengue Unclassified Middle-Aged 
C01 - 8 Control F Unclassified 
C02 - 8 Control M Unclassified 
C03 - 8 Control F Unclassified 
C04 2 6 Control F Senior 
C05 1 7 Control F Unclassified 
C06 1 7 Control F Middle-Aged 
UNIVERSITAT ROVIRA I VIRGILI 
EXHALED BREATH ANALYSIS FOR NON-INVASIVE DIAGNOSIS OF TROPICAL DISEASES 
Tesfalem Geremariam Welearegay 
 
166 Exhaled Breath Analysis- Chemical Sensors 
 
Chapter 6 
C07 1 7 Control M Young 
C08 1 7 Control M Unclassified 
C10 - 8 Control M Middle-Aged 
C11 2 6 Control F Young 
C12 1 7 Control M Middle-Aged 
C14 - 8 Control M Unclassified 
C16 1 7 Control F Unclassified 
Table 6.5: Samples classification achieved by the majority of the chemical gas sensors from the 
array. Correct predictions are indicated in bold; wrong predictions are indicated in italic. 
Unclassified samples refer to the cases when two classes obtained the same prediction score. 
 
The fact that each individual sensor was able to provide high classification accuracy 
greatly enhances the application potential of the breath test proposed in this study, as the 
misclassification produced by one or very few sensors is readily compensated by the 
accurate classification of the other sensors in the array. Therefore, the false response 
from one sensor will not compromise the overall functionality of the whole sensing 
system. Moreover, additional sensors could be trained in a similar way for the detection 
of the Dengue breath volatiles pattern and replace damaged sensors from the array, if 
needed. 
6.3.2. Leishmaniasis Diagnosis 
The chemical gas sensors selected for assessing the diagnosis of Leishmaniasis from 
exhaled breath analysis are presented in Table 6.6. The organic functionalities of the 
sensors were selected based on their affinity to the breath biomarkers of Leishmaniasis 
identified by the analytical studies. The molecular ligands of sensors S1, S2, S3, and S6, 
with polar and aromatic functional groups in the tail, are likely to have good affinity to 
breath VOCs with similar functional characteristics, such as methylvinyl ketone, 4-
methyl-2-ethyl-1-pentanol, hydroxyl-2,4,6-trimethyl-5-(3-methyl-2-butenyl)cyclohexyl 
methylacetate and 2-methyl-6-methylene-octa1,7-dien-3-ol. On the other hand, the non-
polar tail of the ligand of sensors S4 and S5 interacts more preferably with non-polar 
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VOCs such as 2,2,4-trimethylpentane, nonane, octane, 2,3,5-trimethylhexane, and 3-
ethyl-3-methylpentane. 
Sensor MNP Molecular organic ligand Resistance (MΩ) 
S1 CuNPs 2-mercaptobenzoxazole 0.6 
S2 CuNPs 11-mercaptoundecanol 2.3 
S3 AuNPs 2-mercaptobenzoxazole 5.8 
S4 PtNPs 1-dodecanethiol 7.8 
S5 AuNPs 1-dodecanethiol 0.7 
S6 CuNPs 11-mercaptoundecanoic acid 4.5 
Table 6.6: List of the chemical gas sensors used in the Leishmaniasis study. 
 
This sensors array was used to measure breath samples collected from 56 volunteers (28 
HCL patients and 28 CCL controls) employing the indirect breath measurement 
approach. Figure 6.6a shows the response of sensor S1 under vacuum conditions, and 
to the breath samples of HCL and CCL volunteers, during four operation cycles, 
illustrating the rapid and reproducible response of the sensor towards the different 
samples analyzed.  
The MNPs are electrically insulated as deposited, but upon ligand functionalization they 
become conductive, albeit with an intrinsic high resistance (Table 6.6). The organic 
ligand provides sorption sites for the breath VOCs, and the conductance of the sensing 
layer is modified upon VOCs adsorption on the ligands [3,5-8] .The decrease in the 
electrical DC current through the sensor upon exposure to the breath samples can be 
explained by VOCs sorption onto the MNPs-ligand matrix favoring film swelling, and 
hence increasing the distance between the MNPs cores, which thereby reduces the 
electron transfer between the MNPs [3,5,9]. The swelling effect is reversible when the 
sample is evacuated from the sensors test chamber [5,10,11], leading to the observed 
recovery of sensor’s baseline conditions. 
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On the other hand, it is noted that the sensor response presents different profiles to the 
breath VOCs of HCL and CCL volunteers, suggesting that it is possible to discriminate 
breath volatiles patterns of the HCL and CCL groups. To assess the sensor’s capability 
to discriminate the two study groups (HCL and CCL), an unsupervised PCA pattern 
recognition algorithm was computed with three features extracted from sensor’s 
response to the breath samples of all volunteers from this study (see Annex II): 
- F1: Mean DC current acquired during 1.22 seconds (11 sampling points) at the 
middle of sensor exposure to the breath sample;  
- F2: Mean DC current acquired during the last 1.22 seconds (last 11 sampling 
points) of sensor exposure to the breath sample;  
- F3: Area under the response curve during the last 1.78 seconds (last 16 sampling 
points) of sensor exposure to the breath sample. 
Figure 6.6b presents the patients classification achieved by the PCA plot. The first 
principal component (PC1) of the PCA model, which accounted for 99.8% of the 
variance in the data (Figure 6.6c), provided 80.3% accuracy, 78.6% sensitivity and 
82.1% specificity for HCL discrimination, while the AUC of the ROC curve (Figure 
6.6d), indicated 87.6% accuracy. Given these promising results, the supervised DFA 
pattern recognition algorithm was also investigated for training the discrimination 
model between the HCL and CCL groups. Figure 6.6e shows the classification obtained 
by the first canonical variable (CV1) of the DFA model, where all volunteers were 
correctly classified in function of their health state. The HCL classification accuracy, 
sensitivity and specificity calculated through leave-one-out cross-validation were all 
100%.  
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Figure 6.6: (a) Typical response of one of the sensors (sensor S1, based on CuNPs 
functionalized with 2-mercaptobenzoxazole) towards exposures to vacuum and breath samples 
of HCL and CCL volunteers; (b) PCA plot computed with the features extracted from the 
response of sensor S1 to the breath samples of all volunteers; each volunteer is represented by 
one point in the plot; (c) Boxplot of the first principal component (PC1) of the of the PCA 
model computed with the features extracted from the response of sensor S1 to the breath 
samples of all volunteers; each volunteer is represented by one point in the plot; the standard 
deviation of the PC1 values is represented by the error bars, while the boxes represent the 95% 
confidence interval; the dashed line represents the threshold classification line between the two 
groups, HCL patients being estimated below the dashed line and healthy controls above the 
dashed line; (d) ROC curve analysis of the PC1 values of the PCA model; (e) Boxplot of the 
most discriminative canonical variable (CV1) of the DFA model computed with the features 
extracted from the responses of sensor S1 to the breath samples of all volunteers; each 
volunteer is represented by one point in the plot; the standard deviation of the CV1 values is 
represented by the error bars, while the boxes represent the 95% confidence interval; the dashed 
line represents the threshold classification line between the two groups, HCL patients being 
estimated above the dashed line and healthy controls below the dashed line; (f) ROC curve 
analysis of the CV1 values of the DFA model. 
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The diagnostic model, further validated employing the ROC curve analysis (Figure 
6.6f), gave AUC equal to 1.00, corresponding to 100% accuracy. Pursuing the same 
analysis for the other chemical sensors (S2-S6), the results presented in Table 6.7 were 
obtained. The different sensors comprise different MNPs-ligand nanoassemblies, which 
differ in MNPs core size, molecular ligand structure, nanoassembly morphology and 
surface coverage [12]. It is clear from the results collected in Table 6.7 that sensors 
based on CuNPs (i.e., S1, S2, and S6), provided the highest classification accuracy. 
While AuNPs have been the most extensively used in MNPs-ligand sensing films for 
breath VOCs sensing [13-16], these results demonstrate that chemical sensors based on 
ligand-capped CuNPs hold great potential for breath VOC detection.  
The sensing properties of MNPs-ligand nanoassemblies depend on a number of factors, 
among which the MNPs core size has been assumed to be of paramount importance, and 
determines the effectiveness of film swelling and dielectric changes upon VOCs 
sorption [17]. It has further been reported that the electronic conduction of the 
nanoassembly, and hence its sensitivity to VOCs, depends on the morphology and size 
of the MNPs cores as well as on how the ligand is attached to the metal cores 
[11,17,18].Thus, the high sensing capability achieved in the present study by the 
CuNPs-ligand nanoassemblies might be attributed to the small CuNPs core size (~ 4 
nm), ligand attachment and film morphology, which exhibited a well-ordered structure 
in the case of the CuNPs capped with 2-mercaptobenzoxazole [12]. As a result, the 
swelling efficiency of the film might be predominantly governed by the formation of 
percolation pathways upon VOCs adsorption [11,19], maximizing electrons transfer. 
The overall classification ability of the chemical sensors array was next considered for 
assessing the synergic effect of an array of non-specific cross-reactive sensors to 
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respond to a variety of VOCs in the exhaled breath, enabling the identification of 
specific breath print patterns in multicomponent VOCs mixtures [15,20]. Employing 
this approach, the DFA model built with the three features F1, F2 and F3 extracted from 
the responses of all six sensors from the array to the breath samples analyzed yielded 
98.2% accuracy, 96.4% sensitivity and 100% specificity in the classification of HCL 
patients (last column in Table 6.7). Thus, the sensor array achieved excellent 
discrimination capability between the study groups, suggesting that the cross reactive 
sensors array can be devised to achieve distinct and robust sensing features for 
multicomponent VOCs pattern analysis. This is because the combination of different 
sensors, with different MNPs and functional organic ligands, provide the desired panels 
of MNPs-ligands for combined sensitivity and selectivity towards the disease specific 
breath VOCs pattern.  
 
The role of confounding factors (gender and age in the case of this study), which could 
influence sensors performance, was finally assessed for all the discriminative models 
built in this study. The results of these analyses confirmed that the obtained HCL 
classification results were not affected by patients’ age, but could be slightly affected by 
patients gender (the accuracy of age classification ranged between 26.8% and 55.4% for 
 S1 S2 S3 S4 S5 S6 Sensors array 
Accuracy  100 80.4 73.2 73.2 78.6 85.7 98.2 
Sensitivity  100 78.6 75 57.1 75 89.3 96.4 
Specificity 100 82.1 71.4 89.3 82.1 82.1 100 
TP/TN 28/28 22/23 21/20 16/25 21/23 25/23 27/28 
FP/FN 0/0 5/6 8/7 3/12 5/7 5/3 0/1 
Table 6.7: HCL classification results obtained by the DFA models built with the responses of 
each individual sensor, as well as with the overall responses of all sensors from the array 
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the different models, while the accuracy of gender classification ranged between 37.5% 
and 60.7%). 
 
6.3.3. Echinococcosis Diagnosis 
The chemical gas sensors selected for assessing the diagnosis of Echinococcosis from 
exhaled breath analysis are presented in Table 6.8. The organic functionalities of the 
sensors were selected based on their affinity to the breath biomarkers of Echinococcosis 
identified by the analytical studies. Thus, sensors S3 to S6 and S8 have a polar 
functional organic ligand in their tail with affinity to the CE biomarkers, while sensors 
S1, S2 and S7, with long chain hydrocarbons ligands with non-polar functional groups 
in their tail, exhibit relatively high affinity to the AE biomarkers with long non-polar 
hydrocarbon chains. 
Sensor Metal nanoparticle Molecular organic ligand Resistance (MΩ) 
S1 AuNPs 1-dodecanethiol 0.7 
S2 AuNPs 1-dodecanethiol 4.1 
S3 CuNPs 11-mercapto-1-undecanol 2.3 
S4 PtNPs 4-methoxy-α-toluenethiol 0.4 
S5 CuNPs 2-mercaptobenzoxazole 0.6 
S6 AuNPs 2-mercaptobenzoxazole 5.8 
S7 PtNPs 1-dodecanethiol 7.8 
S8 CuNPs 11-mercaptoundecanoic acid 4.5 
Table 6.8: List of the chemical gas sensors used in the Echinococcosis study 
 
When exposed to the breath samples, each sensor was characterized by rapid and 
reproducible response signals as well as good reversibility after finishing sample 
exposure. A typical response of one sensor to the breath samples provided by two 
volunteers is presented in Figure 6.7, which shows successive responses of the sensor 
to the breath samples during the four transient ON-OFF measurement cycles using the 
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indirect breath measurement approach. This was further confirmed by calculating the 
average current through all sensors during breath sample measurement in all 
measurement cycles, which was very similar for each measurement cycle (Figure 6.8). 
The sensors exhibited on one hand completely different sensitivities when exposed to 
the same breath sample, while on the other hand they presented different overall 
response patterns for different health states, suggesting a broad cross reactive sensors 
array that react differently with the breath VOCs mixture and thus could a priori be 
employed to differentiate different breath patterns [19,21].  
The differences of the sensors response to different breath volatiles patterns were 
initially assessed for discrimination between the breath samples of CE and CCE 
volunteers by analyzing the responses of the sensors array to the breath samples of 52 
volunteers (24 patients with CE patients and 28 CCE controls) measured employing the 
indirect measurement approach. Because of the reproducibility of the sensor responses 
during the different measurement cycles (as evidenced by Figure 6.8), only the first 
cycle was investigated in this analysis. 
 
Figure 6.7: Representative response obtained by sensor S5 based on CuNPs 
functionalized with 2-mercaptobenzoxazole to the exhaled breath of two volunteers 
from the AE and CAE group, measured employing the indirect approach. 
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Figure 6.8: Mean current through the different sensors during breath samples 
measurement calculated for four measurement cycles, scaled to zero-mean and 
unitary variance for each sample measured and each measurement cycle. Samples 
measurements were performed employing indirect measurement approach. 
 
The three features F1, F2 and F3 (calculated in the same way as in the case of the 
Leishmaniasis study), which were extracted from the first measurement cycle, were not 
able to distinguish between the breath prints of the volunteers from the CE and CCE 
groups, as illustrated by the heat map shown in Figure 6.9. 
To improve data classification, different combinations of features were tested in order to 
develop a classification model for the CE and CCE groups employing Discriminant 
Function Analysis (DFA) pattern recognition algorithm. The features calculated for all 
sensors were scaled to zero-mean and unitary variance for each sample measured. Table 
6.9 shows all sensor and feature combinations used in the present study. The DFA 
model built with eight features extracted from 7 different sensors provided 100% 
accuracy, 100% sensitivity and 100 % specificity (values estimated through leave-one-
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out cross-validation) for CE classification, indicating an excellent potential of the 
sensors system to diagnose Cystic Echinococcosis from breath analysis.  
Given these very promising results, the capability of the sensors array to diagnose 
Cystic Echinococcosis on-site (directly in the hospital) was also assessed by using the 
direct measurement approach, whereby the sampled exhaled breath was directly 
exposed to the sensors without pre-concentration and headspace extraction. 
 
Figure 6.9: Heat map of the sensing features extracted from the sensors employed in this 
study, scaled to zero-mean and unitary variance for each sample measured. The first 
number after letter S denotes sensor’s number, while the second number denotes feature 
number.  
 
In this study, breath samples provided by 23 volunteers (8 CE patients and 15 CCE 
controls) were analyzed However, the classification results were inferior in this case 
(82.6% accuracy, 75% sensitivity and 86.7% specificity), which is attributed to the high 
relative humidity from the breath, which is not overcome in the direct measurements 
approach as happens in the indirect measurements approach when a suitable VOCs 
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hydrophobic storage material (Tenax TA) that does not retain the water vapor is used. 
This result was produced even though the sensors were operated at a lower voltage in 
the direct approach than in the indirect approach (5 V instead of 8 V) for reducing the 
sensors response due to local condensation of water from the humidified breath samples 
that adds a competing conduction mechanism by ionic conduction in addition to the 
electrons tunneling mechanism throughout the sensing film [2]. 
Based on this result, the indirect method was employed for assessing the potential of the 
sensors system to diagnose the AE form of the disease. In this study were analyzed 
breath samples provided by 22 volunteers (14 patients with AE and 8 CAE controls). 
The discrimination accuracy between the breath prints of AE and CAE volunteers 
achieved by the DFA model built with 8 features extracted from 6 different sensors was 
92.9%, while the sensitivity and specificity were 92.9% and 88.9 %, respectively, 
demonstrating the high capability of the sensors system developed in this study to 
accurately diagnose also the Alveolar Echinococcosis type of the Echinococcosis 
disease.   
Finally, since the analytical studies revealed different breath biomarkers for CE and AE, 
the capability of the sensors array was evaluated to discriminate between the CE and AE 
patients from exhaled breath analysis. This analysis was performed with the breath 
samples provided by 38 patients (24 patients with CE and 14 patients with AE), and the 
DFA discriminative model built for this analysis with 8 features extracted from 5 
different sensors achieved 92.1% accuracy, 91.7% sensitivity and 92.7% specificity. 
Table 6.10 summarizes the classification results obtained in this study, and Figure 6.10 
presents the corresponding graphical representation of the results. 
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Sensors CE vs CCEa CE vs CCEb AE vs CAEa CE vs AEa 
F1 F2 F3 F1 F2 F3 F1 F2 F3 F1 F2 F3 
S1 x         x x x 
S2  x  x     x    
S3 x       x     
S4 x   x x  x x  x x  
S5 x x   x       x 
S6   x x  x  x     
S7 x     x x  x   x 
S8     x   x  x   
Table 6.9: Sensors and feature used in the discrimination models built for the 
different analysis realized in this study. (a) denotes indirect breath measurements, 
and (b) denotes direct breath measurements. 
 
 
 
The collected results show remarkable accuracy for the diagnosis and detection of 
different types of Human Echinococcosis disease (Cystic Echinococcosis and Alveolar 
Echinococcosis) considering the simplicity of data collection and associated 
straightforward DFA analysis of exhaled breath samples employing a chemiresistive 
sensors array. Such excellent classification capability of the sensors array might be 
attributed to the broad range of MNPs – ligand nanoassemblies used as sensing layer, 
which provided different network structures that contributed to the development of a 
highly cross reactive sensors array, where each sensor reacts differently with the VOCs 
mixtures exhaled through breathing. 
DFA analysis CE vs CCEa CE vs CCEb AE vs CAEa CE vs AEa 
Sensitivity (%) 100 75.0 92.9 91.7 
Specificity (%) 100 86.7 88.9 92.7 
Accuracy (%) 100 82.6 92.9 92.1 
ROC- AUC (%) 100 95.0 98.2 99.4 
Table 6.10: Summary of the classification results obtained by the DFA models built 
with sensors responses and the area under the curve (AUC) of the receiver operating 
characteristic curve (ROC) built with the first canonical variable (CV1) of the DFA 
models. (a) denotes indirect breath measurements, and (b) denotes direct breath 
measurements. 
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Figure 6.10: Classification between: (a) CE and CCE (indirect breath measurement method); 
(b) CE and CCE (direct breath measurement method); (c) AE and CAE (indirect breath 
measurement method); (d) CE and AE (indirect breath measurement method). (Left panels): 
Box plot of the first canonical variable (CV1) of the DFA models built with the sensors features 
presented in Table 6.9; each volunteer is represented by one point in the box plot; the horizontal 
dashed lines represent the classification border between the groups. (Right panels): ROC curves 
constructed with the CV1 of the DFA models. The areas under curve (AUC) values are 
indicated in the lower right parts of the diagrams. 
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This can be supported by the fact that different sensors/features were suitable for the 
diagnosis and discrimination of the two types of the Echinococcosis disease analyzed in 
this study, which is in accordance with the differences between CE and AE found by the 
analytical GC/Q-TOF studies. Therefore, the combinations of individual sensor/feature 
responses obtained with the highest sensitivity to the individual breath VOC patterns 
revealed the desired selectivity and provided distinguishable breath VOC patterns 
between CE and AE. One reason for differentiation of CE and AE may be associated 
with the volatile biomarkers chemical properties. The breath VOCs biomarkers 
identified for AE are longer chained alkane hydrocarbons compared with those for CE, 
which can result in reduced ability for adsorption and diffusion into the nanoassembly 
network, and a concomitant reduced swelling of the nanoassembly films [22].  
6.4. Conclusion  
Specific chemical gas sensors arrays were developed for assessing the diagnosis 
potential through exhaled breath analysis of the neglected tropical diseases investigated 
in this study. The sensing materials of the sensors arrays were judiciously selected such 
that to possess high affinity to the breath biomarkers identified by the analytical studies 
for each disease. 
Two breath analysis setups were designed and developed, aiming both the direct breath 
samples measurement (for on-site analysis) and the indirect breath samples 
measurement (when the samples were measured at a different site than their collection 
site) with the chemical gas sensors systems.  
Indirect breath samples measurements were performed for all studied diseases, 
revealing a remarkable diagnostic performance in distinguished diseased subjects from 
healthy volunteers. DFA models built with selected features extracted from sensors 
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responses yielded diagnostic accuracies that ranged from 100% for Dengue and Cystic 
Echinococcosis, to 98.2% for Cutaneous Leishmaniasis and 92.9% for Alveolar 
Echinococcosis. Moreover, the two dominant forms of Human Echinococcal infections, 
Cystic Echinococcosis and Alveolar Echinococcosis, were discriminated with 92.1% 
accuracy.  
On the other hand, the indirect breath samples measurement approach outperformed the 
results obtained in the direct measurement approach, presumably due to the high 
humidity level from the breath in the case of the later one (the diagnosis accuracy for 
Cystic Echinococcosis was 82.6% employing the direct breath measurement approach, 
compared with 100% in the indirect breath measurement approach).  
Importantly, the diagnostic models built with sensors responses were not affected by 
confounding factors such as volunteers’ gender or age. Smoking habit was not 
considered as a confounding factor in this study because of the low number of smoking 
volunteers that participated in the study.  
The combination of different sensors, with different MNPs and functional organic 
ligands, provided the desired panels of MNPs-ligands for combined sensitivity and 
selectivity towards the disease specific breath VOCs patterns, which led to the excellent 
results obtained. The results were furthermore favored by the sensor operation 
methodology proposed in this study, where the sensors were operated for 10 sec in a 
switching sequence, which provided a dynamic modulation between the OFF and ON 
states. This allowed to extract multivariate information from the kinetic reactions that 
occurred between the sensing material and the breath volatiles. This multivariate 
information enabled the selection, from the transient response of each sensor, of a set of 
significant features that gave very accurate classification results.  
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An important finding is that CuNPs-based nanoassemblies yielded higher diagnostic 
accuracy than AuNPs sensors, which up to date by far have been the most used 
biosensor MNPs material in breath detection. While sensors based on organically-
functionalized AuNPs have been previously studied for the diagnosis of a number of 
diseases [16], the sensors based on CuNPs organic nanoassemblies used in this study 
have very different morphologies. They have higher exposure ratio of the organic 
functionality to the breath volatiles because of the much smaller particles size of CuNPs 
(~4 nm) as compared with AuNP (~10 nm), which is of utmost importance for 
chemiresistive gas sensors. 
The results of the present study paves the way for the development of reliable, fast and 
easy-to-use tests for rapid diagnosis of neglected tropical diseases, which would 
counteract the present lack of reliable diagnosis tests for NTDs. The measurement of 
exhaled breath samples with a simple and easy to use chemical sensors array could 
represent a strategic tackling for the diagnosis and control of the most prevalent 
neglected tropical diseases caused by viral, helminthic and protozoan infections in 
remote areas that lack the necessary socioeconomic and medical facilities for combating 
these infectious diseases. 
The test proposed in this study presents outstanding features, such as: (i) it is easy to 
perform and interpret in both specialist (e.g., medical doctors) and non-specialist (e.g., 
disease-suspected individuals) settings; (ii) the biological samples analyzed (e.g., 
exhaled breath) are collected non-invasively; (iii) the results are obtained in a few 
minutes; and (iv) the disease could be diagnosed in an early-stage. Therefore, it holds 
excellent potential for fighting against the spread of neglected tropical diseases by 
providing early diagnosis and adequate hospitalization and specialized medical care to 
the patients positively diagnoses by the breath test.  
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6.5. Pattern Recognition Applied in this Chapter 
Besides of the supervised Discriminant Function Analysis (DFA) algorithm that was 
explained in the previous chapter, in this chapter was also employed the unsupervised 
Principal Component Analysis (PCA) algorithm.  
PCA is a linear and unsupervised technique that reduces multidimensional data by 
calculating new orthogonal variables, called principal components (PC), as a linear 
combination of the input variables, which capture the maximum variance in the data, for 
projecting them into a low dimensional space [23]. The classification success rate of the 
PCA models was estimated based on samples grouping [24]. 
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 This chapter presents the general conclusions of the thesis work and the future 
perspectives. 
  
7.1. General Conclusions  
The aim of the PhD thesis was twofold: on one hand, a novel technique for the 
fabrication of ultrapure metal nanoparticles was introduced, while on the other hand it 
revealed the diagnostic potential of chemical gas sensors based on ultrapure ligand-
capped metal nanoparticles for the diagnosis of three different neglected tropical 
diseases (Dengue, Leishmaniasis and Echinococcosis), whose sensing films were 
selected based on their affinity to the breath biomarkers of these diseases that were 
identified through analytical studies.  
The first goal of the thesis was to design, fabricate and characterize chemical gas 
sensors based on ultrapure ligand-capped metal nanoparticles. For this end, it has shown 
that the Advanced Gas Deposition technique employed in this thesis work provided the 
synthesis of ultrapure monodispersed metal nanoparticles (MNPs) from the evaporation 
of a pure metal precursor in vacuum. I focused on the synthesis of three metal 
nanoparticles (AuNPs, PtNPs and CuNPs), however the novel technique that I 
introduced in my thesis can be easily extended to practically any MNPs synthesis using 
the proper metal source and adjusting the synthesis parameters. MNPs capping with 
organic ligands was achieved by dip-coating the substrates in a solution formed in high 
purity reagents, which led to the formation of self-assembled nanoparticles-organic 
monolayers with a network-like structure. The MNPs-ligand nanoassemblies presented 
hybrid characteristics, where the nanoparticles served for electrical conduction, while 
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the capping organic molecules promoted electron tunneling through the MNPs. The 
electrical characterization of the AuNPs and PtNPs nanoassemblies led to the first ever 
observation of Schottky diodes fabricated from nanomaterials based on metal 
nanoparticles. Preliminary sensing measurements showed the good potential of the 
novel chemical gas sensors that I produced for breath VOCs detection. 
The second goal of the thesis was to develop a non-invasive, easy-to-use and patient-
friendly methodology for rapid diagnosis of neglected tropical diseases. For this end, I 
investigated disease diagnosis via exhaled breath samples analyses, which are easy to 
obtain and present no discomfort or risk for patients’ health. In my thesis I focused on 
three different types of neglected tropical diseases (Dengue, Leishmaniasis and 
Echinococcosis) caused by three different pathogens (viral, helminthic and protozoan 
infections, respectively). Breath samples were collected from patients and controls in 
Colombia (Dengue), Tunisia (Cutaneous Leishmaniasis and Cystic Echinococcosis) and 
Poland (Alveolar Echinococcosis) with a simple to use Bio-VOCTM breath sampler, and 
stored in Tenax TA sorbent tubes before analysis.  
Analytical studies performed with a GC/Q-TOF equipment (state-of-the-art in analytical 
chemistry, which was employed for the first time for breath samples analysis in my 
thesis) identified six putative biomarkers for Dengue (three aromatic compounds, two 
esters and one alkene), nine putative biomarkers for Cutaneous Leishmaniasis (one 
ester, two alcohols, one ketone and five alkanes), two putative biomarkers for Cystic 
Echinococcosis (one alkene and one acid), and seven putative biomarkers for Alveolar 
Echinococcosis (all alkanes). Importantly, although Cystic Echinococcosis and Alveolar 
Echinococcosis are from the same family of Echinococcus, the putative biomarkers 
found for CE and AE were totally different, indicating that the pathogenesis of CE and 
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AE infections and the changes that they produce in the body chemistry appear to be 
completely different. Classification models built with the identified biomarkers yielded 
fair to good discrimination accuracies: 84.4% for Dengue diagnosis, 80% for Cutaneous 
Leishmaniasis diagnosis, 65.5% for Cystic Echinococcosis diagnosis, and 80.9% for 
Alveolar Echinococcosis diagnosis. 
Based on these biomarkers, I selected several chemiresistive gas sensors based on the 
ultrapure ligand-capped metal nanoparticles that I produced in the first part of my thesis, 
targeting to detect the breath volatiles patterns of the studied neglected tropical diseases. 
Although the sensors are not sensitive to a specific volatile, but they respond to the 
collective exhaled VOCs pattern that comprises a range of compounds with 
concentrations under the limit of detection of the GC/Q-TOF equipment (and therefore 
not detected in the analytical studies), the putative biomarkers that I identified did 
however form a sufficient basis for a rational design of the sensors arrays for each 
disease. Classification models built with selected features extracted from sensors 
responses to the exhaled breath samples of the patients and controls yielded diagnostic 
accuracies that ranged from 100% for Dengue and Cystic Echinococcosis, to 98.2% for 
Cutaneous Leishmaniasis and 92.9% for Alveolar Echinococcosis, while the two 
dominant forms of Human Echinococcal infection (Cystic Echinococcosis and Alveolar 
Echinococcosis) were discriminated with 92.1% accuracy.  
Remarkably, CuNPs-based nanoassemblies yielded higher diagnostic accuracy than 
AuNPs sensors, which up to date have been by far the most used sensing MNPs 
materials in breath detection. The CuNPs sensors have higher exposure ratio of the 
organic functionality to the breath volatiles because of their much smaller particles size 
(~4 nm) as compared with AuNPs (~10 nm), which is of utmost importance for 
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chemiresistive sensors. Moreover, in comparison with the metal nanoparticles sensors 
used in previous studies, which employ chemical precursors that often leave traces of 
residual compounds, the active materials of the sensors used in my thesis were 
synthesized from a pure metal evaporated in vacuum. With this technique, ultrapure 
nanoparticles are produced, which ensures reproducible sensors responses with no 
influence of confounding reactions with synthesis residuals, which is crucial in 
chemical sensor technology. 
Finally, it is worth mentioning that the sensing methodology that I introduced in my 
thesis for neglected tropical diseases diagnosis is simple to use and interpret, and is 
amenable for use in both specialist and non-specialist settings. Therefore, it could 
provide a powerful tool for the facile, rapid and non-invasive diagnosis of NTDs even at 
an early stage when metabolic changes are already produced, and would be especially 
important in regions lacking specialized healthcare diagnostic facilities. 
 
7.2. Future Perspectives 
I performed my PhD studies in the framework of the H2020-MSCA-RISE-2014 
TROPSENSE project “Development of a non-invasive breath test for early diagnosis of 
tropical diseases” (ref. 645758). Based on my results, a portable prototype has been 
developed and is currently employed for on-site validation tests.  
On the other hand, further studies are necessary to elucidate the similarities and 
differences between the breath volatiles patterns of other diseases with similar clinical 
profile or characteristics (e.g., arboviral infections such as Zika and Chikungunya for 
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Dengue, other diseases that produce cutaneous lessions for Cutaneous Leishmaniasis 
and lung cancer or other diseases produced by helminthes for Echinococcosis). 
Finally, the novel ultrapure ligand-capped metal nanoparticles nanoassemblies that I 
produced in my study are of high technological importance for different applications, 
and allows to considerably widen the variety of MNPs-organic ligands combinations 
that can be used as (bio)chemical sensors, SERS surfaces and molecular electronic 
rectifiers.
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XPS Analysis of the Ligand-Nanoparticle Nanoassemblies 
 
 
Figure AI-1: (a) High resolution XPS spectra for the AuNPs-1-DDT nanoassembly; 
Corresponding elemental spectra for: (b) Au4f, (c) S2p, (d) C1s, (e) Si2p, (f) O1s. 
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Figure AI-2: (a) High resolution XPS spectra for the AuNPs-4-MTT nanoassembly; 
Corresponding elemental spectra for: (b) Si2p, (c) O1s, (d) Au4f, (e) C1s, (f) S2p. 
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Figure AI-3: (a) High resolution XPS spectra for the PtNPs-11-MUDA nanoassembly; 
Corresponding elemental scans for: (b) Pt4f, (c) C1s, (d) O1s, (e) S2p, (f) Si2p. 
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Figure AI-4: (a) High resolution XPS spectra for the CuNPs-2-MBZO nanoassembly; 
Corresponding elemental scans for: (b) Cu2p, (c) S2p, (d) C1s, (e) O1s, (f) Si2p. 
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Schematic representation of the sensors features extracted 
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